var title_f11_27_11696="Rash in erythema infectiosum";
var content_f11_27_11696=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F75125&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F75125&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Erythema infectiosum",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 383px; height: 252px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Reticulating pattern of an erythematous eruption on the extremities due to parvorvirus B19. Rash is more common in children. The presence of intense erythema (a slapped cheek appearance) on the face is highly characteristic.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Lee T Nesbitt, Jr. The Skin and Infection: A Color Atlas and Text, Sanders CV, Nesbitt LT Jr (Eds), Williams &amp; Wilkins, Baltimore, 1995.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_27_11696=[""].join("\n");
var outline_f11_27_11696=null;
var title_f11_27_11697="Tibolone: International drug information";
var content_f11_27_11697=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"16\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Tibolone: International drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F4369846\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Boltin (ES);",
"     </li>",
"     <li>",
"      Discretal (AR);",
"     </li>",
"     <li>",
"      Donna (BR);",
"     </li>",
"     <li>",
"      Libiam (BR);",
"     </li>",
"     <li>",
"      Lifar (CL);",
"     </li>",
"     <li>",
"      Livial (AU, BE, BR, CH, CL, DK, FI, FR, GB, GR, HK, IE, IN, IT, MX, MY, NL, NO, NZ, PT, SE, SG, TH);",
"     </li>",
"     <li>",
"      Liviel (AT);",
"     </li>",
"     <li>",
"      Liviella (DE);",
"     </li>",
"     <li>",
"      Livifern (ZA);",
"     </li>",
"     <li>",
"      Livolon (BR);",
"     </li>",
"     <li>",
"      Paraclim (AR);",
"     </li>",
"     <li>",
"      Tibofem (AR);",
"     </li>",
"     <li>",
"      Tinox (CL);",
"     </li>",
"     <li>",
"      Tobe (CL)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F2638203\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Estrogen and Progestin Combination",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block iuse drugH1Div\" id=\"F2638204\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Reported Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Prevention of postmenopausal osteoporosis; symptomatic treatment of hot flushes and associated sweating resulting from menopause (surgical or natural); improvement of bone mineral density in patients with established postmenopausal osteoporosis",
"    </p>",
"   </div>",
"   <div class=\"block idos drugH1Div\" id=\"F2638206\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Range",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adults: Female: Oral: 2.5 mg once daily; optimal results are obtained when therapy is continued for at least 3 months.",
"    </p>",
"   </div>",
"   <div class=\"block prod-avail drugH1Div\" id=\"F11821157\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Product Availability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Product available in various countries; not currently available in the U.S.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F2638207\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tablet: 2.5 mg",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10484 Version 28.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-83.177.194.223-77399545CD-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_27_11697=[""].join("\n");
var outline_f11_27_11697=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4369846\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2638203\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2638204\">",
"      Reported Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2638206\">",
"      Dosage Range",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11821157\">",
"      Product Availability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2638207\">",
"      Dosage Forms",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_INT/10484\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_INT/10484|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f11_27_11698="Small airway OSA MRI";
var content_f11_27_11698=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F74113&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F74113&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 611px\">",
"   <div class=\"ttl\">",
"    Reduced airway size in obstructive sleep apnea",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 591px; height: 236px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Comparison of an axial image at the minimum airway area (retropalatal region) of a normal subject (left) and a patient with sleep apnea (right). Note the smaller airway size and airway width in the patient with sleep apnea. In addition, the thickness of the lateral pharyngeal wall (distance between the airway and parapharyngeal fat pads) is larger in the patient with sleep apnea.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Richard J Schwab, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_27_11698=[""].join("\n");
var outline_f11_27_11698=null;
var title_f11_27_11699="SEER age adjusted rates thyroid cancer";
var content_f11_27_11699=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F67859&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F67859&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 521px\">",
"   <div class=\"ttl\">",
"    SEER age adjusted incidence rates by sex for thyroid cancer, all ages, all races SEER 9 registries for 1975-2003 age-adjusted to the 2000 US Std population",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 501px; height: 459px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov). SEER Stat Database: Incidence - SEER 9 Regs Public-Use, Nov 2005 Sub (1973-2003), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2006.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_27_11699=[""].join("\n");
var outline_f11_27_11699=null;
var title_f11_27_11700="Edrophonium and atropine: Drug information";
var content_f11_27_11700=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"11\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Edrophonium and atropine: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?0/57/916?source=see_link\">",
"    see \"Edrophonium and atropine: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F2527470\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Enlon-Plus&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F2527474\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Acetylcholinesterase Inhibitor;",
"     </li>",
"     <li>",
"      Anticholinergic Agent;",
"     </li>",
"     <li>",
"      Antidote",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F2527521\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Reversal of neuromuscular blockade: I.V.: 0.05-0.1 mL/kg given over 45-60 seconds. The dose delivered is 0.5-1 mg/kg of edrophonium and 0.007-0.014 mg/kg of atropine. An edrophonium dose of 1 mg/kg should rarely be exceeded.",
"     <b>",
"      Note:",
"     </b>",
"     Monitor closely for bradyarrhythmias.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F2527522\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F2527523\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adjustment not required.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F2527524\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adjustment not required.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F2527527\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Injection, solution:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Enlon-Plus&reg;: Edrophonium chloride 10 mg/mL and atropine sulfate 0.14 mg/mL (5 mL, 15 mL) [contains sodium sulfite; may contain natural rubber/natural latex in vial]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F2527472\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F2527475\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Reversal of nondepolarizing neuromuscular blockers; adjunct treatment of respiratory depression caused by curare overdose",
"    </p>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F2647258\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     See individual agents.",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F2527479\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to edrophonium, atropine, sulfites, or any component of the formulation; GI or GU obstruction. Atropine is contraindicated in acute glaucoma, adhesions (synechiae) between the iris and the lens of the eye, and pyloric stenosis.",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F2527480\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Anticholinesterase insensitivity: if patient becomes insensitive to the drug, reduce dose or discontinue edrophonium until patient sensitive again.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Respiratory arrest: Rare reports of respiratory arrest have occurred with edrophonium.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Tissue irritation: May cause tissue irritation if extravasated.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Arrhythmias: Use with caution in patients with cardiac arrhythmias (eg, bradyarrhythmias).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Asthma: Use with caution in patients with bronchial asthma.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Chronic lung disease: Use with caution in patients with chronic lung disease.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Prostatic hyperplasia: Use with caution in patients with prostatic hyperplasia.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Myasthenia gravis:  Avoid use in myasthenia gravis; may exacerbate muscular weakness.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concurrent drug therapy issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Anticholinergics: Consider additive adverse effects with concurrent use of atropine and other anticholinergics (eg, tricyclic antidepressants, antipsychotics, some antihistamines, anti-Parkinson drugs).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Atropine: Patients who are bradycardic or at risk of being bradycardic (eg, those on a beta-blocker or cardiovascular patients who received anesthesia with a narcotic and nitrous oxide only) should first receive atropine prior to edrophonium-atropine combination. Most arrhythmias occur within 2 minutes of administration and reverse shortly thereafter. Atropine should be available for immediate use in case of severe cholinergic reaction. Bradyarrhythmias respond to small doses of atropine.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Nondepolarizing muscle relaxants: Should not be administered before any nondepolarizing muscle relaxant.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Pediatrics: Safety and efficacy have not been established in children.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Dosage form specific issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Latex: Packaging (stopper) may contain natural rubber latex.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Sodium sulfite: Products may contain sodium sulfite.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299254\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F2527506\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     AbobotulinumtoxinA: Anticholinergic Agents may enhance the anticholinergic effect of AbobotulinumtoxinA.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Acetylcholinesterase Inhibitors (Central): Anticholinergics may diminish the therapeutic effect of Acetylcholinesterase Inhibitors (Central). Acetylcholinesterase Inhibitors (Central) may diminish the therapeutic effect of Anticholinergics. If the anticholinergic action is a side effect of the agent, the result may be beneficial.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Aclidinium: May enhance the anticholinergic effect of Anticholinergics.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Anticholinergics: May enhance the adverse/toxic effect of other Anticholinergics.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Levocabastine (Nasal).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Beta-Blockers: Acetylcholinesterase Inhibitors may enhance the bradycardic effect of Beta-Blockers.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Levobunolol; Metipranolol.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cannabinoids: Anticholinergic Agents may enhance the tachycardic effect of Cannabinoids.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cholinergic Agonists: Acetylcholinesterase Inhibitors may enhance the adverse/toxic effect of Cholinergic Agonists.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Corticosteroids (Systemic): May enhance the adverse/toxic effect of Acetylcholinesterase Inhibitors. Increased muscular weakness may occur.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Dipyridamole: May diminish the therapeutic effect of Acetylcholinesterase Inhibitors.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ipratropium (Oral Inhalation): May enhance the anticholinergic effect of Anticholinergics.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mirabegron: Anticholinergic Agents may enhance the therapeutic effect of Mirabegron. This may result in acute urinary retention.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Neuromuscular-Blocking Agents (Nondepolarizing): Acetylcholinesterase Inhibitors may diminish the neuromuscular-blocking effect of Neuromuscular-Blocking Agents (Nondepolarizing).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     OnabotulinumtoxinA: Anticholinergic Agents may enhance the anticholinergic effect of OnabotulinumtoxinA.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Potassium Chloride: Anticholinergic Agents may enhance the ulcerogenic effect of Potassium Chloride.  Management: Patients on drugs with substantial anticholinergic effects should avoid using any solid oral dosage form of potassium chloride.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pramlintide: May enhance the anticholinergic effect of Anticholinergics. These effects are specific to the GI tract.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     RimabotulinumtoxinB: Anticholinergic Agents may enhance the anticholinergic effect of RimabotulinumtoxinB.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Secretin: Anticholinergic Agents may diminish the therapeutic effect of Secretin.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Succinylcholine: Acetylcholinesterase Inhibitors may increase the serum concentration of Succinylcholine.  Management: Consider alternatives to this combination due to a risk of prolonged neuromuscular blockade.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tiotropium: Anticholinergics may enhance the anticholinergic effect of Tiotropium.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Topiramate: Anticholinergic Agents may enhance the adverse/toxic effect of Topiramate. Specifically, the risk of oligohidrosis and hyperthermia may be enhanced.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F2527476\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F2527477\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     See Atropine monograph.",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F2527478\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     See Atropine monograph.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F16322935\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Enlon-Plus Intravenous)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     10-0.14 mg/mL (5 mL): $13.75",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F2527526\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Vital signs, ECG, and ventilatory support; neuromuscular function",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F2527510\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Edrophonium: Inhibits destruction of acetylcholine by acetylcholinesterase. This facilitates transmission of impulses across myoneural junction and results in increased cholinergic response.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Atropine: Minimizes or prevents the muscarinic cholinergic effects caused by edrophonium (eg, bradycardia, bronchocontriction, and increased secretions).",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F2527512\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     See individual agents.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Onset of action: Edrophonium: Antagonism of nondepolarizing muscle relaxants: 3 minutes; Atropine: Heart rate: Immediate",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Duration: Edrophonium: Antagonism of nondepolarizing muscle relaxants: 70 minutes; Atropine: Heart rate: 170 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Protein binding: Atropine: 14%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Half-life elimination: Edrophonium: Adults: 1.2-2.4 hours; Anephric patients: 2.4-4.4 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Time to peak, plasma: Edrophonium: Antagonism of nondepolarizing muscle relaxants: 1.2 minutes; Atropine: Heart rate: 2-16 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Excretion: Edrophonium: Primarily urine (67%)",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9015 Version 31.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-122.72.76.133-A3347AB727-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_27_11700=[""].join("\n");
var outline_f11_27_11700=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2527470\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2527474\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2527521\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2527522\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2527523\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2527524\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2527527\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2527472\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2527475\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2647258\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2527479\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2527480\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299254\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2527506\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2527476\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2527477\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2527478\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16322935\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2527526\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2527510\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2527512\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9015\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9015|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?0/57/916?source=related_link\">",
"      Edrophonium and atropine: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f11_27_11701="Serum cardiac enzymes in patients with renal failure";
var content_f11_27_11701=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"topicTitle\">",
"   Serum cardiac enzymes in patients with renal failure",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/27/11701/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/27/11701/contributors\">",
"     William L Henrich, MD, MACP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/27/11701/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/27/11701/contributors\">",
"     Jeffrey S Berns, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/27/11701/contributors\">",
"     Allan S Jaffe, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/27/11701/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/27/11701/contributors\">",
"     Alice M Sheridan, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?11/27/11701/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 20, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Levels of cardiac enzymes are principally utilized to help assess the presence or absence of acute myocardial injury. Abnormal elevations in the serum concentrations of these enzymes may be the key diagnostic element in determining admission to the hospital",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    coronary care units. They are also increasingly being used as predictive markers for short- and long-term adverse outcomes, particularly among those presenting with acute coronary syndromes. The principal cardiac enzymes are cardiac troponin T (cTnT), cardiac troponin I (cTnI), and the MB isoenzyme of creatine kinase (CK-MB). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/38/39530?source=see_link\">",
"     \"Troponins and creatine kinase as biomarkers of cardiac injury\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Coronary artery disease is highly prevalent in patients with end-stage renal disease (ESRD). As a result, the accurate interpretation of serum concentrations of these enzymes is extremely important. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/49/33559?source=see_link\">",
"     \"Clinical manifestations and diagnosis of coronary heart disease in end-stage renal disease (dialysis)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Issues relating to the clinical use of cardiac troponins and CK-MB in patients with renal failure are presented in this topic review. Their use in patients with normal renal function and the effect of renal failure on hepatic and pancreatic enzymes are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/38/39530?source=see_link\">",
"     \"Troponins and creatine kinase as biomarkers of cardiac injury\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/38/33381?source=see_link\">",
"     \"Serum enzymes in patients with renal failure\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     TROPONINS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cardiac troponins I and T are cardiac regulatory proteins that control the calcium-mediated interaction of actin and myosin. Because of their increased specificity compared with CK-MB and other markers, serum troponins are the preferred marker for the diagnosis of myocardial injury among patients with",
"    <strong>",
"     normal",
"    </strong>",
"    renal function. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/38/39530?source=see_link\">",
"     \"Troponins and creatine kinase as biomarkers of cardiac injury\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Elevated values in asymptomatic patients",
"    </span>",
"    &nbsp;&mdash;&nbsp;The appropriate use of these enzymes in patients with renal insufficiency is less clear, since elevations in serum troponins are commonly observed in patients with renal insufficiency who do not have clinical evidence of myocardial damage [",
"    <a class=\"abstract\" href=\"UTD.htm?11/27/11701/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. Although newer assays are somewhat more accurate, these tests also demonstrate increased troponin levels, particularly cTnT, in those without myocardial necrosis.",
"   </p>",
"   <p>",
"    In the largest study of 733 asymptomatic patients with ESRD, an extremely high percentage had increased troponin levels, despite the use of the latest generation assays [",
"    <a class=\"abstract\" href=\"UTD.htm?11/27/11701/abstract/3\">",
"     3",
"    </a>",
"    ]; the percentages varied markedly with the utilization of different cutoff criteria:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The use of cutoff values that were greater than that observed among 99 percent of a general reference population (which were defined as 0.01 and 0.1",
"      <span class=\"nowrap\">",
"       mcg/L",
"      </span>",
"      for cTnT and cTnI, respectively) resulted in 82 and 6 percent of dialysis patients with increases in cTnT and cTnI values, respectively.",
"     </li>",
"     <li>",
"      The use of the lowest values to give 10 percent imprecision (which were 0.03 and 0.5",
"      <span class=\"nowrap\">",
"       mcg/L",
"      </span>",
"      for cTnT and cTnI, respectively) resulted in 53 and 1 percent of patients defined as having increased values, respectively.",
"     </li>",
"     <li>",
"      The use of values that had been optimized for detection of myocardial infarction (which were 0.1 and 0.6",
"      <span class=\"nowrap\">",
"       mcg/L",
"      </span>",
"      for cTnT and cTnI, respectively) resulted in 20 and 0.4 percent of dialysis patients having increased values, respectively.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The exact mechanisms underlying these increased levels are unclear [",
"    <a class=\"abstract\" href=\"UTD.htm?11/27/11701/abstract/1\">",
"     1",
"    </a>",
"    ]. Possible reasons include elevations of troponin with left ventricular hypertrophy, endothelial dysfunction, loss of membrane integrity with leakage of the free cytosolic troponin pool, stretch-mediated troponin release, myocardial stunning, and impaired renal excretion [",
"    <a class=\"abstract\" href=\"UTD.htm?11/27/11701/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. The finding that cTnT is more frequently elevated than cTnI among asymptomatic patients with renal insufficiency may be due to the relatively higher levels of an unbound cytosolic pool of cTnT and its higher molecular weight [",
"    <a class=\"abstract\" href=\"UTD.htm?11/27/11701/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    These observations illustrate the difficulty in accurately interpreting elevations in cardiac troponins, particularly cTnT, in patients with renal insufficiency. Despite this, the measurement of specific forms of troponin may provide clinically useful information in this patient population:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Serial elevations in troponins may be diagnostically accurate in patients with suspected myocardial infarction.",
"     </li>",
"     <li>",
"      Elevations in serum troponins may be highly prognostic for both short-term and long-term outcomes in asymptomatic patients as well as those presenting with suspected myocardial ischemia.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Use in prognosis",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Asymptomatic patients",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is increasing evidence that elevations in serum troponin levels in stable asymptomatic patients with ESRD are predictive of worse long-term cardiovascular outcomes and poor survival [",
"    <a class=\"abstract\" href=\"UTD.htm?11/27/11701/abstract/7-18\">",
"     7-18",
"    </a>",
"    ]. A 2005 meta-analysis of 28 studies consisting of 3931 asymptomatic dialysis patients noted that elevated cTnT levels were associated with a poor prognosis [",
"    <a class=\"abstract\" href=\"UTD.htm?11/27/11701/abstract/14\">",
"     14",
"    </a>",
"    ]. At a mean follow-up of 23 months, increased cTnT levels (defined as &gt;0.1",
"    <span class=\"nowrap\">",
"     ng/mL)",
"    </span>",
"    were associated an increased mortality risk (RR of 2.67, 95% CI 2.17-3.20). Conclusions related to increased cTnI levels could not be performed due to the wide variety of assays and different cut points.",
"   </p>",
"   <p>",
"    The reasons for the association between elevated levels of troponins and a poor prognosis among asymptomatic patients with ESRD are unknown. Some reported associations include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A correlation between increased troponin levels and diffuse coronary artery disease in this patient population has been reported [",
"      <a class=\"abstract\" href=\"UTD.htm?11/27/11701/abstract/9,18,19\">",
"       9,18,19",
"      </a>",
"      ]. A similar association has been reported in asymptomatic patients with chronic kidney disease who are not dialysis-dependent [",
"      <a class=\"abstract\" href=\"UTD.htm?11/27/11701/abstract/20\">",
"       20",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a study of 70 hemodialysis patients, cTnT levels correlated with the severity of hemodialysis-induced postischemic dysfunction or myocardial stunning (defined as &gt;20 percent reduction in segmental wall motion at peak stress during dialysis compared with wall motion at rest with evidence of recovery after dialysis) [",
"      <a class=\"abstract\" href=\"UTD.htm?11/27/11701/abstract/5\">",
"       5",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?25/61/26584?source=see_link&amp;anchor=H9#H9\">",
"       \"Myocardial dysfunction in end-stage renal disease\", section on 'Overview'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      In a study of dialysis patients on the kidney transplant wait list, increased cTnT levels correlated with abnormal echocardiographic findings and decreased survival [",
"      <a class=\"abstract\" href=\"UTD.htm?11/27/11701/abstract/17\">",
"       17",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Acute coronary syndromes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Elevations in cTnT levels may also be highly prognostic for both short-term and long-term outcomes among patients with renal insufficiency who present with acute coronary syndromes. As an example, serum cTnT and the creatinine clearance were evaluated in patients with acute coronary syndromes enrolled in the GUSTO-IV trial [",
"    <a class=\"abstract\" href=\"UTD.htm?11/27/11701/abstract/21\">",
"     21",
"    </a>",
"    ]. Elevated cTnT independently predicted short-term prognosis in all patients. Patients with a creatinine clearance &ge;58.4",
"    <span class=\"nowrap\">",
"     mL/min",
"    </span>",
"    and an elevated cTnT had a small but significant increased risk of myocardial infarction or death compared to those with a comparable creatinine clearance and no cTnT elevation (7 versus 5 percent). Similarly, patients with a creatinine clearance in the lowest quartile and an elevated cTnT had an increased risk of the same outcomes (20 versus 9 percent).",
"   </p>",
"   <p>",
"    An important limitation of this study was that most patients had mild to moderate renal dysfunction. Only 25 percent had a creatinine clearance below 58",
"    <span class=\"nowrap\">",
"     mL/min",
"    </span>",
"    and only 2 percent had values below 10",
"    <span class=\"nowrap\">",
"     mL/min.",
"    </span>",
"    Thus, it is uncertain if these results apply to patients with an acute coronary syndrome who have ESRD.",
"   </p>",
"   <p>",
"    Elevations in cTnI levels among patients presenting with possible acute MI and renal dysfunction also identify a population at increased risk for adverse events [",
"    <a class=\"abstract\" href=\"UTD.htm?11/27/11701/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Use for diagnosis of MI",
"    </span>",
"    &nbsp;&mdash;&nbsp;When used as a possible marker for acute myocardial infarction, a number of studies have reported a large percentage of false positive elevations of serum cTnT in patients with ESRD [",
"    <a class=\"abstract\" href=\"UTD.htm?11/27/11701/abstract/3,23-26\">",
"     3,23-26",
"    </a>",
"    ]. In the large study cited above, 82 percent of asymptomatic dialysis patients had elevated cTnT levels when the cutoff value was 0.01",
"    <span class=\"nowrap\">",
"     mcg/L",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?11/27/11701/abstract/3\">",
"     3",
"    </a>",
"    ]. The elevations may also be quite marked, with levels being 14 times above normal in one patient [",
"    <a class=\"abstract\" href=\"UTD.htm?11/27/11701/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, the exact percentage of patients with elevated cTnT levels depends to a large degree on the exact population studied, and the specific assay and cutoff value used. As an example, the Enzymum assay for cTnT may be associated with a lower false positive rate for acute myocardial infarction compared with the first generation enzyme-linked immunoassay (ELISA) (17 versus 71 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/27/11701/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    By comparison, serum cTnI is less likely to be associated with false elevations in patients with end-stage renal disease and suspected myocardial damage [",
"    <a class=\"abstract\" href=\"UTD.htm?11/27/11701/abstract/3,23,24,28-32\">",
"     3,23,24,28-32",
"    </a>",
"    ]. As examples:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The enhanced accuracy of cTnI for the detection of myocardial damage was confirmed in a prospective study of 56 patients with renal failure and suspected recent myocardial infarction [",
"      <a class=\"abstract\" href=\"UTD.htm?11/27/11701/abstract/25\">",
"       25",
"      </a>",
"      ]. Nonenzymatic determination of the presence or absence of new myocardial damage was assessed via the history, physical examination, electrocardiography, and, if clinically indicated, echocardiography, nuclear imaging,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      coronary angiography. Positive tests were defined as greater than 0.8",
"      <span class=\"nowrap\">",
"       mcg/L",
"      </span>",
"      for cTnI and more than 5 percent for CK-MB when total CK levels were elevated. The sensitivity and specificity for the detection of myocardial injury was 94 and 100 percent for cTnI, respectively, compared to only 44 and 56 percent for CK-MB.",
"     </li>",
"     <li>",
"      The diagnostic accuracy of cTnI, CK-MB, and myoglobin was evaluated in a prospective study of 817 consecutive patients with possible acute MI [",
"      <a class=\"abstract\" href=\"UTD.htm?11/27/11701/abstract/32\">",
"       32",
"      </a>",
"      ]. Patients were not excluded due to renal dysfunction. Stratification of patients into quartiles by creatinine clearance was performed, with the fifth group being 51 dialysis patients. cTnI levels were independent of measures of renal function, while CK-MB and myoglobin levels correlated with creatinine clearance. No trend in false positive elevations of cTnI was observed.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     CREATINE KINASE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Plasma concentrations of total CK are elevated in approximately 30 to 70 percent of dialysis patients [",
"    <a class=\"abstract\" href=\"UTD.htm?11/27/11701/abstract/33,34\">",
"     33,34",
"    </a>",
"    ]. The underlying reasons for this increase are probably multifactorial; these include a skeletal myopathy, intramuscular injections, deficiencies of vitamin D or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?21/16/21766?source=see_link\">",
"     carnitine",
"    </a>",
"    , muscle trauma, and reduced clearance [",
"    <a class=\"abstract\" href=\"UTD.htm?11/27/11701/abstract/33-36\">",
"     33-36",
"    </a>",
"    ]. Among patients with ESRD, elevations of total CK are usually",
"    <strong>",
"     less than three times",
"    </strong>",
"    the upper limit of normal.",
"   </p>",
"   <p>",
"    CK isoenzymes consist of dimers of M and B chains; as a result, three isoenzymes are found: CK-MM, CK-MB, and CK-BB [",
"    <a class=\"abstract\" href=\"UTD.htm?11/27/11701/abstract/37\">",
"     37",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/38/39530?source=see_link\">",
"     \"Troponins and creatine kinase as biomarkers of cardiac injury\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     CK-MB fraction",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the absence of ESRD and acute myocardial damage, less than 5 percent of total CK is present as the MB fraction. With myocardial injury, the fraction of CK-MB among patients without renal failure rises beyond this level in a well-described temporal pattern. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/38/39530?source=see_link\">",
"     \"Troponins and creatine kinase as biomarkers of cardiac injury\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    However, approximately 30 to 50 percent of dialysis patients without evidence of myocardial injury exhibit an elevation in the MB fraction (defined as greater than 5 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/27/11701/abstract/23,28,34,37\">",
"     23,28,34,37",
"    </a>",
"    ]. The percentage is even higher among those with elevations of total CK. As an example, one longitudinal study of 18 stable hemodialysis patients found that 72 percent had at least one elevated level of total CK [",
"    <a class=\"abstract\" href=\"UTD.htm?11/27/11701/abstract/34\">",
"     34",
"    </a>",
"    ]. More than 80 percent of these individuals also had at least one increased fraction of CK-MB.",
"   </p>",
"   <p>",
"    Although usually elevated, the CK-MB fraction is usually",
"    <strong>",
"     less",
"    </strong>",
"    than 8 percent among dialysis patients without evidence of myocardial injury. Thus, interpretation of an elevation of CK-MB alone in dialysis patients with atypical chest pain is not reliable.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Other CK isoenzymes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Increased serum levels of CK-MM and CK-BB are not used in diagnosing myocardial damage in patients with or without renal failure; however, elevations in these isoenzymes may suggest other conditions, such as a myopathy with increased values for CK-MM:",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     CK-MM",
"    </span>",
"    &nbsp;&mdash;&nbsp;The levels of CK-MM are increased in a significant percentage of dialysis patients. Possible etiologies include myopathy, hepatitis, and deficiencies of vitamin D",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?21/16/21766?source=see_link\">",
"     carnitine",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?11/27/11701/abstract/33-36\">",
"     33-36",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     CK-BB",
"    </span>",
"    &nbsp;&mdash;&nbsp;In a review of patients with chronic renal failure, CK-BB was universally present in the serum of 13 of 14 peritoneal dialysis patients, all 60 hemodialysis patients, and nearly all of those with a serum creatinine concentration 4.5",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (398",
"    <span class=\"nowrap\">",
"     &micro;mol/L)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?11/27/11701/abstract/38\">",
"     38",
"    </a>",
"    ]. By comparison, serum CK-BB was absent in nine patients with acute renal failure (eight of whom needed dialysis) and in 10 renal transplant patients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Use in prognosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although not currently part of the routine evaluation, consideration may be given to measurement of serum troponin levels, particularly cTnT, among asymptomatic patients with end stage renal disease as it may provide significant prognostic information [",
"    <a class=\"abstract\" href=\"UTD.htm?11/27/11701/abstract/1,3,39\">",
"     1,3,39",
"    </a>",
"    ]. Further study is required to determine whether a more aggressive approach to treatment should be employed among asymptomatic patients with ESRD and elevated cTnT and (possibly) C-reactive protein levels.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Use for diagnosis of MI",
"    </span>",
"    &nbsp;&mdash;&nbsp;Determination of myocardial injury in dialysis patients using CK-MB and cTnT (ELISA method) alone is often associated with false positive results, possibly leading to unnecessary hospitalization of a significant number of patients. The most specific marker for myocardial damage among patients with ESRD appears to be serial measurements of cTnI. There is no established role for the use of cTnT measurement in the diagnosis of myocardial infarction in patients with chronic kidney disease.",
"   </p>",
"   <p>",
"    We recommend serial measurements of cTnI or, if not available, cTnT, and CK-MB to help determine the presence or absence of myocardial injury among patients suspected of an acute myocardial infarction. A clinically appropriate sequential rise in these values may be most consistent with acute myocardial necrosis in patients with renal failure [",
"    <a class=\"abstract\" href=\"UTD.htm?11/27/11701/abstract/1\">",
"     1",
"    </a>",
"    ]. By comparison, the finding of elevated but unchanging values is less consistent with new myocardial damage.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11701/abstract/1\">",
"      Freda BJ, Tang WH, Van Lente F, et al. Cardiac troponins in renal insufficiency: review and clinical implications. J Am Coll Cardiol 2002; 40:2065.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11701/abstract/2\">",
"      Robitaille R, Lafrance JP, Leblanc M. Altered laboratory findings associated with end-stage renal disease. Semin Dial 2006; 19:373.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11701/abstract/3\">",
"      Apple FS, Murakami MM, Pearce LA, Herzog CA. Predictive value of cardiac troponin I and T for subsequent death in end-stage renal disease. Circulation 2002; 106:2941.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11701/abstract/4\">",
"      Diris JH, Hackeng CM, Kooman JP, et al. Impaired renal clearance explains elevated troponin T fragments in hemodialysis patients. Circulation 2004; 109:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11701/abstract/5\">",
"      Breidthardt T, Burton JO, Odudu A, et al. Troponin T for the detection of dialysis-induced myocardial stunning in hemodialysis patients. Clin J Am Soc Nephrol 2012; 7:1285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11701/abstract/6\">",
"      Hamm CW, Giannitsis E, Katus HA. Cardiac troponin elevations in patients without acute coronary syndrome. Circulation 2002; 106:2871.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11701/abstract/7\">",
"      Dierkes J, Domr&ouml;se U, Westphal S, et al. Cardiac troponin T predicts mortality in patients with end-stage renal disease. Circulation 2000; 102:1964.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11701/abstract/8\">",
"      Deegan PB, Lafferty ME, Blumsohn A, et al. Prognostic value of troponin T in hemodialysis patients is independent of comorbidity. Kidney Int 2001; 60:2399.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11701/abstract/9\">",
"      deFilippi C, Wasserman S, Rosanio S, et al. Cardiac troponin T and C-reactive protein for predicting prognosis, coronary atherosclerosis, and cardiomyopathy in patients undergoing long-term hemodialysis. JAMA 2003; 290:353.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11701/abstract/10\">",
"      Wood GN, Keevil B, Gupta J, et al. Serum troponin T measurement in patients with chronic renal impairment predicts survival and vascular disease: a 2 year prospective study. Nephrol Dial Transplant 2003; 18:1610.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11701/abstract/11\">",
"      Boulier A, Jaussent I, Terrier N, et al. Measurement of circulating troponin Ic enhances the prognostic value of C-reactive protein in haemodialysis patients. Nephrol Dial Transplant 2004; 19:2313.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11701/abstract/12\">",
"      Iliou MC, Fumeron C, Benoit MO, et al. Prognostic value of cardiac markers in ESRD: Chronic Hemodialysis and New Cardiac Markers Evaluation (CHANCE) study. Am J Kidney Dis 2003; 42:513.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11701/abstract/13\">",
"      Conway B, McLaughlin M, Sharpe P, Harty J. Use of cardiac troponin T in diagnosis and prognosis of cardiac events in patients on chronic haemodialysis. Nephrol Dial Transplant 2005; 20:2759.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11701/abstract/14\">",
"      Khan NA, Hemmelgarn BR, Tonelli M, et al. Prognostic value of troponin T and I among asymptomatic patients with end-stage renal disease: a meta-analysis. Circulation 2005; 112:3088.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11701/abstract/15\">",
"      Havekes B, van Manen JG, Krediet RT, et al. Serum troponin T concentration as a predictor of mortality in hemodialysis and peritoneal dialysis patients. Am J Kidney Dis 2006; 47:823.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11701/abstract/16\">",
"      Wang AY, Lam CW, Yu CM, et al. Troponin T, left ventricular mass, and function are excellent predictors of cardiovascular congestion in peritoneal dialysis. Kidney Int 2006; 70:444.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11701/abstract/17\">",
"      Hickson LJ, Cosio FG, El-Zoghby ZM, et al. Survival of patients on the kidney transplant wait list: relationship to cardiac troponin T. Am J Transplant 2008; 8:2352.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11701/abstract/18\">",
"      Hayashi T, Obi Y, Kimura T, et al. Cardiac troponin T predicts occult coronary artery stenosis in patients with chronic kidney disease at the start of renal replacement therapy. Nephrol Dial Transplant 2008; 23:2936.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11701/abstract/19\">",
"      Jung HH, Ma KR, Han H. Elevated concentrations of cardiac troponins are associated with severe coronary artery calcification in asymptomatic haemodialysis patients. Nephrol Dial Transplant 2004; 19:3117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11701/abstract/20\">",
"      Goicoechea M, Garca de Vinuesa S, G&oacute;mez-Campder&aacute; F, et al. Clinical significance of cardiac troponin T levels in chronic kidney disease patients: predictive value for cardiovascular risk. Am J Kidney Dis 2004; 43:846.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11701/abstract/21\">",
"      Aviles RJ, Askari AT, Lindahl B, et al. Troponin T levels in patients with acute coronary syndromes, with or without renal dysfunction. N Engl J Med 2002; 346:2047.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11701/abstract/22\">",
"      Kontos MC, Garg R, Anderson FP, et al. Outcomes in patients admitted for chest pain with renal failure and troponin I elevations. Am Heart J 2005; 150:674.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11701/abstract/23\">",
"      McLaurin MD, Apple FS, Voss EM, et al. Cardiac troponin I, cardiac troponin T, and creatine kinase MB in dialysis patients without ischemic heart disease: evidence of cardiac troponin T expression in skeletal muscle. Clin Chem 1997; 43:976.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11701/abstract/24\">",
"      Haller C, Stevanovich A, Katus HA. Are cardiac troponins reliable serodiagnositic markers of cardiac ischaemia in end-stage renal disease? Nephrol Dial Transplant 1996; 11:941.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11701/abstract/25\">",
"      Martin GS, Becker BN, Schulman G. Cardiac troponin-I accurately predicts myocardial injury in renal failure. Nephrol Dial Transplant 1998; 13:1709.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11701/abstract/26\">",
"      Hafner G, Thome-Kromer B, Schaube J, et al. Cardiac troponins in serum in chronic renal failure. Clin Chem 1994; 40:1790.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11701/abstract/27\">",
"      Bhayana V, Gougoulias T, Cohoe S, Henderson AR. Discordance between results for serum troponin T and troponin I in renal disease. Clin Chem 1995; 41:312.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11701/abstract/28\">",
"      Adams JE 3rd, Bodor GS, D&aacute;vila-Rom&aacute;n VG, et al. Cardiac troponin I. A marker with high specificity for cardiac injury. Circulation 1993; 88:101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11701/abstract/29\">",
"      Hafner G, Thome-Kromer B, Schaube J, et al. Cardiac troponins in serum in chronic renal failure. Clin Chem 1994; 40:1790.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11701/abstract/30\">",
"      Frankel WL, Herold DA, Ziegler TW, Fitzgerald RL. Cardiac troponin T is elevated in asymptomatic patients with chronic renal failure. Am J Clin Pathol 1996; 106:118.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11701/abstract/31\">",
"      McLaurin MD, Apple FS, Falahati A, et al. Cardiac troponin I and creatine kinase-MB mass to rule out myocardial injury in hospitalized patients with renal insufficiency. Am J Cardiol 1998; 82:973.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11701/abstract/32\">",
"      McCullough PA, Nowak RM, Foreback C, et al. Performance of multiple cardiac biomarkers measured in the emergency department in patients with chronic kidney disease and chest pain. Acad Emerg Med 2002; 9:1389.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11701/abstract/33\">",
"      Soffer O, Fellner SK, Rush RL. Creatine phosphokinase in long-term dialysis patients. Arch Intern Med 1981; 141:181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11701/abstract/34\">",
"      Green TR, Golper TA, Swenson RD, et al. Diagnostic value of creatine kinase and creatine kinase MB isoenzyme in chronic hemodialysis patients: a longitudinal study. Clin Nephrol 1986; 25:22.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11701/abstract/35\">",
"      DiMauro S, DiMauro PM. Muscle carnitine palmityltransferase deficiency and myoglobinuria. Science 1973; 182:929.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11701/abstract/36\">",
"      Bohmer T, Bergrem H, Eiklid K. Carnitine deficiency induced during intermittent haemodialysis for renal failure. Lancet 1978; 1:126.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11701/abstract/37\">",
"      Apple FS, Sharkey SW, Hoeft P, et al. Prognostic value of serum cardiac troponin I and T in chronic dialysis patients: a 1-year outcomes analysis. Am J Kidney Dis 1997; 29:399.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11701/abstract/38\">",
"      Weseley SA, Byrnes A, Alter S, et al. Presence of creatine phosphokinase brain band in the serum of chronic renal disease patients. Clin Nephrol 1977; 8:345.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11701/abstract/39\">",
"      K/DOQI Workgroup. K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis 2005; 45:S1.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1920 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"footerNav\">",
"   <ul>",
"    <li>",
"     <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"      Wolters Kluwer Health",
"     </a>",
"    </li>",
"    <li>",
"     <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"      Facts &amp; Comparisons&reg;",
"     </a>",
"    </li>",
"    <li>",
"     <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"      Medi-Span&reg;",
"     </a>",
"    </li>",
"    <li>",
"     <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"      ProVation&reg; Order Sets",
"     </a>",
"    </li>",
"    <li>",
"     <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"      ProVation&reg; Medical",
"     </a>",
"    </li>",
"    <li>",
"     <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"      Pharmacy OneSource&reg;",
"     </a>",
"    </li>",
"    <li>",
"     <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"      Medicom",
"     </a>",
"    </li>",
"    <li>",
"     <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"      Lexicomp",
"     </a>",
"    </li>",
"    <li class=\"last\">",
"     <a href=\"/home/privacy-policy\">",
"      Privacy Policy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <div id=\"footerLogo\">",
"   <a href=\"./toc\">",
"    Wolters Kluwer Health | UpToDate",
"   </a>",
"  </div>",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"sfInfo\">",
"    <a href=\"/home/terms-use\">",
"     Terms of Use",
"    </a>",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     UpToDate Marketing Professional",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-85.214.214.87-757A43BAE4-14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_27_11701=[""].join("\n");
var outline_f11_27_11701=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H13\" id=\"summRecButton\">",
"      <span>",
"       RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      TROPONINS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Elevated values in asymptomatic patients",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Use in prognosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Asymptomatic patients",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Acute coronary syndromes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Use for diagnosis of MI",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      CREATINE KINASE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      CK-MB fraction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Other CK isoenzymes",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - CK-MM",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - CK-BB",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Use in prognosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Use for diagnosis of MI",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/49/33559?source=related_link\">",
"      Clinical manifestations and diagnosis of coronary heart disease in end-stage renal disease (dialysis)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/61/26584?source=related_link\">",
"      Myocardial dysfunction in end-stage renal disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/38/33381?source=related_link\">",
"      Serum enzymes in patients with renal failure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/38/39530?source=related_link\">",
"      Troponins and creatine kinase as biomarkers of cardiac injury",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f11_27_11702="Stage III PBC - low power";
var content_f11_27_11702=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F50803&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F50803&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Stage III PBC in a 40-year-old woman (low power, Masson trichrome)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 274px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Bridging fibrosis and early nodule formation are present.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Marshall M. Kaplan, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_27_11702=[""].join("\n");
var outline_f11_27_11702=null;
var title_f11_27_11703="Dermoscopy seborrheic keratosis";
var content_f11_27_11703=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F78870&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F78870&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 569px\">",
"   <div class=\"ttl\">",
"    Dermoscopy of seborrheic keratosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 549px; height: 488px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAHoAiUDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6I8aeKrfwpZ2M9xY3t895c/ZYobTy95by5JCSZHRQAsTd/SucX4n7olkHg/xLsbkHdY/y+0034zIsqeEEkYqh1o7iPT7Fd5rndC0j+338Vaje+I9U0ix0y88hYrRLby44VtIJSx8yF2JzI5PPpxUOTvZG0YR5OaV9zpj8TSuM+D/EvP8At2P/AMk0n/Czj/0J/iX/AL7sf/kmuL+F8Wi/EnTb290Hxb4wh+yTCKWG8h09JBlQVbCwMNp5xz/CeKTwddz6j4S0S8vJDJcXFlBNM+ANzNGpJwOBkntUTnOO9jSnSp1Nrna/8LNOP+RP8S/992P/AMk07/hZTH/mTvEn/fdj/wDJNYCuFc5PJqwO3TnpUe2kaPCxXc2B8SnPTwd4l/77sf8A5Jo/4WU//QneJP8Avux/+SayUGFIY5NMJ2nqSD09qPayF9WgbH/Cym/6E7xJ/wB92P8A8k0D4lsSceDvEnH+3Y//ACTWTgbM80gGFwBT9rIPq8PM2B8SnOceDvEvH+3Y/wDyTSf8LKb/AKE7xJ/33Y//ACTWSxyMU3GDgDmj2sg+rw7mz/wsp/8AoTvEn/fdj/8AJNH/AAsp/wDoTvEn/fdj/wDJNYxYA8jBpiSeYeOnrS9s0H1aJt/8LKf/AKE7xL/33Y//ACTTW+J+04Pg/wASD/gdj/8AJNZLY7niqk+1mPPApSrSS0KjhYPudCPidnp4P8Sf992P/wAk0v8AwsxjnHg/xJx/t2P/AMk1y2GABUP1/OrcT5XGDmiNaT3HLCQXU6AfEpj08HeJP++7H/5Jo/4WU/8A0J3iT/vux/8AkmsQuBgd6FcdB1qvasj6tE3P+Fkv/wBCd4k/77sf/kmkPxJcf8yd4k/77sf/AJJrHVuPekZypyBwexp+1ZP1eJs/8LKf/oTvEv8A33Y//JNIfiYwxnwd4k/77sf/AJJrGRt5wePah0LDHFHtWP6vE2P+Fmn/AKE/xJ/33Y//ACTR/wALNP8A0J/iX/vux/8AkmsIRnB7mnEDGM89xS9rIf1aBsn4ngf8yh4k/wC+7H/5Jp3/AAs0/wDQn+JP++7H/wCSa551C7iBSIcnjJ7/AEo9rIr6rDuzo/8AhZbf9Cd4l/77sf8A5Jpp+J2CQfB/iTI/27H/AOSaxRJuHynkUScc4GT3FHtZdCfq0Vvc2h8Tj/0J/iX/AL6sf/kmnr8SXZQy+DvEhB5B32P/AMk1gxnseQeDmpQfLZSFDpn7ppqo2J4eKNlPiS7kBfB3iUk/7dj/APJNKfiQ6nB8HeJAcZ+/Y/8AyTWKrgfMz9GA2gcgU93/AHy4XCe/pmr52L2ETWX4lM33fB/iQn032P8A8k1s+EfGEXiPUNQsv7K1PTLqyihmdL3yTvSUyBSpikcdYnznHauNcMjspOAORnir/wAOCT4/8Tlt2f7M03r/ANdb2nGTbIqUoxjdEk/xWtEvLyC38N+ILpbW5mtGmi+yBHeKRo2K751bG5DjIFRn4swj/mUvEv52X/yTXmk4ld7yC3uZbV7nxTNaNNEFLokurNGxXcGXO1zjINSeKRoXh7WtesLjVvH1yNEihnv7m2TS/KiSUDacNGrN1wcKTSvJ7E8sI25rnpA+K8R6eEvEn52X/wAk0v8AwtaL/oUvEn/fVl/8k1xeu6N/wj2t6CllrWqalY6np9zc7L5IAVKNbbCvlxIRxM2Qc9qcrHGcfnUynKLsy40oSV0dj/wteHOP+ES8SZ/3rL/5JoPxYhH/ADKXiT/vqy/+Sa4oM27I5BpzkDrip9qx+widn/wtiHH/ACKXiT87L/5Jo/4WxD/0KXiT87L/AOSa4h3x0pQxI9qaqsfsIna/8LZh/wChS8S/nZf/ACTR/wALYh/6FLxJ+dl/8k1xJbionmCJgEnHHPNL2rW4ewT2O6b4t269fCfiT87L/wCSaQ/Fy2HXwp4k/Oy/+Sa85F7C7SIrqzj7wB6VBJcqG5kUD3NZPFNGqwafc9M/4W7bf9Cp4k/Oy/8AkmlHxctj08KeJPzsv/kmvOIblHxzz2OOtTg/7XQdqpYhvYTwsV3PQP8Ahblv/wBCn4k/Oy/+SaP+Ft2//Qp+Jfzsv/kmuBEnSpozhfpT9tIl4aKO5/4W3AR/yKfiX87L/wCSaP8AhbUH/Qp+JPzsv/kmuGDEtwOKXgg5NHtpC+rxO4PxagH/ADKfiT87L/5Jo/4W3b/9Cn4k/Oy/+Sa4Zm2jJxz61C82w5yCtJ12ilhYs7//AIW3b4z/AMIn4l/Oy/8Akmk/4W5bnH/FJ+JOfey/+Sa4ETqQQMfnUsTK6dQSKPrDH9Vit7ndf8Lag/6FPxJ+dl/8k0v/AAtqD/oU/En52X/yTXATHBwxANIrMoGaPrEg+qxtuegf8Lag/wChT8SfnZf/ACTTX+LluuN3hPxJycDmy5P/AIE1wxkCrwMk8ADqfanxjDb5MGQjHHRfYU1XbJ+rRO4HxZhPTwl4l/Oy/wDkmj/hbMP/AEKfiT87L/5JriZGANNaTamTgAUe3YfVonan4vWwOD4U8SfnZf8AyRTh8WoD08J+JD+Nl/8AJNcDC4fHy556+lW0VQOBTVaTHLDQXc7X/hbEP/QpeJPzsv8A5Jqvf/GOzsLK4u7vwt4kjt7eNpZG/wBDO1VGScC4z0FcmST8qj8axfHC48FeIMjP/EvuOf8Atm1UqrZDoRSPpeiiitzkPOPjTjyvCO7OP7aPT/ryu65K20TWvFngH4g6L4ens7O7v9YjgkluGZUSE2VpvxtUkkqCPxPNdh8ZMEeEM9P7aP8A6Q3dcNfeGtD1C8kub7RNMubh8bpZrWN3bAwMsRnoAPwrnnPknfyOylS9rS5V3/Q6jwJ8MtQ8D/EKXUtK1Rbvw/d6ZFZ3UV1sScSwgLEyrFGqFQgC888knNct4A48BeG8f9A22/8ARS01PBnhjG5vDei/T7DFj/0Gt2ztoreCOG3iSKGJAkcaKFVFAwAAOAAKidTnNKVF0222P8sEg9xU4wfTHpSYPGKXOOgqbGzdxWOQMU05BHQ/0pxB29KACe/FDFclC8deKaVAyaBgEcUx2yTTIHrnIJxStgDNRK+Qc0Z+T1pgQSnqD+YpIyFBGfwokTJzkVD5ZEmQetQ1rc1WxZZwwxzn+dRLHvzk4BqJgy5O7pT7Zyck55/Kle7sxrRaFuJAEwcUFdoGMUwNg4zx1prTL34q7WIu2KRg5/Ohm2g8cVXklOAFHPpTTMAOTk4ouOzZaSQADniiV1Ix1qk0h9QM9QKp3N2YG+VQWHfNZupyocad2ayybDz+dTCRcD5utc22pOy7nUgdeDTrfUGMmSQV9DUKsti3QkzombBx+tGQOcZqlHdK4BHSrHmDAzW6dzFxaBySSRwKrySbGyjEN6Yqwp3EehqO4QcHqPah6oqLtoJbSq7HGQ/fIqy2CMmqSylGHynHtU/mbgPQ9/WiOmg5LqTIAcbT74p4LAc1CpUsM07f15qkzNoZO3zcfex+lLHODiM4ABH5VHIcnOKrPGVO4N16Uuazui1G+hqTyecS5YbwwCj1Hpn2qz8MGz488UdeNN04f+Rb2sqxmY3EMTYwW+8e3vWt8MyG8e+KCvQ6bp2DjGf3t7WsHd3OfELlhY84BH9pkf8AU5/+5quk8d/CjWNd8ZeL9Vt7Hw3eRa1ZwW1pcX80iz6e6RhTKgELfNnkYdegye1cu9rbXcuvwXlvFcwvrWo7opkDo2L2YjIPHUA/hVf/AIRbw8QP+JDpAz0P2OPH8qXtFG5LoOaUk+iO38eWM2k6p4E0+6u5L24tdFvYJLmThpmVrIFz7kjP41lLIWAJGM9vSsvTdE0rTJWlsNLsbSZl2GSCBI2K5BxkAHHA/Kr5wR1IrOU+Z3Lpw5VZkuPYY9qHO7oOazbnUEhcxrmWbtGnX8fSoDFc3Y/02XZGekERwPxPU1DfQ15O5PNqlpHJ5Xm+ZLnHlxjeR+XSo2vbnb+7spCv/TRwtPVIraILDEsa+ijFZmtaq9hbebHHvAPPPaobaLjC+iLrz6hs/wBVbD2MhOKyr+61GW3cCOD5hjKOQf5VlXHiGVrYXEpWOF+ERTlj9TTLHxHHds6BcMBlRngis5Sckbxp8o3TTc2N5JJLCXDDZ94fz71r3F3bSxbZonhfGBlamVIZkVmIJHOPWpbsf6P8i7gRjpmps2VfUitLlI0Ecbh0ReMHmoTq376NIzl+6kY57CkazhMTB43Vz3Wq0dpcRTh43VnC4Hmrnj61OqKsup0FvLJgApgjr6CtCN+gxn3rAS/MUO28iePkZdfmH6Vr21xFLEGilV09VOa0jIwnEtK3JOadzjIxz3qE/MQQeO9S57EgGtEZMglX3JPpVG8aVBg8KeOa0GbaSwIyKqzxM8m4Z3dQO31rKaZrTZMhQwrzxjGaWGVIztBz2rPvYvLtkjDnJPLVWik2sXQsUPAxUObWhoocyN9yrKGbk/SoyQSF6e1c/JdXBcgvt2jOe1aFlcbrVXlbLHp2qlUvoJ0nFGhHKquGbucKTVwAc8AA+lUo5IsAEg49asxyK4whzWkWYyuPYDI3YJFI4DqR0z1NIAFBNI22MZDFRVkodDEYl2sQR2wMVLwMAk03hhknPHUU7IPoKpEyuxy/eGPu1jeOSP8AhCvEGP8AoH3H/otq1+2c8e1Y/jg/8UT4gz/0D7j/ANFtVx3M5bH0tRRRXWeeeefGLn/hD/8AsNH/ANIbuuf8v58jt+tb/wAYj/yJ/wD2Gm/9Ibuuei3JnB4OTXJX+JHoYT4H6k+3kdMU4PzgD/69NgX5ck/SrAjBGe9Skbt2DoORSEDjmg5zihh6UyB4ACjHNMfr/Slyc0jACmIYWxTGcU1yN2CKC3c9Km40gLDscj27USSALyarGQMzYHHeoDKMFWbgdPpS5i+S5a35xzx61FvIY4Oahe4ULgHPuKyrq7kUnLbVJ4waic0jSFNyNdpNzortwSAfpTn1BYsupTAOApYDj/ZHeueF+FH70AdvrWf5s7SP5L+ZEwxy235T1B/LtWaqXNPYPqdRLfgzN5edp5PPT2pn2wAAMeD1Fc9bXBGfOOWJOSO/0p8t2CxwcLng+oqXUvqV7C2hvmceWSOcVmTzyC5I8xsEZAJwPaqcF+YgcHcO/fFR3j/aIvMJIxjGB1FJyctio0+V6l6K85yTk4I2k8mp7zBhVy6ntx1FcvJdYkz0ccfWnm5ZgCGJI6DtUX0NfZapo2JSGiATexx0HeqZuNs4UZCjAw3aqcd5KJCEwrDkjPFOhn3zLJcDcAfpn1rM0UbI6C0vkgmw7A54rZ3efhkbnsQeK4iQRXF8ixE+WT/FyQK7K02IiBeABiuijJt2OWvBJJl+I8cjkVKCCdp69aqrJwV7ipEb1612I4mNmdVzkDd2PrUcdxkYIOfQ0ssavJuPJ/lQsQUkkUrlq1iaM7+RjBqTbxj86qrjzMDgCrKMRjNNEtDWwp65FRysu0Hv2p0hIl6ZBpzRL5bevY0mhplGUNImEHzevSt/4Urt8ceJ/X+zdO/9G3lYyfIVA5Wtn4VMH8c+KSuP+Qdpw4/663lVS+IyxT/d2OBhcfataAByNa1L/wBLZqnjZQduQPT2qC3GbzW8EZ/trUv/AEtmqrPc/vDFbqHkPBPZazqN8zNKSvBF+a5jiXMj49u/4Cs6e4uLjhMwQ+v8Tf4UsVqNzTTsZZfVuij6VDeS4JK84FZSlZXNIx1BNtuMRbU3ck9T+JpVvHVgCAfeqkaEjcxzmmn5Sy9jWPtHc15Easku8A5rI15lexlVjxt6etV47xSsivJsYHA75rOu3kuiUZwUH8R61rzXVxKNmc8dOja2aWaRtp5XngVnaKf+JgnBcFwcjt9K6C9QmAxMd4x9KyNPBtLpiqDb6kfdrSLvFomaaaZ3r3axYRMF8cHtWjaXAnhDjIPQhh3rndGKvIJZNh54JOa3ncJGzxqGcDofWsUaSXRF+IksQSM4pGgWReGzzWXBcTsMzYUt028YFW4HCjBbZz+dDaZDi0STRskTKigsRjJrPgiSRnbaLeRBglGwSa0XmUZO7jHrWRZNBeXs2ZT64HQfjUS30Lgrp3NdFvowPLnjmHYSLg/mKRru8jXbJZbgB96OQHP51LaqigiMHaO+c092354ORWidkZWVypFeO+7chQ5wVJq9A4YDDEE1l3YYTJtHU8kntVy1wku1mGCMrg1Kl0KlHS6LF5GTAw2Z4xxWPb7vKdsENnbx0IrfDKUwSSPWqhhAlYYAU84pTjrcKc7KzMiSJt398DB+ntU9nH8zKWO0cqMevatFokA3Dg1Sh4EjbTgHqO9Q4tM2U7ogkdnbbHvV+3oTWzprOEHmcH0qiqqwHO056kVp2SbY+c59TVwjZmVWWli0eoU5BoZBnJGQeDQCNucZ+lSAgDnpXQrHNewzYUA2Hp/KmGTACleQal3AnjI/SkwDnb1PeqsF+5FE5ckrwvvWZ43J/wCEL8Qen9n3H/otq3YkCxgeg5NYXjmQDwZr4HfT7gf+Q2q0rMibunY+maKKK6zzTzv4x8/8Ifn/AKDLf+kN3XPoheTOQR6eldB8ZOnhD/sMn/0hu6xrYcew9a5a2s0ehhf4b9ScAbRxTkyvpTAcUHk5qTQUH5iaR3HHODUbHnrxUUrhc80XHa5Yz6U1j6YzVVJDkc8DmpTIrY568Uk7icbDZs4yPzqo8mO+alupNgODWVPKcHmom0janG5ZmmQJnPy1k3V4DuEeTjrinPcK6nJGe/asG8kZCwWTaM4471hKR1U6aLwv5A2AQOetMuHd/nlYH0HpWMboJGUL7hn8ahe+dlYK+Me1ZHRyJPQ1JX3EAsPTae/vTJp/LPlAcp1IP8XcmsuC+ZZ0kUlvL+fOM8jp+tSi5+0EnIJYktj1ocQ6l2OZWjdnfHPPvUbyK7ZDbUHXNZbTPHMTGQ0JHQ/561X1G9DYKHYuPmHY0cjb0C6W5YnuWjl2rJx254NWU1N/LVRg7RgH1+tYIO4bhwD+tEksaYTzNrsMBa2VPQhzTNp5ldACfpSpLIqZUrsP8RrHW5LIATwveteKMPp5lEq7V4Kk8n8KiUGtBqa3EXLSFs5z74rVgWN4vmz06CsOe8Mrp5Uaoqrj5e9TwXbwp0z7f0qeXuVq9S6XS2uRIMsuenSt231XewCnj61y0tyk4VGBC8Ak/wAq0lt1jVDEQpXqPWiLsKUVLc6q2vdwLv2PSr0NwCOv51ykUg5IkI9eavC7IiBQ5QcGto1GjllROg89QeeppzTjopyfQ1yyzXIPmq2UA+761NFdk8k8mk6rF7E6ReSDnrUxOMY5rBW6lt4t8v8Aq/XFX7LUYbjaEbJ+lbQqrYxnTa1NbaHHBxQy5UD0psGCamDDr0rbfUwbsyBIgQ3FaXwuQR+O/FIAAB07Tj/5FvKp45+U1ofDM58e+KP+wbp3/o29q6a1Ma8m4Hl7LJLqGtohKRjWdS3MOp/02bgVKtuEA8sbABj61atVzc64QM/8TrUv/S2amXTzIqNBAJSWAcE4wPWspq8mdFKdoqxDvYkBgM9uOtU5F3nBO0E1pzJjn8OlU5oQc7e/NYzg7GykiqMBMc1XmGRxVnYwwD1PpUF1+7ikf+6M4xXK4t6FqSOanmkgv33AbM5yRUX2lDIsZDKGyy+v0qXVZztViBuz+PSuXlklgvvPldirjBU/w/StFpoVbm1OhmjknDq/EbD5WHJBpk6wxR7H+9joaSyuh5Xmk8kYHvULsJrsNcOMHAHv7VrFPoQpK9mQ2l41rdkuu5Gx1rbGqwIwZpsMzYA9P/rVGba1cFGAzzxntWLe6QIQ5jkVmzlRnmiXIy4qSOkl1WJyY3fafUd6stFIF3JKxKjOCeDXM2FoLpUZnCEfe9q6DSoJwAnmBogcZJzx6VlJLozRbaluRs6cwlZkfGFPWjQ7N40PzqQ3IYDrWgLdEiLZJYdM/wCFPgDN02ggdBWbTJ5tHYtWrER4LZxx6ZpBIBccupU8D2NNChEIJ+91rOuQoJdeAvXFNyaREYqTJ9ciJtzJFnzFYH5e9V9PBlkHmlsgZB/u1YluD9nXncWHSm2FxFuwuATz9PapbvK5rG6hYbql/JZqqg5BHFTW+oh0Rzyrcg9qpeJm32qhV5JrnZZ3WNYlm5xnA/z1qm7MI01KJ3scyypuUH8aC2BtGADyaxNH1Am1CuAHAwcHIPpWgZ95VhuxxzVKSZDptM0owCOV6GriEKB1AFQWxVkAyKs4BxnpW0V1Oab1sIGXnYuT14qUMT257ikwCfl6CmkkLnB49K1Whk2LJyox09DUqYAAxVdZULDO4E+lTxgkjdzjvTTTG9EK/A5rA8cj/ijNeP8A04XH/otq6GQriuc8cceDNewR/wAeE/8A6Laq6kdGfT1FFFdZ5x558YxkeEB/1GW/9IbusRCVTJGMetb3xd/1ng7/ALDTf+kN3WFIAeK5qvxXO7DP3LeZJFIHBORjsaY8nOBSKRtwTzUYXDZzxWaOgGyASc81WuJQq8jJ64qZ3yMd+wqjcOQ/3azm7bGkFqNjuQFPmKVGc+1D3aEnaxwPSq1zIvTGTj8ayr21GowmBZrq3cEMJLeQo6kfoR7EEe1Yxq9Df2aaua5uhKgUjnp1qvcHbbtnJ2ntXNvNrumH98sWrW4/jiAhuB/wEnY/4FfpVnT9esr+R4Y53W7A5tplMci+7K2Dj3HFU07XCNk7bCXeQdyHgiuVmtdTtlK6fe/aYRz9nvSWP4SD5h/wLdXbPCrI2Bh8dKyJ7R1y6jB7rWezN1ZnJ2euR290yanE1lKeF87BjJ9nHy/gcH2rYuQZohsZMEbgVGKheCK482OZM9RtI4I+lZUuimxUvptxJZn/AJ5Ab4T9UPT/AICRQ0pPTQq8orXX8/6+41dPRUtz8uWZsHPtT3cwQmRykSk4x3IrBTWrmwuUTU7TEYjz51vmRMnnJXG4fr9atXWqW19aeZE6SxsPvoQwBqpRbFTlEfOrlZXifKLzg9cVmXI4DiQ7iM4qCzuS9s5ySEbZkdD7fhVWVDNN5gYMAOM/w1vCNtTmqzu7Nly1nYrtJ6dvWmXQ3XIlLEdOMdcVRt7yI3ckM0nkIinaSpbzH7D2+tXmbbCWJIY8KRzg1UknqzOEpLQtxSYGWKp/vGnTtdbl+zKpjBG4Z/Ospo5Ad7yiRHGOeDirVswUiFJgzdh3NRuaK6NhQWQgDtx7UjRlgikhechh1qtclmstsWSwI3L3IpsTmOZRbFtjLyp6A1lKN2dMJWW5sRgmNWQbiH5zWxHIN2WyVbB57ViQMTDvDbcdTirljNmXZKMjH3vWla5Tloa7FD8i4HfI7VMrjGA3FUGulimEWwY254p5kikUjcFJ6E1Ca2BplkvJBuUHIP5VYS7VIlJjJcH86zw/lpsLh2B5INSIAVJcnk7VAobsLlTNWXUfNtPLIAbGan0BUwOAr4JB7Z9BWJBEzOwOMHj0Na9sFjAjBYEjkinfqZzhZWR1ELhRx0J5p+SWzms+ByqIh5z0YGriMWHPX2rrjLQ8+UbMnjbitL4X4/4TvxRj/oG6d/6NvayWb5etanwryfHPijP/AEDtO/8ARt7W1Pc5q/wnB2pIuta9P7a1L/0tmqSU5+YNgVXg3fbNb2n/AJjWpf8ApbNU64Cgk5JqZbs2pq0EyFyQec5qJjnqcDGKnuWCrvPaqCXEbsMEFulZuxqlfoI+QCCpP0rHv1unR1wBEOd3f8q2ZHAOQfz7VVvJoxbtvOCevsKhxGnbocTfRlRxlm659qzb8q86rH8xAzyOK0tQmEkzhFG0D5cdD71T2oLZ5XI3joKyS1Ol7XMxZHtyGK8MegNV7i+CzjcmcdATyDWhMqyFWiGGPQ46U+x0xbmVwy429z1NbwdtWYVIN6IrC7nuFBeQ4PAbdyK0oImRY2aYmRiE+Vd3Xufb3qzHYqi4ZFP4VVmBsrhGUv5fUbTyPaspTUnobwjyo21jhNv5Cj96o5xx+NXdAjxuJJHOOTWRDFHf7ZIZGSYdc8ZrotNgEceORKevPesLWZo37pcurpIlxID7Y9aSxu4LwboWww4IpLci5jMNwvIOOnNFv9mhcrGApB2ggdaL9TOytbqWZy0ZBC7uMjPeudl1AxXzPIn7vdjb2571qXcwiuDLKzCMDg9s+lc5fXaXErcd/XFRLVmtOPc12cztItuGTaMgnjjvUFnKfOUE7dvX3NU1uJLVV+XGRkHPUVPZXiSyIQCJFGMAcYqUupraxoazcFoQsfUjH0965i3tvOdyHB8s87e9bOrTuGKqyqSOCRnP+FZ1rYkSoscg3MecGtE7kpWReuoUbaIC4GQcjjNWIZJLd1kQMxByc1es7VbeItI+X9Tzn2rShMDJyqZ46c0KNzOVS3QtaIQ8IkcnzW+8Ow+lauzJAFZ9oAMYxgVfBG4EHFddLaxwVXrdDwOveg4JyaUY7mlKAg8nBrRmVxhQE59KlGdoIOQaagA4OetK7AD5RSSsBXdlLtnqMYzWJ43XPg7Xj/04T/8Aotq1HRi7Mx5zlV7EVk+NBKfBmu5UAfYJyST/ANM2qU7suStE+pKKKK9A8o8/+Ln+s8Hf9hlv/SG7rEPJrZ+MB2nweR/0GW/9Ibuuf83jAGT3JrmrP3juwy9wdIATxQSCo3d6YjgcE5PanSHoOB9KyudJG+A3FRTLGUIYkGnPnPPSq1wjYyxyKyky0vMybncGJhUbhwB1qq9wG3LcqVkHG5a0ZVzyOKr3FuDgSLhiKws2dSa6lAh3fKPnHIU9TVLVEsdVhSHVLZJViOUZl+ZD/st1B+mKnuoXjYOmVA79TVF0kI8wnKk8gDmjmcdjXljPRkMVvqFkVOm6kl5EP+XXUWJP0WUfN/30G+tStr1ujrFqscumTtwFuQPLb/dlGUP0yD7VHLvgYTRKAo6g1Yub6O5g8pljeOQbSrAEH61alzboxlTcdYsinWBWMssyRoxGWOAMk4H6msHWLkQsY1bKniuc+IuhX2n27afo8EojnH7yOOZfIC8EYVjwen3cCs3QrjVobRI9ZgYNGQqStIrbxnABwc59/wDJ3VLS9zL6w3Llt8+h0V35ck7AkMUwAT06ViavbIttLPbwyLd44eBtjN9ezfjmpr2UT3UolLo+4lcHj8qrDUSHjhkyXbjdjjNOK1FVbsrs5rw3/bFneytJbtLaysWlXzFABJ+8OcZrdlv5JJWjslXYO5Gdxq9IoeAgDhgRgcdayLIfZgY7j5Gzuz64rSTvqY0oqOl7ltSlxIFnUxTgY6cNWiYd9usaMfkxyaiv4xLAtwHxKmNpHep4JCYgVXOcZFQnc1aatYjiu1dHM4Er4IAxjb7/AFqutxtkR9gUxtkZ4J9qnlsmEpktnGH6q3b3pTaBomRnJc4+bHcf0pcppzLY0bO+WZm+Qow5INadvEkx5bAA5NczYxyJcs75VcYYn+L04rYsplL4YkKeDjrila6uNNKVuhoWsglupI4kGwDAPrV6MIjiLO2UjOKpWUAgXMRLHfk544rQXaz7iME8fX0rnbdzptoKzh0jCk7lPDL1x3FPNrBLdwBnO5RnJPC5604wtIpPygnn5Riop4mSZHJ2kc57A1nPyKjruXIoArMBgFeM+oqZFboW4J/M1Bp8rPLuUjBwPWttkTcMgbh6Uo3sTKVjMCMyu0iMwXnjNaVhaqybkldkPOC3Sr8QEiqqoBjt2qeO3VVZUAQDnFaJPoZSq9CSHKquB0rQhcMpAHzAZArOjLdDU8E21sY5B4x1rWPunLNXNHogBGTWr8Lv+R78UY/6Bunf+jb2siN0dcg5xWt8LTnx14oP/UN07/0be12UnqcNdWiefWzj7brmOca1qQOD0P22ap8g9ar2gA1DXDgYOtaln6/bJqssMZPXHpUS3ZvT+Behn6pKVhO3PTjiuaguDHMzYGB1J4rpbzMgO04x3rltUgkjgkUHg5Oc9u9c89zqpWsTyamCp44xwCetZk13LO+HUrEeA3v6CqunqLhAysQDycdPpUzxSKpickhjuPsexpX7ltJbGMzZumDkKo+77+9JqVwpWNCV3IPlwOT/AI1pS6ekixnA2qeexrPvrSOGGRVA4PXPb0pxs2EtFoR6ddxwOxMSsNvG7gZ9f/rVp6S5ZmLYO7uBWKLZN4Cnj0JzW7YLAluZHYhl/hHenOVtjOMX1LF9IsCl96lMYJ9K5i9vhc3SpHuKLxxxmnaxcySxSAEBPrWTo1y0F8kjKGC5GKapppzDncZKB1OmzhcCQbEB5PcV1dhIWjRo8Nu5yaxbCOG8haRwQpGFJ61oWtxLaKqzYKDhSOtcreup1NaWRqjzROZJBjPBAqysEfLKACfyNVUvUkjxghj29RVyKVDHyduP0qo8phK66GDrqTs6xqAYyQNo6VkXNkRciQqoCt9wHkV0+ruklpJ5RGSO1ca18yRttQhskA5qHHXQ3pv3TSv4hcWiyRyM+08jNaGiWwVVLpgnghvX1FYFhd+USTG3lkgkdQavaNeSf2jz8yMTjnoKLa2Kex0F3py3C8nArm74SaZdiUAjJ5JwQfpXU3F55UW4Kf8ACuU1q4lnbLN8g7Gq0vYmF+oy/wBYlnbbGWQKPuCtCxvpEtR5x+b7wHQ1TsbFr7S5GjjXeTjd3rNa3uUkALEv79RT0eg2ux6Hpdy0y5IAwOgrThnO05GMHvzXJaNHdxQZPA4ODXTQykohYDcOtVCXQ5asDSict1xxUpYBTWWt2FQ+Xj0+lUGvJmm2EkkntWntOUxVJyZ0ayA9KD69zWFZ6li4WIgrkHqK143D4IOe9NT5iZU3EkzuPA6dz2rJ8cHd4L14AYxp9x/6LatfgMCDknqKyPHB/wCKM8Qf9g+4/wDRbVcd7mc3ofTVFFFd55p538Y+nhDP/QaP/pDd1zjDjIJ610fxjzjwhjr/AGy3/pDd1zqbi53AiuTEfEehhPgfqRgkMuR16YqUhm5B9xQMCXaeh6YHekYEHg4x61gmzpZFM+Wwep7+lVmZwSCcipJl+Ut0qg85x0yah7msI3WhJclEAyS2fas+STYC6scj170lzK5Az09RVGWX92Q5b2x1rPmvsbwhoV7y6kZj5hwtZn2poiyDO0HIYdqtXLpJA3I3Dg896wpZmwwT7vQ5GTQk3ubaJE9xqJkGwYI77R1qhIQoDLJs75Ud/pVeSYxSMyEsPTtTRdmRdqIOvpW0aaWxhKfSSKOr3s8bAgSSADO/PSs6JkntlCoylyGxknJzV28eTLhGVHI4B6Gs25M0bwNncFyG2jqcHpXQlqck56aFKF2uZ2JJIXOQe4zVyGzVyDKxLLyoJ/pVHTEeORMgbJG+YkVbvp0hQkHMiHBA7VdjFyZbzgbWKhsY5NRzW6SIVI6jhjzisi4uDM4f7OIwcLnJwSOv40/T7qSO7EAYtE/TPY02iIyNe1imdgrriKIYZu2K0vLCMy7NgU49ye9Q2FxLby+dDIEkHQnpjGCMfQ1PMkgUSli3mEnJ7msmkjqjO+5S/tCLOwxsozgv6D1qxIqsu4ORjkVH5UIOSnz/AKVMD8hBQnHcUldFNRZCRyBnrTJrh4J444wowNxZu/tVkJHtXnDA5z6fWi+tlkhjYncobkqM0pPQdOJqWurLJEGaNVxgEL7d/wAa0orpcKSMk9B3rmbeNVDeWD5YA5x3q/Zt5eXfhFHJHasXG+p0xm1odGhuHwU29eVPJxSXfyZUkhx3qpZXZkG+EnaTwas3EkjDLdKxaLvqRWsrRANjp+takE9zO24E7fbtWTCyseoK54rbsr5YleLZx0zjjND0Q35Gvp90DHsYEsOo9atvMgcjcFXoCx6+1YkMYaTPm/ODzWoQki4fa4BBGRn8frVxdzCcVe5YaQINx5qlHcv5pOOM9KJFfdkEY9aLe13zfMcA96bb2Ekkjfh/1e4dT1re+FRz448T/wDYN07/ANG3tc9bLsBUE7feug+FP/I8eKP+wbp3/o28rso7nm4r4TzmKbbqWuKxAA1nUv8A0tmqYuNpy5Bz0PcVm3iub7XjEQCNZ1Ln/t8mrDl1W5tpzHKgJ9axnNqTR10aadOPojp5JERsMTg8Vl6qkUkRUgH0P+FPt7iK6iEkZDMR0NI6+cm0gKB0GOtQ3zGlrHNy3iWatD9nCqOAF4yaZFP503mABMKBs9K177SVeI4Xk9z3rn/7NkiUjzWBGaS2sVe5YuyzRt5bYxzg81iHdKP3khwOeO59K2ltf3SlmbGBkk/0rPnUCQGNQcHORTi7MHHmRBDb7EYYwT0461AJZ2QlcYHXnFWvtXkylNrE9smoGCeWxZsHsPrVpp7ktNbGTcyFk2j7xPzHPX3xVeNZUYuiMFHRgK27XS5LmQtEoKr1rT3wxkpMNrdBVOSjojJRlN8zKmj6gTIq7SrHj5jjP0rprV1uIwtwowDwR1H1rmGtIpGDI+eflX0rXheOGFhP5glxhc9/rXHO19DuSbWpeuJkMqRxOE28qx4qzdTPBZmXcrJ/Ec5rNW6is7EPPESWGBx976msvS557qSaNSBGxyU7VCjdNh6m7a6gAAjL8p7k5H4VcuNNspMMu1iwyCO1UrG6t33BAAsbbORgBhV61lVmJERjI5oTFJdUV7uwXyFjjiI7Egdazkt3sb1DKMl8Yx2NdD/aMSzrE2C/t2qpr0JuLZXjwdpz+FVbsJN7M0yFlgAOMEVhGG1a6eB8AZ+8at27h7cfvOQozz1rJvXiDmQhsKcBqUnccFa46+lOnuba1LHJHAPFWbCJLgbpjtkB6Z5zVO4jjkRZw2xgvb9KzbG4mW++QM2TnHr600ubUcnbQ7PftUAEjHFTRTMInPUj9axrzUY4YdznqfxplrqZZCwcFQMnPf6URT3Mmr6Gpp5k82Quwwf4elWRtSZ5nIBx+VZguoZUYq+6UjI2mn3OZLZFI+ZyBQ+w2rsuW1zBOMsRndkE1r2NwqNtdsg9K5pozDbbAUWRed571Yt53aSJmQg4zzTUrMmcFI7BGUHjGTWR43P/ABRuv5/6B9x0/wCubVLBdL95Afl4IxyKreMpFfwXrpVuun3Bx/2zaumErs4akHFH1BRRRXonlnnnxi6+D/8AsMt/6Q3dc87BSegzXR/F/wC94Pzx/wATlv8A0hu6wnWM84JOK5qyvI7sK/d+ZCkijkjJpsjLIpK55pW4GdgwKQMCpJIrCx1ehVnlUAKePT3rMuiq5JOCeavXiHG4DPpWReAsGzkGsJPU6KaKU90y8Lkj+dQNOuwlgvIwRSSgMMEEDPBqlqKEDIQnHcVn1OpJFC/Y5Y4UR+1Zty4dB9nlKH+I45IqS6JI3OcAcbaz5B5eFyC3Ue9aqNxOfKDRMwLFmcn14xVS/dre0GwqrMwGT2qVZtr/ADMRxjBqG9iEyBG5VuRzyD6itY6aGE3f3jPnDQ3CLO/mq/AfoQfepYJUzKAS2FbHtxWbfWsxC4dn2HJz3pmmRXBnZ2AC7Dz0zXRHY5Kur0LrSRxlVfAfdgbj/Kq11p5lnEiSkHOeByDVXVbWb7QJly244xjkYre0+wE1m9xvSOXALLnkkU27GVrnPPYzsgjX5gpyeatx2Ihy27Mp7gVoIA5b5fbPrTZpVTDzOAq9eOfqaaJ0RVmuvs0qooMkpXoOgq1aX5uUwSQydvSqLLHeTeZaSskg6t6itK30xLWzN40qYzswDznGelKSsyoyuiVH3HncWHp3pt5cFYdkSvvbuP1zS2c4Mmdj/N8oOP1qlJFPuberyoejA/yrORvC5JFdyoMZWVB3x1rStpxIFMJ2nGSuayR+6cxjEigA5A9unNamlRCG0fcf3rMNoxyB61DubpouY3ocJTLje1sEiGCWAIxn8q19OtTLFkfKR13dxVHUkWGcDOD0NQnzaFfDqLY3AtYVEh+Y8lR2Oasy3xmBABHHFZMatIwYgBF5LE9vrT5I/PcMhDAj5drY20pRSKheW7NK3d8qei5ya1BOCWaJhlhgg9DWb5btAdqnHHPcnvU1qu/ywPkkB5yOtZyipG0XY0HlnndVjYqY1ALbep7DFb2meYYR5jDf3ArA065CKpIy7EnB9Sa3LN9pJchR7VCdhT2NOKE7gWOVB6VMV/eAIOtIk2VHlnrxzVyNWJGByPWrWuxySk0WIk/cD9a2vhR/yPHij/sHad/6NvKzIlO0A1rfCwY8deJx/wBQ3Tv/AEbe13UdzgxD91nl0oK6lrrAEhtZ1L8/tk1UrnTVuFy6vnsRW5AgN5rnHXWdS/8AS2apCoAHTFc84+8zppVLQXocNDBcWE7bEdlwcc9f/r1c067aYlpUYNnoT0robq2BBI5IP3ay1tXikYIBtY9TUOJuqiZOXjdMAjcDVGSFdxIH44onidcg7sdQB/WqN9PJatGDk5HP0qG+5Sj2HXMDOGO3A9h1rJNsyScDIHIOK1bS6efCDOR7dKuLHubkAg0NXKTscjfxk3MbeUwUdDjrUeqbmhjdExg/dPBIrs/sysw5X64on0+OSIBogRjuKuLtqRJp6HA6dqE9vMIlUkN6cYrRdZZisvlAlegrUvtNWOUOF3L3T1qU3MUIYBcL/dNTOomyqcHFGRaJcSyMVUI38Xy4xVySOe4jeKF0Ekfc/wCelSjyrspJAwDdGXsPSqdwzR3pRZRDgfMw7Vi1qbp6EF1ZP9nY3MpJBHy5/lTbS2l09VmSQFT94YqK+M80bhZt2CAB7VONQK2PkywMJMAEj+dXG9hPclkvWd4/s8TjHzZx94+1OudckAVRGYpByTVKOaS1j85mwucbW/hzVhhFcwm4cDP8PNTZIZVQXV/cNcwOVkJ288AjpxWob+8WARyDAH7thjFVbe8ie3SBDiVjjgYx75qxFdl5ws5H7sHkd6BosW5J00yEHI96yZr1pUCg4T+IHvXRRiNrPIPyc/TFZclrbvfksB5YTgdj+NEWluK9yjBcOSsTgmPPAIqRHktbtZfKYK3GCKs6fLb/AG0xjICthAe9bl1Cjx/OQDVLXUlvoclrV2kkQRODnORWdbvKY/k3E549K1tcsYI4AyBtxPX1rKSd4I9isNpOdvrXRBLlsjnk7SuzS0uQ+ZkuVI7jvW/p8jlTMz5xng1y+kXkcF2DPESnU4reXUILi9cW6hUcZ2jpmoqQLhO5DcahcTzrGEGc9PWtOK6m3wFoSqE7QfUiqWm2zwXpefkDkNWpcTRxuhdwQDuxng1jK17F3Nq0ObkyF/nbqDUPjAAeD9d24H+gz5wev7tqrRXULxFwQwPQd6zPEeph/CmsxtkZs5lAI6fIetVTdmjGrBuLPsiiiivYPAPPPjFx/wAIgf8AqMt/6Q3dYAlBX5TW98Y+nhDH/QZb/wBIbuudjR8HkYHUjpXNW+I9DCpcj9QcFnGeAKaQuOtP2DGQSWpqKcHI5zWTVzp2K87buudo6AVmzqg3M3CgdK1pUyCQM5rLvU6g/TFYTjY1pu7OevZlMbfZ8gbutVo3Z7bYjqz5P3+laLWpUsIyCCOhrHmIhuAgUKSPvHgVhudqt0M67hLRkyR4cEgj0+lZEzqrYy3pjFdKJPMwepJ5IqjeQx4JwATznFXTdhyjzbGNcmNYwqRlnIzisma5eGULNG0fdSea1tQtwVUqxWQEFWB/zmsTVXkU758EOMjH5GtoNtnPUjGxLvycqc556VXknjjkPzoWIxy2MUtoXFou8Y69O1YN3BKjsWUMD/FmuuOp589Lm6WDEHkL2I5FQ3FyLZeJDnoB3qpo6TxRS72IjbhQeaiu4x5o3ryx+8nX8qox8x41aUOMgKgP3QOtXcf2hZk5ZA4w23+VY8oRYWjwS5OMkY/OtGwuGghVXTahPUHoaCrJjhHHYxFYGbe3ViP5VXRpmZTIrOhPT/GrV0gSV3kBJ6qTyM+9WLGZYZWaXJVhkYHA/CocjWMLBFMzxhZFKDocDkelaMMizwbkRgy5UljkMfUen0qlcXEcj7Udi+QNqjqPWtKEBAqgfIvT3qLMuPYaVYAM6jGM9OlRyXJg+cDJPA9q0GUNESSAQc/h6VANizqpCOXUgD+79als6ErO4yz1C6XCNgBhkHrUtyZJCWnQsPU9qkstOEVysszgQbhnnoM1dvpVErpaKZFBIMm7jHQj6c1n8LuF1LQzwAIkYoWCsCV9qtOEFwxgUYIB49fWq7EWqsjhWkGMITg4NPimMkRKjYyjgnt7U3Zu5olKxoxSrIixyEowbdxSzDcco3I7njNVrZsTI8hBKnJz0rUW3WXLhQfY9qyfuste8tSrp+944CeTjv0rdE6xBcYJ9KytOtXTy+GABKlfTFdJFpglVeenOMVnLXYLpLUuac5u8OBjAxit+zi3EA8Ed6z7K3MAVIwAD2rXto2WTd0H861pLW5xVZdi2sQAzzV/4ZgDx74nx/0DdO/9G3tUuf8AGr3w1x/wnvifH/QM07/0be13w3PPq/CcBZR5u9aYj/mM6l/6WzVYePAyRlT+lRWJYXGtEdP7Z1P/ANLZqmmbpx9axna7Nqd3FFKeIHkdfY4rNIYtwGBBxWoQC3HPtmoSrZZWH4+tYtXOmLsZtwvmfKCNwHIFZ9/Anlqz5ZU5NbDLgELweevrWPqsjLCy7G+YHBPrWcmuptT8jGt5443curBmyRirVrdmXOCMnj0rNs2MZCygs23AI/h5p8kfmTebE+GHJwMVJvY3kkJYYAGOSRV4SZ4wSPWueg1BkkyQo9zVx79lCeUVZs42j+tK7Rm6Zozw7mBPRuKr3elQzj5hg9iKliZzHiRt2Tww/lVuLdLE2IyHHADfzoVmJ3icra6PJY3TncNh6Vn64iR3wV0blQSw6jNd0kDkN5n8XUEVU1CxgmwZlGRwpxTt1Y1U6HnkzxwP8rmTGDkfypl9eeYY+HRgOMdTWjqekLazO6wu0RLfJnnGOuaNNtmMKkxrKud/B5wO1P3VqaavQzXuzdI0UqLgcnLY3GnTw3EVul3tY2z4UlRgZ9PrU94q3F0DY25Evpt4/Kqd616JJLaaZljPzBSMA/QVUbCd0X7S2jY+Zbv94ZWNj1xTFc+ftniRd68DoOayoTc2zLNAGwp6kcA1sWcc+p4RQG285zyPWk421KUk9Op1Ojwg2PzYPGfaquoXaafatiIFs5UH0rT02ymgswjEbvXqaZcaXb3VjILhyLkHAGOtZpEua3OEtppJb8MAFdmyOcAelX7m8u5pmbcWCEjgdqvLoqtD5kLk3APzKfT2rV0q3tlhaML+8z8+etW5JvQFomc6q3UkYaUFo8feboKi+xIIJHkw38SkGupu2hj/AHchGMcg+ntWBcIbd2YqTC5+X6e9HM1sOya1K7w21xboIVIlA+YZ5qez02S3xMzAAc4HJqBI1eRlVxvGNuBjNa9p5vlFJuuO4xihzdiVBJ3Kn9rOI2VUy3aslJpJblRMxz2JNa1nYIs0juOQcBSaztVVFvVKHDcbsdBVRavZIlppXbOhaJIYkAzGwx89UdYlX/hF9YWQsxNrNtfHX5GqxHII7RRuMvAJzzx6VR8S7Ljw/qckY8orayEp/wABPQVnFaoufws+4KKKK9k+aPPPjCMnweP+o03/AKQ3dc/s556V0HxiO3/hDz/1GW/9IbuudMoUgMcZ6D1rmrWud+FvyfMk3Bc5ppbKljwKYXLjJBGexqMMcnaDWNzpsOmJyQPunse1Zt6oK5IG4Dr61oKDJuJwKrXMRzwcnrUyu0XB2Zz8wkL5QKMc5bvWZdzNPIqyIq7DyuM81tXV3tUqyh2HQ9K5C7upk1BmmQAE7twPU1zKLbO2HdmhJJGXdRtDd1UdKzNSR5oWEbBCOhxyKiub95MhFCMTk4H3jT5bqCWJUbPmNxn3pqLRfMjEnchQjnOOrf41z+uK7TBoSTGBwBXRXsZDsD19ayZI2yRgc966oJHHWk0YUbXz3SP85HAOT1HvWiV5bcN2T37UtzKLe4SAqTI3p0FTRjaGODwOh9a3RxyKt3IsKFVRzICMAcKF7/jTXtlnhWZHYE9QOtP1FoWhH2gMGA+Uqev/ANap7VIJRGsUgSI4BHdRVXRm0zNNmFZWUFiOOnNOZQP3JBJf7orYvfJinaCC4VwD8rYxu/wrKvSQ8cJypc7ie+PTNG44osvJGkoMUYnfAU/NwKdBDbXCM5EkRU/Mmc81WsSokUEnaD0ArXitjDMsqHKScdahySNYpsLa0gt13RqXZvXrgU6xupLmZhOnDcLgYxirSwNGrSOwb0960reCMQvImG2jAcj2rKUrM3hBkCxKqgnk4yc9AKilt0ZxIp+boecZq8gQwYc/MD170kcEZRmILNgkD1qL3OhRaIILR7qGX50RYxu2s2N//wBeq1jbMm8om1mHUH7wHan24laUiQnYeoC7cVrvHM0kTwbSpODk9qlsqMEncySiXDb2jCyMQAAPu47j3qxLGYeI0Ukjcd1dDLoc6YnCMsjjIK+lZ7aeXkK3AYbOcj+VSyk09jJZBcbRHjJGcHiul0mNpbYcqDkDaKz5rSM4VASwIA78Vv6Dp26TeH2lTz70N8yM3eN2zSttPAkEjKxQgeYAORjow9fcen0reigRowYyrR/3hyDSWahgMcEdumKsNaoTuwVb+8jbT+laRpqxx1KjbIjBtICnntVqDIUA9qhW1ciLddSlgBvJC4Y/lVhgAeB+NWo2Zk3cnSTAPvV/4anPj3xOf+oZp3/o29rFdiOEXJPrWt8Ls/8ACdeJ93X+zdO/9G3tbU3qY14+5c4O0YLda11OdZ1Lp/1+zVOVyMDpTbAD7RrJP/QZ1P8A9LZqlONxrKoveZpTfuogeLnP40xAdzdOvWpWyRknHP50zYdzDJB9azNUVbhMncvU/pVC6COT5nzAdFIrSJ/dYAzk1WcKzN5ZBYDmspamsGcxcJGJ2iKcHpxzioJLeQgtEvOcDjrXSNagnLqN2chsdKtJAiE5UByM89KySdzo9okjmvsU0tsEFugwMHNT6Zo8kKbRIpBOWyv6V032csRtXAxkjPDUqQhRlsAegrTkuZOt2KVrZKjZclnbv2FXhGAeBk+tPWLAyM1KnynnkVpGNjGUrlOTLEjb7VQ1BN8OVYpKvQDHI71vui7ckjI7VmX1urQOqkZ65pTTSHTlqczuE8TR3AG3sc8gVBZaZJAf3J3R56Z6e9apt41dQ+5yBxgYyfQ1NHkOV8oLGB1U8VzI7HLsZ82mpDP58Cbt33sDH1rB1qyuJ7gHyiwI2jK9Px9a7KC9jaQxuo9Vqc7Hbbjj36Vpy9UR7RrdHFyaTHFp7KpbG0/N079xR4eiFsG/ug4yOgHrXT38cQidXAC9AKybazYqywfdBz9R7UrvYtNNXNuxl8+EkdB0zTLmzEzbwxXAwMVLYRrHFnp681LOf3RAG09ueta2utTBuz0KUEUURIUrkAZ9az72FEufOhOxgOccZqHU7trU75CQ54G3v9az2v2uYz5mAme3WsrdDaKe4GEXkRlkdtzZGfSqAujM32Z14XhmHfFXUnRIPLGUkJwCTTFgjjZZDGd5Oee9JOxbMZpxFdo27O08irt9qu+4RBny+Dxxn2qPW5rSW4Ty49u0YYVFLZg20cwfLjkAHPHbFaO2lyU3qWHW6mjXyt6sRnHrWPcR3D3AV1O5jjpgVvxahuiAmV0kA5wOtVZbxhJLKRujbB2kf1ojJroEoqRqaWbUaY7SuVk27eOn41j+IJhPoF+8Lkn7LIm0HGFCnJPrxUkupR3ER+zxLGVOWUjOR6iq+oWs0uh6rKgIC2kpbI427CetKN+ZXCatBn3fRRRXsHzR558Yv+ZP/wCw03/pDd1zckeVLJ96uk+MOM+D89P7ab/0hu6510wjYbB71y11dnoYR+78yNuSrY60r846fhTOSeuO2MVLJhQvGB61ijqYwfKD2FQyEtGRnHfFPd84UUjYI6c/yp2bQWsY0trukYk/KBzisfU9LjYgBicHoT0rpJ1YMdv51Rkgac5clivpwCKwlHU6IzZzUsUUAIC7sdyKy1aLzNwwzfpXV6la2622cZLdOehrFurSOO3R1Az+tTbU3U7ox9RT5S5BGe471hSxlsgkgn7pPSuqlLSQ/d2hR1FZl5CHVAG3DhUA/hArWErGdSHNqZCW4lGZdpdBnIHNRrCDB5wOWJHA6Y9K2Z7U2wWWNSVI5GOlUHjil3eQdgb73HNVq9UQlGOjRlX9mtwyKBsK5AOeopthBGssRAUbeCAOMY71oahbs/llF3Fckk8Y9MVJHDIgyyE553Ad/WtkzlnG2xzrrzNGykzhs9M55/SpL+3caiZQjSRMBtwM9q3ljTa0koAXGc5qvud4iywyCIn72cU3JISg2QWFq5dCUMS4BUEZZvfHb8a6a3ggSydwp3fdLsB69FHqag0+3SSFp5AzEnCgcAH3NWJFdmO7txgDAX6CspSNqVPuR28X2q5igiKhnO3LHAFSXSSWjva7l+VsHaePeqF2nlHzmPlheCe5pVdvLDiQncM8+lRob+83foK8u3qcAdTUlrdx3CMEJQ5496p3P76Eqg+fOcevvUWnRy+YVdCNvQe9KWhcfeOiSRmBAPBGCT0q9FaZ2g/MxAPBwKzbVHJ2gZXv6ZrajfO3awLDgZ/lUSY7Gvp2ptbIVk+dMYw3asy6mSSZmUcMOnpUE7yZwMb2OMDpVgRiPBByw++Km/QlQUXco+R+9yjED06ZrR02VoplDnPOMZ61NeoGhVgV+boBUGm2ZuLnZkqoBPX+VBTd1qdxp7BkBxgntV0DdjkYrL0mMpEEXoB3rViTK854rqpu6PMqKzFI2gZGRUZcA4FTsjHjvUbWxYZIFW0ZpiRrubpxWn8NBjx74nH/AFDdO/8ARt7VGNWXtxV/4bf8j74n/wCwZp3/AKNvaunuZV/hPCvFt9rA8XWuk6Lqv9m/b9Z1vzZfs6TfcupGXhvxHBHWrZ8P+MAcf8J11/6hEP8AjVLxAQPiloW7oNa8Qc/9t5a75vmbjOMYz3/Cs5yaen9alU43Wv8AWiOM/wCEf8X448c5/wC4RDn+dRf2B4u2lv8AhN+pwP8AiUxZP15rt0C+YVDAsoxt9Ka8PDAZ+bsTxms+d/0kaqC8/vZwbaF4tUHd40OB/wBQqI/1qvJofieKVQfGfzsDt/4lcXP616E4Tyi7Y6HOOaq7YwAZArNnCHHTNZub8vuRpGEfP72ch/YPisoXbxsNqjJzpUX+NVNX0nxVpuj3+oL4yEotbeS4CDTIgH2qWxnJxnFd5EWWXy9i+Vnb159j9KzPGMBh8Ga6qj5Rp9wM5/6ZtTjNt9PuQpwST1f3st+FJpbzw1pF3cvvnns4ZZGwBuZkBJwOOprWCcc/yrE8Ehj4N0HBOP7Pt/8A0WtbwOcf5xVNK5CvZEYUgnGD/Sn7AeR+tIQd2TnbUgG1eeaaQMgYHoMVUmtC68NzzWj5YLZ6U1UG3HUUShcanbY55YGywOd4PJ9ahvsxkBJG2jhm6nHpXRTQgqSnDdz61i3sDKQOVDNhsdh7VyzhynXTqKT1MZ1OUEcme446fjW3YsksZV/9YOPTNUjbRchkO852kdKmiSUTqc/KACcjp7VMXZmlTVC3GnJcffyNpzwakWAwRAQjO0cAVeWPLZIODUM4cbdozzya1t1MOZvQ56K4njmk887G5x71a+3RlFa4O11O1e9Xby1WX5pOMc8Vm6jaRiHJUuvUjsai7RunGRn6xcJPG6Ljb7jqax57RreBXOSwGQB2roLe1hktwroA3XFMmQbPKYK2exGP1pXbNF2RzkEhOGk256jPc1ttZz3Vk8qqBwNwz/Sq95pSiLdFIynqFUZ5p1i95GN8ikgDJxyKL9Qeuxyt3aStOwfl+uMc4q/pbsuFmfYB90mtGS+829dljAdsqB0z+NZUthctK8oQ7e4YfoKvm5lZi5eXVGpMBK6sCrKOpNStELq32BfLccZ7YqxpVtJDab5YcOecA54pFkE1y5CODgquOBWV7Fbu5zMVpPJInlpgKxxJ/SujvQyeENYS4AExsJ2GO/7tqXT1SGdyrDdF8xRx1p/iZXl8O63KoDJ9jmII4wDGatTvJGdRe4z7Mooor2j5s89+MChm8HgnH/E5bn/txu6wdisOBwOma6D4ujMng7/sNN/6Q3dY8kfGRx6Vz1Vqd2Gdo/MhCKUCnG7rzTSm9yMfKKcvAy4wR3pcgJkVldHQVZQInLYXb3HpTJCrJkAg+3NSTRgwgY6H86cbdJI1IOCO9QrlXXUqtBnBYHFQ3FsVVioJBHTPFayRKU2+lIY8D5uavluL2hxl9DKyMoGfTArLttNe5mAlOFB5GcV3726j5lA+tYN5DLBcmWBNwY/MMVhKDjqdNOrze6ZF/paIB5Z+X0HrWK2neXOhI+XNdUsrTPtKbP5VWvLIAEnPNRc1UujG34sptKWJIys4HLdjXGfYwszxvhB1DAcV1ClRIAQCAOtQJEsl0GkUbR0OOMU1MPZqJg21qU3+YjEkfL9attDbrYTIYWN4W3RzA9PY+mK25rURqGPlghTjaPvZPc+3asWeELIScZaqUieRSRkLDuZw67kPtnFV1tL2EmOBhLE38I610lra89Bz0pXtN0m6Phu/arckxKFtCjpMbxW6+eo+UEqg6bu1S2sTSPyWy3X3PpVqW3IjCsoyPQ9ahg3wyc5APc84+nvS5h8nUh1LTYHbdIGZicBc8+9Zgt8NsUNtzgZ7CtmRWnnWNCDuHGT0qKWNgzYDZU4yegqW0i0m0WItCxardRTKJk5A7j3qeG1ae1k/cl3h+ZpAQu1T7dzVazWZkYByST0969m0f/hGNb8INPqdhZx3VttSYITAGc8K2U6Bj7YzniqprmurmNaTpWk1c8etwsch429s1ft7ciQYyC3O70FWtV0ia0vJvMt/syAhlTO5SpPG1udw981PFCI5GmI3HHK9BWKWupvKaaujLa2khmIYFhu+9j+VXSoZyYxweDntWotrLeRK6qApOATVm001k4nO7YTtHYZquRtkOqkjMjsHZD5cYJI4HQip7DT383H3QODnrWwsHluRGhJYc89KvQwnywWXDe/pVxpXZzyr6WIbW38lcDkZ5NXEOAdvb9aeqLgcU5Dt6jPNdKjY5XLmAElASDmnqcr1p/3hwMelR7TVELUXkP7HtVz4cH/ivvE//YM07/0be1ROSzE9B05q58NTnx94n/7Bmnf+jb2rhuZ1vhPBvEC5+Kmi/eAOs+IOn/XeWu5ZtjfvASAcDbxk9vzri9dGfinoPOP+Jz4h5/7by13F0FSGVyjNkYODjPvXNWWt/wCt2bUHp935IiuGVLmN0GJduPm6SDuufXvUhlBUYYK/Ug9QM+lVVTzS0YZXjXoknzfketWEUrbAIV3Y+XnOfbJ5rC50OKFKKAYwMRkce/rVV18iRY2bK9VOOlWA4iTLLhM9+q1Bc3ayRALyM8nHSpk1YcUyxDFmQE8A8/Ws7xwoHg7X8HH/ABL7jj/tm1XrZcjJbkdMnkCqHjVw3grXwOcafce3/LNqum9TKpewvgnP/CGaBx/zD7f/ANFrWtHEwZgWPI49BWV4IP8AxRWgd/8AiX2//ota2N2V7GrluTF6DijKo5GM9OuacjZQ5zjp06GmiTCYA3EcAVGqklhuA29j0NF7bBvuSRSkltw4H54pzDg9loTKqMqOvLDvSSHcP7op37hbUY5IC4P4VFLEJBhl+maPMjDfKwJ70jTc5XPHpWbknuUk+hA2nRk5HBp0kSjbuGAB+dDXOM7z+ApGkBByecfhUe6aWl1JVIKfjUEpG8cfhSoQ23aykeopJo8ncp6cfWq5rom1mQTOTycAVUdNyDK/K3GPap95ViGxnqKjueY0XJyc421mbR0KYihFwPLG0d6ju7QODtwuOQetR3UsZ2KoKDnGDzn6VJZzu8TLIMsPXg+xqU0b2a1KaW07SENI+1cbCD296V45RuOVCA4weOK1YHwo83AI7USqZCxRQx7/AEpW6hzu5j21vZGfKoBIOenQ1rYtsHzAMDjGKgEIilUgbGTJ4HWlWPzXYuoPPB6YoE9R0wg2koTuxxjt7VkvELecqxCuVwQa1pI2WAnglyeQc4rJjs5HLM4eSUHALtwaTKh6lm20tPPjeQhvmyR1B/xqfxfFt8J62Y1VV+wT9P8Arm1XNPt5Et1Ei78fNkfw/Sq3iZi3gvXwR8osZ8H/ALZtVU17yMa0rpn1fRRRXtngHAfFttsvg44z/wATluP+3G7rFeUNxnn0rc+KoDXHg0McD+2XJ/8AAC7rDjgdlnlBPArCruduGtyu5FISeAc+2KWMKVwOtDxyIm6QbAw4JpIflXnrWFtTp9BpwAN/B96UMcE9fai5dfL3E8jnNIJE2Bsg8cnNK1mO10PRgWAGQTzzTnyTgdKamJSCMgjoaMEEjNWQ0DIeQo4qtIqjII+lX4lwhYY5OKjuIVOMc4ptXQlKzMSaz8wcAYzzUL2xkU7uM+1bYjGDnH0pFhUKXGPasnSRt7VnLy2KLJsRRjPzHFQTWwBOM+3tXRPCo3MeorOvAGyBjcRisnCxvCo2YEzFSQTkCq0Vt9qnVUwfqcYq3qds8a7UX64rMtLkwM7AE7e3c1n1OlfDoX7yxksHZZMgjkgnpVdnyclvmJxnvVqS7e9wZmIc44brUd3FHGOvK/dAHU1ad9idVuaVhBasg88nfg/hWLq0O3d5YYISQG7VDDcTKvXBz6967T4aeJv7I1Vra/IbTLshZQ/Kxt2bn8j7fSnGzkkyJRlTTktThbDzA5dgN46AVbuLYFd4bA6sPU123jBYdf1KZ9BgswLd2V7aGBY5jg4L8f6wcduR6d65RIhMhBOFHUUTjbQdOpzK+zKcVmwVShIZiDjv610EKSw2EpQHbJtjwO/+etVIAZJ8ykdMAjsK6azjWSSJI1HLfKPU0Rs9iKsmrXKunSzpbfZbqNbqyzk28hwVP95T1U/T8QavroKNA8unTPcQDl43GJY/qO49x+lNYA7+RlnJPoKsW7tbkOkhR1OQ6nBH0rSMVsznlN7xGqu1EBA2xjCgdhQjqTkjHpWm89tfIftAEFxjiZV+R/8AeUdD7j8u9Y4gMjjkcVre2xEddy5BtchkHBPzH1q28gOOOR196giXaoAPA4GBUjE5xiriYytckBBHKkA+lCxbX5zg1KFO0c/hTtwJ6cinYhvsIApAIPy01oyw4Py05iHOAefapF67TmmK5WKEHaQQRVr4bjHj7xPn/oGad/6NvaVioXBP5074eY/4WB4nx/0DNO/9G3tVDczqu8TwXXG/4uroXtrXiAf+R5a70uMlME9+a8/1/j4q6IQf+Yz4g/8AR8td+xwAG6E9/Wuarv8A13Z0UVp935IrxJlVJVSpO/IPGO/uKmdY4kyNqgfxHnFMQKshAYoT1GODSybkKnhux44rDY6HqQupmyWXzAeBzjimeSgZmUDHAHGB7Y/xqVmxkgezZoVSwOeM+lTZMpNogdZVKmE4Oec9BVbxn8vgnXh1/wCJfcf+i2rR+VEO9sAHpWT4zcHwbrwB/wCXCf8AH921VDRozqaxJvBHHgzQQBg/YLc/X90tbGPnwAc9c1keChnwXoH/AGD7fH/fta3CnyjHNaNXbM4y0QxThu2SeopwZWPanNH8p7mkC7WyuOOcetC0DQkdwqe1Zt5L/orc/dJq+WCKMgVXutjKRt6jNTPVFQ3MSCRnA2gMoPzLnn2qfzPmBdgi9QBwSaqNA0c/yEgk53H09KtbA+yNyuccH0rmt0OuSRKhLqSxwOgB64psmzY24Hb6DmnQxh3KFgmDkljTJHVUcx4ZwcYXvTsT1CGSMg+UuMHJIPFTrOsgIjweO1V7EmZZXdAhHAX6U6KKQSu2zAY9BxiqjJicVdjGhDncfvjpVGdpInLMG2BsAkdK12hKoxDYB/HFKIN6bGA2sMZpuLYKaRzF/JcEqirG5bndH1H/ANb3ptpexhwZEl8/uCucDtzV+/tks7VjszIxKAH5RWMlxcQQBbqNo27kLnB7Vi7rc6YtSjobdxMc5QDjnkdajt2aZCcfvd30plmsrRIynLDv1NTyXYJCqQhPbHX6U733IatoixDDlAsj5YdzTpLdDxvIweQozn2rPe5LAkkq5bGR3FT2cc0U/mSSs4PLYHAo5kJxe9y4IcxMr4UHkf8A1qIbeMMG3M5PT3qK9Z5JQEJAA4x3+tRadPsnYMRhz90HpTur2Js2rm8sKrH25rE8XxLH4M19cYxYXGCP+ubVtK7HgD8fSsLxLa3EXhLxRJPcebHJYXBjjK48seU3APeuqMVdHLL4Xc+p6KKK9I8k4D4tELN4OJ6f2y3/AKQ3dZzSkWrbBt3EDI71o/FkAzeDgeh1lv8A0hu6pXQCJHCRyADgd6ymtTsw/wAPzGXkRIDbsjjOKpyQeWuQ2QOT2FadxICp67MHBNU2BZEJXcvOR61lI6I3sUkUSl1bKkdcjr7VBcW3BHHPIq5Lyq56rwRUe11BYn5e4NZtJ7mqbWo60cbAARnFPCruLsOTxmqCxSLKXQ7e9PSWVG2sCVPQiqi+jJlHqmXSxVhzxSSMMZFRFwR7U4MAvHbtVpkcoxmAznjNMkfMfy9adKm9AcYxUBJD4xUvQpIjnchcLwT61SdMyAkc9/etJl3KCwz9arvGMYHOPWs5RuaxlYx9UmCRuADkjt2rmJFXeCvOTznrXTajbySOwKkNngjvWQLaQGTdGd2cAY/WuSW520rKJThDSPuXPB2jIxz61be1kbAPvk+n0rQ06xfc3mYCgYGfXua10sUddygZ6AE9ferjFvYmVVRepxssGxsOvT071cLptTYqg4OF9K19Qs0PCLznr61QtNPlE2Sqq3972pNWZXOpK5QhBS4jIDrKGyGBII966iO6g1JtmqjZO3S8jXJP/XVR97/eHzeu6qxhEYbKhn7t1xUUBMBIWPKHqSaSk09SZWkie706exlXzIgImH7uWM70k9SGH/6x3q4swhdXyF2Lj6VNpN7PaGSNY1lgc/PBJyjHscevuOatTQWskxNujiJhko5BKnuAe4rRRvqjnlN7SIIjuTaoy3c1MIcn5sEDtU8NuFU7eKk8tgQRz61uo9zFy1BIlK8ce1OSPaTg0ik7sEcCn5HJYc+1WlYzdx8YVOnLVMSMZFVwwzwOakUbmGe1UjNolDNkZxnvTpDtHGM4zxTSyk5JFRkjGRn2qiLAhO/OBU4YMc1XQ7MZ704yDtQU1ckkzmp/hzj/AIT/AMTY/wCgZp3/AKNvapO53etWvhr/AMj74n4x/wAS3Tv/AEbe04fEZVVaB4F4ru7ex+JmjXF3PDbQR6zr+6WZwijNxKBknjqQK6W48V6AzgDXdJKnr/pkf+NS3el2Go32r/2jYWl4U1rU/L+0QrJtzey5xkHGcD8qcnhXw42AdA0nP/XnH/hWE2m7M6KalGKa6/5IRPFnh3audf0rj1vI/wDGh/Fnh44/4n2k9f8An8j/APiqY3hfw75pUaBpWO/+hx/4Uh8LeH3U7dB0kZ7/AGOPj9Ki0S7T3D/hJ/DgPGvaUR2zex/40qeJ/Dqpg69pPy9heR//ABVInhPw+MZ0LSjkf8+cf+FLL4T0EqCugaQCf+nOPj9Km0Q9/bQhm8T+HiAP7c0kg8N/pcfP61meKvEmhS+Etahg1nTJJpLKdERLqMliY2AAAPJJrUTwn4fJB/sPSyOpAtI/8Kl/4RLw8p3DQtLIOOPskf8AhQuVahLmtYs+BGz4M0HI/wCXC3HI/wCma1tEnPQfSqtsYbYR26RLDDGoSNEAChRwAAOn0qwJO5Ge1VzXI5WiUnC8c0Acc9aiDFV3ZPNPDELkjJNAWB2HRjUQQDjbnceOOv1qSM5b5ueKAOeeBS3HtoVJIlkjIUDHTGKhS0MchIwowGBrS8tTnoeefY0gjILDqvYVLhfUtVGjNltWZ1JOQeeR61DBZGA7iAAxPyitpflH6c0yQKgOeueMd6n2SGqr2Med1hnCF/LLep4pyJLvzkHnkf1FVLoOk8rkgMRgjqDWppkLLANzltwyB2FRFXdjWT5Y3HQAgEc4NWBGc5zgVJEABgnP8zQM5JA69jXRGJzOV2QXFsk6lZAGX6Vh3uhxyPlGbIweW647V0u0j6Uxow3XFKdNSKhVcXuc5aw/Z45IXwuT9Kp4iimZXZcjJG49/SuguLMMSzkkLXG6mmzUWOwbC2WyeStcs48p2Un7Rl57tY1BlTHPQDqKsR3ZLfI6eURkeuaww0hTa5D4JZd38I9KjmvFgkB/gOAQeiAmsbs6ORM6b5JYTGC0fHzbRUsGnbXWUHBBwPpXPDU5fOfyxlEOz5ep9DjvW/pN/LdlkmiMckZ5xyDWkbPcxqKUVobaLjGRWX40c/8ACF+IBg4/s+45/wC2bVqxEkZ6A1leN+PBev5P/Lhcf+i2rsh0PPqbM+m6KKK9E8w4H4r/AOv8G/8AYab/ANIbuq8gR3UqeM7Rn+dWfit/x8+Df+wy3/pBd1RZiSufunGfQVlPc66HwhOvyZU/Ljiqyh4x6qO1WJAzZQYPNRz7mLKmTtGcYrNo6V2IGTzGBGeevNPu0CxAKQQcfWnQjdExPGT1FNYAoRjI4B/xqehTeo1IQqDcBnrk+lMmhJ5HDD2/nVl2GUJwRjBFPJBDZBI61VkRd3uZ5UjhgOOCaidCCeF4/WrYj3S7WycnBI7elSoiFF4G8Ej6Yo5Sr2M/5sZVmwexGRTZlYDld2OpHBFbAVUKlgOmMVTchZgxyQDzjvScSVLXQobxt2/xAdD1qhLkyh1BDDg1rTKsqP5i4Ycjjr+NUHgYAbD17Oen0NRJdjaEktx8G2SPEijmlNqrj5Qqn1IqE74ZAZVKemeh/HpVgSZKnt7UrR6jd+hHFb+WdgwST1I7VcYARgbeF4/GnxuNucZprzIA3qa0SSWhi22ym9oHJPQVH9kSNs4JB4OTVxSrc9RUcrsM4x7Co5UaKT2GfYInJdV2sRyR3qg1my7gQCAeT6itWNysSlwc05VUg+nYHtUyppjVRoqWkW7C7eWPWrke1Q4YcnhfaiOMqcDp3om5z6mqUbIly5mLFJksPQ45qcAP0NVYUCQEEFju4HpUyvjGB+VV6kyXYnMe4dKY0WOvT0p4cqCcUB9wBPXpV3RndiRxgAv26fjUoXgt2p7sFUIByKdKAPlHJUc/Wiwm7lNicDkjnmhG4znjvTuMkEHIpkhKDd2qeXUYM7EggcU1EJH0pY2JOfyFOOQDgYqgAfdOMGr3w2/5H3xP/wBgzTv/AEbe1mK+V4A471o/DNt3j3xOf+obp3/o29q4bmVf4Tzq3kU32uIy/N/bWpY/8DZqspheOoqlbH/iaa6zEca1qQA/7fJq0BgLkYwfSuSfxM64aQj6IbtDMQQeRShMHYg+U/pTsAqRikycjnj2qQuTRqBgHsKJjhcgZApikHnNSZypzzVIh7lbnzNwXgfrUy+9GABg4wKdxwM5NTYq5E1uHIbjNPwQBnqOtSAjHemsRk46H0osLVixcZ3etTCPp71EoGDgVOjArx1q15kSIwhRSOvPFNTkk9hVjjA4/OoyvPI+tDQrkcp8obyDtzzj+dSDBIIzzzUbAs3JPHUZpUyEZckNjO7rmkmMWQhVBbk5zUE7MsZZRuY8AepqfljyM+tJL8oAXJ9AKfQFozmg8rXjOw2hsKVIrchUpGq9+lMS2AbzNuS35CrDOqYDEZbp6msoq2rNakuayQ+NTlm3cH+H0NSgDAyOKqrI5PyrkdCO9TxODjvW0WjFpofjHcnPegqOT6U48nikJAZaoRBLjp+lc5rNg04LR7gxwCQOnvXTTsvGcDHf1qB8Mmeg6g1hUSloa05uGqPPEsrhLiTAJkPyjHII/wAamOm3kqeVcwBHcc8AV1V0Cx3cBQeG6c0kZEsoZjuwMc1zciudvt3uZ+nWCxwx56x9OOfoa1LZUjdiinB9KkjU8EDvjipvKwe3I5rSMLbGE6jluOLjcq4Jz3HQfWsfxqM+DNfz1Gn3H/otq1twCnAxzz6GsTxu6jwlryEH/kHzkH/tm1axeqMZLRn1JRRRXpnlHL/EG68L2+lWi+NLGC+sprkRwQS6c19um8t2G2NUc5CLIc44Geea4b7V8IP+hQtP/COuP/kat34yMUHhBh1Gst/6Q3dcdaQ6hqdt4k1Rtd0nRtI0a58lzdabJOdot4ZmdmE6d5SAAvYdc1LbvZGkYrl5maZu/hAOvhG0H/cnXH/yNR9r+D//AEKNp/4R1x/8jVn6Bpd94gvBb6d4vsTN5P2iNbnwvd24liyBvjMs6h15HK5HI9RWT4b1ObVPD+lX86os11bRTPs4VWZATjJ6ZPf9amU3HdGkKUZ7M6U3nwfBIPhGz4/6k6f/AORqT7d8Hf8AoU7L/wAI+f8A+R6oLne2ck0xlJOTjHWp9qy/qy7mkL74OkZ/4ROy/wDCPn/+R6Pt3wd/6FOy/wDCPn/+R6zwMKOfc0xzgEY+v/1qXtWP6qu5pi9+Dx/5lKz/APCPn/8Akel+2/B7/oUrP/wjp/8A5HrM25Uhj78dvepOVOAwz6djQqrE8Ou5f+2fB4f8ylZ/+Edcf/I1H234Pf8AQpWf/hHT/wDyNVRTnnGPahV3MOR1p+0YvYLuW/tnwe/6FKz/APCOn/8Akal+1/CDH/Io2n/hHXH/AMjVWI5BwM4qMsWO08EDt0puoxKgn1Ln234PD/mUrP8A8I+f/wCR6BffB09PCdkf+5Pn/wDkes1WwjAmpHcJHlfX8qXtWP6uu5e+2/B7H/IpWeP+xOn/APkej7Z8Hz/zKVn/AOEdcf8AyNVBWyM9vfv+FCyhGIOMUe1D6uu5f+2/B7/oUrP/AMI6f/5GpPt3wd6DwnZf+EfP/wDI9ZjTLnoOePqPWk8wbx05HWj2o/qy7mr9t+D3/QpWf/hHT/8AyNSfb/g7/wBCnZf+EfP/API9ZrPgqc8Gmh9yngYHen7QFhl3NT7f8HM4/wCETsv/AAj5/wD5HpPt/wAHM4/4RSxz/wBifP8A/I9Y+4lge55FDAsxPtyPWl7Vl/VV3Nlb/wCDjcr4UsmHt4Pn/wDkelF78Hj08JWf/hHT/wDyPWXbImCcDJPNWQu0gdeO9NVGQ8Ok7XLn2v4P/wDQo2n/AIR1x/8AI1H2z4P4/wCRRs8f9idcf/I1QgbVAB7Up5Hpmnzk+wXcl+1/CDH/ACKNp/4R1x/8jUfa/g/1/wCERtP/AAjrj/5GqEMcYGeOtKhBAFHOHsF3Jftnwf8A+hRs/wDwjrj/AORqPtnwfwT/AMIjZ4HU/wDCHXH/AMjVE6DjA/Go2G0/KfxHWl7RgqC7lhL34POm5PCVmy+o8Hzkf+k9PS4+EUm/Z4Otm2Dc23wbcHaPU/6NVHyQzlkJhm7unQ/UdDSLO0TqLtRGeiyr9w//ABP48Ue07j+rroy79s+D/wD0KNp/4R1x/wDI1db8O7vwVPPqUPgnTLbTpo1ie7SLSHsGZWMgjJDxpvGVkAPOMGudQ2l5b+Td7YLoZ8q6HQ+iv7f7XarPwzglt/HfiaK4geGUabp24Mc7v3t78w9j7ValdmUoKKuU9U1H4TSarfm+8OWN3ercyx3Mw8LTT75ldlkzIICHO8MCQTk55qt9t+D3/QpWf/hHT/8AyNXLPLcxx6gli8MdxceJrmzSSaMyInnaq8RYqGUnAcnGR061Nqs0OkatqWmX3jfTUutM8s3pXwreyR2wkAKGSRZyiggjktioUpNuyBwgrXZ0f2z4Pf8AQpWf/hHT/wDyNR9t+D3/AEKVn/4R0/8A8jVlanY6lomt6Tb3esaZqtlqdlcXUU1pZtBjy2gAIYzSBlYTZ4x0HXNS/NnOMZqJVZRdmjSFGM1dM0Pt3wd/6FOy/wDCPn/+R6Ptvwe/6FKy/wDCOn/+Rqzw24dMUYPJpe3fYr6uu5ofbfg9/wBClZ/+EdP/API1J9u+Dv8A0Kdl/wCEfP8A/I1Zu7HWgFaPbvsH1ZdzT+3fB3/oU7L/AMI+f/5HpPt3wd/6FOy/8I+f/wCR6zSRnBowB9DR7d9g+rruaf234Pf9ClZ/+EdP/wDI1L9s+D//AEKNn/4R1x/8jVmRtyADmp9w70/bPsL6uu5b+2/B7/oUrP8A8I64/wDkej7Z8H/+hSs//COn/wDkaqe4U0k465o9s+wfV13L32z4P/8AQpWf/hHXH/yNSi7+EHbwjaf+Edcf/I1Z6setSo/4UKs+wfV13Ln2v4Qf9Chaf+Edcf8AyNSfa/hB/wBCjaf+Edcf/I1Vt/oaa7ZFHtn2D6uu5b+1/B//AKFG0/8ACOuP/kaj7X8IP+hRtP8Awjrj/wCRqpIx4zUpbjntS9u+wfV13LH2v4P/APQo2n/hHXH/AMjUfa/g/wD9Cjaf+Edcf/I1VWLMMDApoJUYpfWH2D6uu5c+1/B//oUbT/wjrj/5GpRdfCA9PCFp/wCEdcf/ACNVVGJwTUnIHFNV32D6uu5N9p+EP/QoWv8A4Rtx/wDI1H2n4Q/9Cha/+Ebcf/I1Rqw6Gl3BRjHSm677B9XXcf8AafhD/wBCfa/+Ebcf/I1KJ/hEeng62/8ACNuP/kaoxIuOTipUbbjml7fyB4ddw874R/8AQm23/hGXH/yNQZ/hGOvg62/8I24/+RqnEhxUckpK03WfYXsF3I/tHwh/6E+1/wDCNuP/AJGqK4v/AIO20Es9z4UsooYlLySSeD51VFAySSbfAAHens+VwODXP+PG/wCKF8SZPP8AZtz/AOimpKu27WB0Ele59BUUUV0nMecfGkkQ+EiASf7ZPT/ryu65Cz8NXPjP4Z/ErQtOmWK6u9UTynf5QWS0snCn0BK4z711/wAahmHwiM4/4nJ/9IruuFXSYhPcz293q9m1y4klFpqlzbo7hVTcUjkVc7UUZx2FZylyyudEIOdOy7nrPg3UNant7Wz1XwzPpCW9qqySy3ULo0gwNsSxuxK4BOW2EccHJx4r4G48FeHSMEnT7fr/ANclrSbTpM4Gs+JB/wBx69/+O1NZ2cOn2VtaWqbILeNYok3E7UUYAyeTwB1qJy5jWjTcHdk69ORyetS4Ur2B9qbHg4zxT9gzwOlQloat6nP6lrr6beSpqOn3C2IwUvIB5yAYH31Ubk79iOM5FX7K4t7+2S5sLiG4gflXhcMp/EVcOF4rEvPDlnPcveWTS6bfty1zaEIXP+2uCr/8CBptILtbGqnBwDubPIPU1Ic4JVevaudW81rSWYalZLqtqP8Al5sFxKB6tCTz9UY5/uitjStWsdTjd9Nuo7hVOGAOHQ+jqeVPsQDSUQcky6qsApOT9acWCY3YGT+tNMjEZ/Sql1cKIzuyccgAc021EEmy69yIhx8zH7oPrUcjqhwu6SQ4Hy92PYetczJezSElsYJwB2qFL5pBt8xwAcbdxAB9qydY2+rtHUfMvDK6MGKsG7H0+tI5C7txCsvXJz+H1rAju3UcuPqTkZ/xqU3f2iM4ILL1I6Gp9oh+yNc3ACEoQR15/lVOa6CMXIz2xVRJgE2sevQZzxTGIZcNubHTmhyuOMLEpvlGeeeuMdqkhnEn3ldDjI96z5wGIJGCOnpUisqN95iD3HaovqXymqJd6/7Ip3mZGOoxjgVnxyMCVGOBk+n19qikuWVQVOACBjoefarUxciNJmIYZY49Kl81WHGM9KyBdyd1XI/vD9KlilDqGL7Dn5YyOG/H2NPmDkXU1Y7gYHyYxxx3q0kyyHkjINZsZ28PjP8AEAcjPtViJ1HI4q1MylFM0VYsPWkfpwfxxmq8b5Ktzj0qwrhgPQdK0TMWrCMwPQU+Ngeaik2luenepF4HPTtTBkhPGQM+1IvK+nrQo6+3608EY9DQITaTz0xQ/CjfyOhHUGgsCQM1Keg4BHpQBSWJ4F/0Qbo+v2cn/wBAPb6dPpW38Kbhbjxv4mKOxVNN05NrAgx/vb35SO3X9azJFYEbe9avwuJPjrxRnGf7N07/ANG3tOCszKtrE4Tnz/b/AITP/wBzdbmpeHfFVl49+J13Y+GpdQtfEtpbWtlcfardIQVg8t2lDSBwoLHgISce+ayorKHUINXgufN8v+3dQkBilaJ1dNQldWV0IZSGUEEEdKkaxdeTrHiXH/Yevf8A47UqooNp9yXSc0muxY1bw9N4VX4eaFPOtxPY6LfRSSKDtZvMs84z2yePapMsfvfnVCCxhS+S7a61K6uY42iR73UJ7nYrFSwUSOwGSiZx/dFXTuxlTnPrWNSam7o6KUHBWYZx0NKGagYPPT2akGQTxxUI0GsSTg8e9DKAM5BPrSswyfU+tRk49aqwEg5GT2pSOOKjXg8ng07djO3AFNJEsbt2nI61IkhxzioyeMnpTA+fTNNKwMtNgg8gU0n5eKg3gd+acZOMUMRMD6Y96PNAPIqr5u053VBPfIBgkClew0mzQMmM44+tBmzgd6yP7QAHBpRqEe0bjS5kPlNnzFNDSED1rJW9BOVfj371Kt6hGGYfnU3QcrNQSccUMwxis8XHTBx/I1NHOpOB+VF0ybWLUZ29ehqUNxwaqB8D5TThJt6c+tAWLCMeexqQNmq6SZzSK5BJ9KYFo7SMMKkiVUTAqsshanhj0NCQE2/tSFs9KiPPHNMLNwBSY0iTYQ2d2c9qwvH/APyIviE9/wCzbnP/AH6attWJHPPrWF4+b/ihvEIGf+Qbc/8AopqErMUtj6Hooor0TzTzn4z/AOr8I5/6DJ/9IbuuXAyOORXU/GXlfCH/AGGj/wCkV3XOgYHGKzmtTqoP3SMruyMc0xl9MjsamJ+UnvTF+6D3qLG1yNfvADkUpB5btnFITycH8qUEZ55oGNAyTkf/AF6bIDlSv4+9PZucY/GmSOdoOOtKw0NQnIzkDvzVDWNC0/UpVlng23cY/d3luximUezrg49jx7VoDn5s9utQXEjBflbGO1F+UOXmZz0kuu6SxRSmuWo9dsNyo+vCP/45+NYWs+P9J01rMXBliMs3lTRyoY5IMgkMyHkrkYyMj0zXV3UjlCU5JPJrh/F3giz8S3aXepX2oAINqRRyKEX1wCp5NYuak/eNPZyS9w6EXKXKMFZXUjKsuAGHtUMYijl+9uIHCtxg+9ZehaFFodmLRLy5mgQ/J57Biq/3QQBxV+5VXm+UHacZB71zPfQ7UtLsty75oUwMYPK5pIHWFFLLuyCMH0pHZlYZ4GMACop0KIpHIKg5J5NUK1y1BteT5sbP5VOZNrBRznrzVezTKM4dVU9yKQjzGLM3U8GjoK12WnK7OQSO5NRJsAYBz83FQXEnBPJA4PHFRwP5jnuP5Ur6hy6FzexOwdD3x1+tRiTC5J3N0yetMd8DG4/h3pko/dgH7rc8dj71Vw5RwkLSYxgDnipjJIAPJ2lwR94du9QW6ndtDA5HUDpUoAGA5BYZxg8GhMqyuXo5i4OOPpU0MuQFmXBHQg9aypZGVPlDDoQyc/N6H2q4jZxvwGGCcGqTJlDQ04p3B42lfQnrVoSjdlTxjOCf5VkNNtIBAIIyTUsUpxuzx3qlIwcLmqrkk+o5qRG2soOefyFZ6TYwd1WY5jyDkEfrVqREomgNxHAwKRiC2c8ioFYnqxH8jT+wB6+taXuZWsTRjIyPyqUZ7nBqJGwODgdD6VLnnjrTSJYjbiw45rV+GAx478Tj/qG6d/6NvayiTvHYj1rV+GGf+E78T5/6Bunf+jb2tI7mNb4Tk9I+/rHvrOp/+l09XZFBHaqOlZzrGD/zGdT/APS6er3Vea5Z/EzWHworGNc8j8alVQfepAuT6Y5phTaDjpUpF3GPFnnFAUjjtUgbimPluWFVZBdkMoXGTVd1bPU1YnwR061AD8xGeR1zRYqLBc4HOfb0p5cY56+1NOBnmombByMZ9qYbkhYsPpQx4HHFRGQKPmyKr3N7Ggy7BQOpNF0txWZaZsfSqN5qFvbf66VFPYVhalr+0nyhiMd271yWpap5zuylsE/eYdfaspVV0NY031OuvfEClStoSXI6sOB+FYE2pXM12QsrM5X7uMDP1rGtJWbeyYCj3qwtyx2spHA+YgVg5Ns25EjQh1W8UOHKnacZzUMuvuox8688kjOKpb9x/dgM7NnHXIodUl8sJGQAcNis3JlqK6lxtQvbiPzPtXlJ2PbFQrqN3BdxhroSoeST1qo5UW7WpYAbsq2OntVKe2dGXaPlx1A6GjmuWqcT0W01CV41IcbTyD14rQ/tNVAyeT0NcbpckkEKyXDhUI+6ak1C6jkjyrhmAyq9s1ftLIxdLWyO4tdTEnTp3rQt7hH5DV5fo8sjecFkY5APB4U+mK6HS9XyrLI43xjnFVGqTKlY7wOCMg04S88ViafqcVyoMbg/StBJMtg9a6OZPY53BrcvrzytSKc/SqschJqVW9DTuQT9RScg0R4IpwxmgLjM5Ye5rE8ejPgbxH7adc/+imrecYNYXj3/AJEXxF/2Dbn/ANFNQtxN6H0NRRRXeeeedfGYAp4QB6f2yf8A0hu65pWwCHxkeldL8ZPu+EOM/wDE5P8A6Q3dc2Rl/fFZy3Oqh8IzORjmhAEXjoaec9xikOGHB6GpNSPjPTvSYHIzTiu1sU1uO/NAxRjrmmsRyD+nekBzjpSEg8nOKQxJCAGI6elZ9w6quS+Ezg8ZOPb3qw8v7p9uCpBOf8Kxrq4ZwEbsM1lUlY2pxuxssp5I+RVJAHc1WZl2FXyD7etQqjsvzNzu6EUTAbiAPnHSubU60ktCU2ZliV2IC56Z5pvlxtO4XqRgU4NIkA+UsegHpTYOLhd3XntxTsiU33LJtsRBwCccc1RuImMpAHBOACOK6PcskQyAcjmsuaABw3O5ScetU0RCbvqRSCTZFEqBQnBFRXSNBGVUYOABgetW4tx6nB/vGm3KnduDZbuSalo0T1sYXmybxkfLnJAPWtGNVUHaNuRmmsiHadnOe3epM4z1UEYPvUJWLeuxExIGeDx2NCnzB6564qWOP5sA5wM49aaFYcldo6gCqfcLoRQAeOT6g0rgrOOdw243dP0pY8quRjk+macwy/I5x0pgtxCRsx3NLap+/kY/ecjNNYIzD0HBHvUsA8scDjt7ULQp7FiRoym7eAijknsaeGdV5XLZxis+5fy7V5EyRE4kx7BhmrDXOTgHkHBXvVGbh0RcL4UEMuO9WoZBIoyAMe9ZivjbkKVI5zTEYLLlScZ6UuaxLgmdHAxOMDkD1q1GSRWHZzsvzMcn09BVuPUVMpR0246HPP41tCS6nNODubEZ2DkZFKZDkEAjJ71BBJlQdwII4B9KlB3HB4NbLUwatuWV5IPpWn8Mznx54n4x/wASzTv/AEbe1lwjBOSMVp/DL/kfPE5HfTdO/wDRt7Wkdznq7HJaTjdrGT/zGdT/APS6erhbBxVHSFJl1knp/bOp4/8AA2erTgcgcVyT+Jm8PhRIHwxB79DRkbuvHpUA3BuDgCnocj5qEVYOBxmmv6flSy4BBHFNdM85zQBEe/PNQFsud2OOPSrJ7jvisy+lWAeZIQF9TTbsVHUsysNnPX61j3+sWtm2JnAbGQg+8a57XvFMkamKyTMrHAJrlmeSWVpLyUvIoy2OS3tWcp9jWENTp7zxHdXUuy2QIh79f1rH1HUZUkPmNI2RySc89qoW2pSPeD5dsR4wBwKl1FklmMc0ShMj5wecetc8m76nTGCTLRJvLJwfvqMACq8IEsGycY4xtA9O9TgLb28axTfMW4Pdh1pupXWxPNSPKrjJNT10Aq6kypbeXCu3cRz/AHjUls0SQIQVB7k+tU5EvbmOOZdoA5CYxiryWqLHucAFvvjPSrSshMZbKFuHkU7lU9qjcytM/lSMi4+6QM1Cl5FbMY13kZwAvce9QzXQNyXLmItzzUW0Gr3C6Z3cKceY3AK8Z/Cpo5bm3GZYpGHQ7e9U2ZIpVZWyzevUe9PhuXS6ALM0b8YJ7etTyvqbXVtB0l8ZVIO9l789amjeC4ZRlonHbsR9ajbTN7lrZwUJ6E9Kz5YZEuFiU8k8E0cqexV1bQ6G2lMdyAh2xqMn3+tT2reW0s4O1sEgEcGsd0uIVYRupzjqclfep4Hlu9qzMAD/ABJ91qhqxNrnRaXqKxRCcxEHftwpwGrrLHUPOC4BXIyCTXD4UQxQIc44z6mrSXaTw+VGTHLF/ATVQm4mM4cx6ElxyM/jVuOXOCD9a5LS7uRrZDKcuvByetbNtc/KO+a6Yzucs4G5E+DyamU5GRWdHJwKswyEcE1qmZNMskk9TWJ47/5EXxH3/wCJbc/+imrZEgOR3rD8dt/xQ3iIf9Q64/8ARTU1uS9j6KooorvPPPOvjMcR+ED/ANRk/wDpDd1yyMdwI6frXU/GUZXwgP8AqNH/ANIbuuYPBXAyKznudVD4SRXVvr6UjHap6etJ8uc45pjSBmIzz6VJpbUCQ+WAP0qN1yeAaOi8NxUNxIFUl2wPY0my0iQqQQB+HNQvIAD0BGf4uorPmv2LELzHj+Lgmqj3LHJyGGKylUS2N40m9y3POXlOcjCkGqEoyF7U97guUGxQoXAIGTUMoO7Jb/61ZN3NoxsPi24yMFM4PH51DIq4c469MdakcFEAXAB5BHf6VWeTIC8hu9S3YpK+o+aQgtnIYDgbqakm5uuGx1qrOSjgMc+lOd1Tnp65qFK5XIjWgkaMM0rZY8k1HNPuPHORgn0rLF6XIAB5HGTVqAmSME59afN2F7OxZRgzFR2GfrT4YXnc7wMk9qjgljjYHby33iafb3bSsx2hcHjFXdEtPoR6iht2+4c5xgd6jKqQmR9asTP5koJyeOM/1/GqsjANg9z6d6hlxWiXUshhkYUE05kyjnpu5A9DVXOCMVKs2QoY4DHFCdiXHsVwGjJGc56VJydpI59qWRQFK7gWoTAGMcGkapkYjwqjHA6VKgyT3pwjLMD/AHVIxTmheMhW4BGaeopS6EMa4Zk25U9QeQfaiS3xL5o79qnxmRSKPOYlkfqtUgu76FY7tykc7aZn5yxyPapZsnlSAOp96Z5asd0eeePeoZVx1rO7b/NAUDtUqTMS4BGwj8c/Wo9hWNRxu9R3p0IVGIx3yfQGrRhOz1RsadLIZRvYFCMAemK2om4zjNc9ZSiNslTubg/StaObOBg/Ud63pyOWcTSB4BU8Vq/C9t3jvxOf+obp3/o29rn0kLfQ881u/Ctt3jnxQf8AqG6d/wCjbyuiD1OStG0TltIcBtZz0Gtan/6XT1dYZ+bis3SzibWAV4Os6n/6Wz1dzjIyeK55fEzWC91A+Bg0xgff8KaWGdoqMy4Q+o4qLl2HyE7TySaZ5uQeeRUbSYGWwM1CzhxnI47U7hYZd3vlAnqxFcL4o1SVklIDMqD5QOma6jUHBTbnBBwDXK60nMbK52g/MoH3q56knfyN6cUc5ZM0qC8uBtfG1Qe/rSQRm6LEbFXcdzE4I9K09RshNar5BJxyFz29BVBLSW205yyZZn6dxQ3fU2Vird2rwucduQQeoNWryJ2t4i3MQUAnPJNPt0bALhzCByG9fam3CutsUj5GflyajctvoS20IntEK7g8fA96crBVaOcAgj5h7+tZ2k3xt7hoJm6ngj1qzc3cQvijg5xj60PQTRoMsc8H7okY4GDjFZryyW48q6JVT0PWmR3fk3OIG3xkgFT2rSniSdSJFyfejcl6HORQn7RNISfmIxzzSXmxt6bBwcbs5OKtSwLFIylwB/CScY+tUtjXDp5UuSDyKZrErOCjBomG08Y9DV62fZbGWQtu7HqKbcW/lBy3U9PWrdnLBb2QSXDbuaUndFaDtHuS94AD8rc49K0ru3hZtz4JJqnYpCQfs42nqfWrdxA88O6IkyZxUPyE9ypPFlMRgb88HpxV21RWCqu1QvTHc1nQWdy0h3/JtOCfar6WkO4PDIQRzx0NTZIG9LXLEdpiXzJGd8HPFQ3cUqXLTWrZRuq9x65pLu/eCABGBYnaQepHtVOK6mQsxZiDj7x4pNXV0KOjOrsHkRITk/N1HoK07ecxzN8xK44XNczHebbYSk4I6AdzVT+3ZopNseBnnPvSUraA6blsei2eoIyqWyM9q1oZd+CD0rjNLuhe2qvwJB1wO9bmn3W5Rn7wOGrohUOaUDoFYkZHWsbx3z4J8Qc/8w64/wDRTVpwv6Gsrxz/AMiT4g/7B1x/6Lat1uc0lZH0nRRRXonmnnXxl+74Qz/0GT/6Q3dctIeQQevH/wCquq+Mn3fCH/YaP/pDd1y7KO+RzWc9zqoPQYSSOO9QvtUliBuHeiSRUbG4DnmsnVL1Y1wxJU8j3rKUuVHVCDkye41AK/BAIH4ZrD1LUgGZzjc3GfT6VWuL0scIpB6DI61Tl2zDZIDu7Z71yzqNnbCioj47p5CCXLH69KswzylDhhuHtxVOxgEUTsxA55x6Vftgu8hvlIBqE2aNKxNbtuuJG8zcvYY6VckiLAFeABg55rOh4mUjpnvWxb/vI+VwvbnqKuLuY1dHcpTKcHH1znpVZgd2cA56YNXJjHKD5ZxjIxjFVFVS42kKCep4xSe5UNtSIxgkEnpyKilhMjHccjHTpmrHCyEnpSzMix/NwPzqbFq99DPFqyl2UFt3yjHNaMKSxp86lVU4wf5UqLgKAcg1Oi/L157Z5xTUUKTZX8vLNkDk0+MNCyiMEs3cHoKV4PMxvUFhxup2xlK55BO0+lFtRNovW8GMnqMfUGqGpR4wTgYYE8Vet5HDElcoB26mq+o/vFTABUsMmqkRC6mUWOcD2/KptjABu2OlRbdzlVPIHOPStDyd1ptUYGKm1zSbSsVVGfm9P0pSq7cnJbPygd6e6iNflB345Dd6WNCX+bp7Ukh3HwkDPG5Tzz2q3M2YsuoBXv3xSxwBosR8E9s8Gkl+RMNyQOPetbGDakysPvg9j3oaMNk4G6mFgY0Pp608MvykHDetI1ZAYiGZT0PIqGckAbSQRjJ64q4ZD5pYDHriqs+RJuAGG4NS0WnfcbBMrMEJ6HBLdDUirskZyQAw9c4pjQpjdwncn0p3y5IIyAOuetGtiFHXQmEnlsCcBT3FaVrOAwyew6VkxfOm3+729qnhBiG3qaadiZw0N1Jd0i7lIxxnt/8ArrpfhUc+OPE+f+gbp3/o29rkbKX91lxz0PPT3rq/hG2/xr4nJ/6Bunf+jLyuukzzsSrROT0w/vdZGP8AmM6n/wCls9XeD97rVLTR+91nH/QZ1P8A9LZ6sOpHt+NZSXvMqGsUOdBnI64qm67W3ZP0qy79CeKrTuPLz1NJpFK6MrU9QWAAMrbRycd651vEkdx8savgHscVo6qDNBIpHLAgVxNnbyx3BtTGrMuTvArlm30OqEE1qdJ/aPmhgTnGetZl1qixSmGbBDep6fjTEcxSbepfqc9DVfU44zG0jLngDntUrUaSvqJHOpykMpXqQueazJNRkjk2yK2wnB71TLZn81GC4yxJ7VK1z9sRmIGGXbkcc+taqJDmkE2qRfaAvmER46GrgulKoxPPOM8g/jXLXFtJGypIVGDj5Tn8a0YplkVIkU5XG0GqlBWBS1NGaaKB1n8tXBxg+9WNPvo7m4OYtrYzuqMxqludyrtY4C1WsnS3jkMg2tuwcj+VZuJaldGit/axzFY4wSW5OO9UdSuLmVgRlEPpUapgOQyEydMHpVhJ0a2aOQrk0rNFplIq8svlzN0+8etXtLtSsrvhVjHA9ahj2IWk2NIw5LA8VZgu2nICsFUgcAUNjb0C/kT50VQMD8T/AIVkQ+YZTmLdg/dHpWnePDbhhIC7dgP61VCfaNhjQqT2H+NTfoOCtqy1ZSsjtLtY5HQ8YFalhKuz7wOehqnvKqXZQVH3gKsWaoT+5GFPJqfQJSvuWySyk5Iz0FRmNlG7hj7cVMsAZWCEbvX3pkysDHlvnJ5oaJTKd7DCYJGkUE4yD1/AVkwCYq5QERIRweSa15A2SpGQenHFROyquWOFB5UDipv0RqnpqN8tnsVTJBYlh7UyDSnmjJVh5yHO0HqDVyORCoZRkegFW7eTBzEuN3U1FmV7S2xf0nFjBHBI6idznFdHbBWHA+Y1y5QMAY93m9A/pWvpjtBH87Fj9auDd7HPUV9TejumjdQ2AvSovGshbwTr+CSDp9x/6KaoxMGQZ71V8WTf8UVryk5zp9x/6LaumDszmqR0PqaiiivVPIPOvjMcJ4Q/7DR/9IbuuWkfIYDtXT/Go4h8InOP+J0f/SK7rh7y5ZUIjYg+wrGpJLc68PDmRRvr3LMsa/MONx4NZN26uQpwQeQamcMNzdz29KolwWKtkMvSuGU3I9anTSK93JstwVzvV+fTFMP7xcqMbBlvf8anlAwSfmB4xVa4BUDyG2qTgYNQbLQklZRhU+7jIIGM07zXdvMkbLOcNk8k1FEhwobOcDPt7VZeEMiuRg9ee1KJTsTwkD5iee1attLuiBzt9xWKATG5/hXrViM70wDgHpg1SdjKcbosXjAuJImyQeSO/wBaq72D7xjcDkVLsHl4JPPBqoEYNMGIGSACec07DgtCxNkuxwSW5YsOppiRO8ofI2Kv3e+acAfLT5uScEegq9p8sc0LLgBlOOucj1pqNwcnFXRnjzTcgf8ALBVzx1z6VYgcmbYfXirUtujHMQ56VGIShK4+Y9W9vSq5bE86kLGpMpG47CcgHtV2RUSBnIPA5A6mqkO/zXDAYBG2ruMxZOMg9KDKa1IkUgblH4YptzGGBIGcdR61fUbUDnjB596fJECN3XI4PtQRz2Zl20MUSkBeTz9aswMqnYfunmonUo2M9OKj3EOemaNin7xJeLxlOo556EVDIrLFHhxhsfUVcYLswx/E1TnbaAucY/yKC4N7FvTmzld2dpxk96lvh+7GcZ/lWfp8hXJPLHrVy6kDxdfarT0IlG0zJCkYUH+In8Kk64wOlMfcCxUDpkA9zToNxcluhHAqDp6XB2G7knPY+lSKu7qMA+vemiAoZN7F8sWUN/Bnt9PSpA25QCT6e9BDImGDtY8fyqEqOShwKWZjG64+YH25pJCVG4DKjkj096llpWFhZkuQy4IIwTn+lWJyWUbcj1waqISrnpsxnml80q7Z4HY0XE43Zq2kr45xjGPeuy+DzbvGnik4x/xL9O/9GXlcBBOWBySPSu6+CjFvF/ign/oH6d/6MvK6KDvI4MbG0LnNacf32sj01nU//S2arRbII59s1SsM/aNZIPA1nU8/+Bs1W43+UhhyOlEn7zMYL3URON4OSc1VlHy5zntVh3G7HpVO4kVUfJ461LaLV+hk3yYlOTwelZd9LBbxkuwTtketS6rq9vHw8gyeAPU1zE16L4/OAFRuO49q535G8b21HSReUd6yFz61WuJGYZnmVAeo6mpt8SLh2YNjuep+lYGrXsaRGNiW3E4wORjvThTuxTq6D7lLVbZlZ3xngAc/j7VkGOUMNjfL1IOTgf570S6hdT7ASrbRjaw6D3NZ93qNwTKuX2cKwQ8V0qDOb2nVm0Z4HRA0pDkfM23Az6YqcFIgZBcB0HZDgj/GuSe4dRuznPYn/PNJHJ5e3OcDoVHf0o9mT7RHQy6yruAGdxnowwR9DVqG8S4ZBMMhe2c4rklkUzndkAdD3qeO4xIN+W7ZA5/GlKmXCsdr50K87QwJ2jb9OtQvNGpUqjY3fdPTFYNndv520hmHHBrVtEjLr5rMTngMKxlGxvCatdm5DGJHBTGxeTuNW4bdcZIAP6Vnh/LIK856qfXNXYL2J12k4I65pJLqLmfQiutOSa4TdkoPmbJ60XShsRwOqMvUdMVaaVCOSB9ayNXMeAVBLMcZrOUTWEmyVI5IZvKkKmJ+WY+npWjHNHEPLA2qo6isCO6aRY48fKOME9asRTyicQhwVc4IxnArOzib8tzpYWVkDDBbqtGQSSBh+ufSs+JoYgImkG8HI56VajET7wj7mHUZq02zJlW4kKMqrud8k5xVSeYxwys6Aktgk9BWodqkHHzAdaz7rbO3OAAeOwrNouMivZM8akKGLE46dBWlBnJAznOT25qjApXLBwsZ4B9aebiW2Y4wcj5fTNHLcq+ptoGAC5IIPP0q6kgVQvT0965GfVlLhVdlJ+9g9DV/Rr17kfOdxUn8aFpsEovdnYwybSNy9qpeMZ1TwnrABJD2Uyj/AL9tVb7UyLuJ49DUHiaVLjwnq4znbZzMP++DWkZapHPNaM+xqKKK9k8Q8z+OR22fhQjtrJ/9IrqvOp5vk46kd69C+PJxp3hU/wDUZ/8AbK6rzKSQO3APvXFiX7yPUwMbwfqQ3Bbyjg9DnP8AjVJi4VgQvPHHWrczDYwH4is55MkKCM/xZ7CuVnpwQEkhOoU8k1BJLtBCnIptxJkqcDjjjio5MbuCM4yfapbNFHuW4Z/mx/kirsjKyADPPOBWIWAwwOPWra3G4qRxj9RRHzBxuWpN2/Z0B7etJZnbcOWLAEYwf50xLgz3G5v4Rj8KtQIftQzySOKtak7J3LDFgij73cn0qthi+HKlg+Rit6C1Bhz1rMu4THJnIOcgcYrSxjTmm7EIG9ZFPXHApdOJWIvn75zz1x70m4blf04PHANVrDc1xK+5sZwF7HNI1t7rOntrJGlhuSw4G3k8U/UI1QttI9jWc12YbNww3AUouWuI1LHkjn3rRyVrHJ7OV7sYX2OrH7r8E+hqzESu4sSxJ2gCoFwEwOnp604hTtHJA5+tQaOzNWNwVG7BHpTJJtjhDko3Q/3aqqzELjOKc771OOee1Bio6jLj53B5qJztmY8Y4INTRksXDDAXoaqhZXmlUrkKN2R2FJmkUcRpfjfxJrlhFead4SWa2l3bZDqMalsEqeoB6g1O2u+LCCG8GdOD/wATWL/Cj4PvjwDpu5TtAl+fsP3r12hUNtwMDHAq3ZSen5/5mVNScU+Z7eX+RxKa94sjH/Im9/8AoKRf4UP4h8WE5Pg7joB/akX+FdgE3yYweuKHU78bSRyoOe9O67fma8jv8T/D/I4x9c8Vvhv+EN4z/wBBOL/Cpk13xWBn/hCx16/2rD/hXWiImPPp2pLfK5V+RnrRzLt+Yckv5n+H+Rx/9veLI22nwd1ycHVIs/ypY9f8VsmR4NzzjjVIh/Su0lRSM/5FRIoVAo4xS5l2/MfI2vif4f5HHPrniwkk+DeM8f8AEzi/wpl94j8T2ljPdXPg/wAu3gjaSR/7UiO1VGScAZ6Cu0zxjOQfWsnxjKqeENaUkZawnwD/ANc2oTTdrfmTKM0rqT/D/Ij0e++26VZ3flGJLmFJghbdt3KDjPfr1rQxvQA4BrJ8MxCTwhohxkixg5/7ZrWoCCBk4A5zWclZnRGXNFMkIICjqBXe/A1t3izxV7WOnj/yJeVwanJA798dK7v4FDHizxXj/nx0/wD9GXla4f4zjx38IwNOGZdaP/Ua1P8A9LZqnbHUdKg087ZNa5/5jWp/+ls1Jc3CrlU5briqm7NnLTXuorXUoQswOBiuU1LUzcXgt48hRkbvet+9HmRsB161zFyEjLFFHm/xEDk1zTbex007LcwL6AG8R5W4VuVI70y+vYIWASSNGHO0d6l1KUuHkJCFRnB71xk6AI7yYO49T1U1dOHMKc7Kxuz6nCSMOWPXg9Kx71xJ5jsyuvbnvWTHg3C4fnOMDpWkEjNvGgVy6scsB1H/ANaujl5TmclIzpxJHiWFiHXrg5qBRJdtKzPjHLY4B98VNqUMkShguEk5yKoROwIUNkdMVrHVaHPLR2J5Y4TbEB8upzx0qkrMm5OmeauQWjSOy4wTn5R7VoW2mbIcSxky7uw+79aXOo6FcjlqZMVvM7B2Vjnpmrp024hBZkDnuN3GPU1oG/jtYmQIvmlsFien0qCa5nlRm+WOHruI/WpvJjUYrQght5Q4YhQByBmty2cFvmzISMkZzisESLsz5zMRyMnFWLOdPM8xQwUD5hj+tRLuaxd9DbAlkfes5ihKjdzlh9PSppeJYxDOr7hhQ3Lt78Vh3nmxAvEu5Xycc7hVTfLsWZyc8DnqBUWutS9YvQ6p5whHnhCCcbUbvTUQs2dxZF+ZVNc/DeomFDkbj97qauPJNw0Mr9erN1/+vUOnqaxqaGp1fczHnnAFT28sUOSI239mPJNZ0NzcbMPg8de4qVxGkOUcySk52gfnzWbhY353bUUyNJIRvVF6/Me9aUN2Lfazg+YePrWRePD5ayIGEw/i7AemPX3qtFcNJKplbgHjHahw6hzcx1Czy3R+VRGO+5qQQujFXjLIT94niqFve26Q7g7BT1zyKtbkUiTcPKxhRms2vItXWxZkgDMpKBV9AccfSmXYjkiMcbD5T2FUbm+Z1dYmDBOOPX60lgnlny5mQPjcMHOf/r0rDIJ7BWO5SBjqAabZ3n2W5QH5Y2OSueatSn/SCrnceoIrPvoGN2Ac5JxkCiK6M1vodvbD7TArxnCkdDzVXXI3i0DWwfumym/9AatHRoQlssYDfKo5Pen+KYWHhTWCRwLKb8/LNEYK6Zy1JWTPsGiiivbPCPLvj4QNM8LE/wDQZ/8AbO6ry8uNuQpHoa9P+P4zpPhcf9Rn/wBs7qvKXbanXp2rgxT99Hr5er036jZnLR7Q21iQuRVS4QiXI6DgD1qWbd5qbQcgZP1p/lgkvnIYAYrmPRvymaU4Kn71RSQyDa2SMjoe4q/LHsYhuB1z2FUzMS4UDJ6KW7UmaX7FNlKOR2PODToHx8vTPH0qzOyvDkrghtpIHU0yzIScOUDex6UXKT6ly3Ux7RwSCckelXLWbdPkYx04qm+QrbSQSe1EDbQcjPGBg4pqVhNXR1MF4PLCg/UCqOoTBnHuePrWbFcY+6enB96l83cp3jJ7VfNc51S5XcVzw4zyvJHrU1mjGNgudqnfxUCxgylxnDL09a0NMOw4PJPB96qOu4TdloLJbPIjYx+Haixt3eTye/vWu0aCLGQWYcEd6oyTG2n3IOnX3q7IxVRyVkWVsiDsPJ7f4VHcQrDJtyCc847Uw6h5sqlMrxmlZzK4dhyfTvnrVNroSozXxFuKIIuTUaOqmVQuc4yas3S+XbKF4qjbldxz06k5oloTD3k2KGCseevpUTyqZEKZ5yOP89KfMygZHc5qKQB2+bHH61mapdzkfhJGp+HGkFh1Mp56Z8567E5Awxrk/g+f+La6TkA/67/0c9dMzEOvqc/hVz+JmdBXgvQnt1BlPGcDrTJiRc5UcH/Cr1miiInqfWqt3iN0b+FTyfSl0LUrysVo0P8AaJz12Z6/pU08W0Egcg5BqW1XNzIx5boPTFLdMDnHWpKcnzWGSR4jHpiqWNv+etWLqfAVc8E9qp5y5B60FRT6jgflOfxrF8cIH8Kaux6rZTf+gGttQMYJxzWV41GPCWskHrYz/wDoBpx3QT0iyp4SZv8AhEdHxg7bKE/+QxWvhsb48biBjP8Anms3wghTwnorAdbGE4/7ZrWghPkEIeUbHSpnuVCzgrEqqNodVIU9R6V3vwN58W+Kj/046f8A+jLyuIhO4gE5BrufggAvi/xUB/z46f8A+jLytcOveOPHP90cSZ5FutbjT5c6zqQBH/X7NWPd3MtlIJpcsp4C9Wc+lbsKbrzW2wDjWtSxz/0+zVTuYY5ZvnXdtO4Kex9a5qybmyaDXKr9iN7sCFZCu3cM4PasLUZUaVJBgAgmtHUG3gjaAO/PSue1GQJEVdhn0/vVPMzSMepi6ujSEkLlcnK+v0rFuoYUI3vuTgMB1Na9/KCrfZ2Z04YkDNcpcTyNlYfv5ye+T6V00rmVVpIllWKEebESypyFIxg1Y0+/DM8jKA5yrkdvwrMlad4QGkLF+GDDGDUMcjxx9BsHJwOp963tc5tnqaIuYZ2kBYAsehHyk/0NIunIA5EHmMR8o38H6VmKQ8g8hGyOcE5rYhuZVtcKCZ2IVEU9zUtOLHo0V41S1uBEIXaVfvKONp+tWDNdSjDN5CnjIHOPrV6ytI4t6ufMkxkkn8+e9Z2uz4cw2xXeQNx9vQUt9hNdynJJZwKVkTeSPvdc1S1G48yTgKFAACg5AqO4j+RFDhnQYIXkVXK/I3I47Vso9TGU+iGAsDnPSrlrPtjf5sZHQ1X8os4QHGR+dN4zhevSm1cUZcupoW85jkMczM0bcg96fFKkMjhpCyvwMjjNVAzRSDbIDxwVOavmJJY1B+9jovUn1NZyVjaLb2GzxboRLHFgeg6H3FQjUZgADllQflTzMYLWSInzSSMAnIU+uaqgs+BIgZSfXH60RXcHLsTRXTLOGyRuPQ+la8WpRgKA5Kj1FYjRjYGjOfQn+X1pqiYq5x8q/ePpSlBM0hVlHQ6lJ4phuUBs8Eg0y8s2mQpbjBzu54zVLRAzSINwUEYJx2rpYojEVVgDGOM1yTfIzti+ZGDBY3UYeMx+Wr9s5xxWjezfZLWGPOWC4Brb+zo7gEgnrkVlatbKXPmjI24zjoKhT5nqUtjIa/ghdfLLbicuD0P0rX0PS3luVunYmNsnrnP4VzNyIRITGhVV/M+9dpoERk08Llht5BHeqq2iroKTetzXtdHUkNIwYjpgfzqZ9GWa4XadsvXcB1q1pSutvhzkk8Vs6ehM+OgUdfeskk9glJjdPspII/3r5/DAqx4rtwvgfXiecafOc4/6ZtWvb2qnG/5vY9KreOPl8E6+McnT7j/0W1dFOFmctSdz6Xooor0zyjy74+caZ4WJ6f2z/wC2d1Xkl3gsQMbR2Br1f9oNiuj+GCBk/wBs8f8AgHdV5LJAwQMVAGM8dzXn4v4j2cuS9m2+49SDjtgdqbB8zR5yO1SRGOOFt5zIe/rTYZVQkModCOOcbT6iuZbHe9h11EsqNzhz0NY0kJ3/AC9j+NbO7zJQo9aqSNl3RMbh+WKbVyYu2hWKgRt1KtyfrSxoAmT69aFR9gcn92Tj8aSNS2dnzBckjNKxsthzMcEKDjPJHakTd1HPrWpZiBbcMzDfjpWdcYJG3pnJOP5UcttRxlzOxJAGdd3GOlTPwikZwKbCoBYEHBFOBGWHcfrQmrCe5ZtxlRxgYxUscixyqMnnpnvUNux3kZPAyfSpAqnPHzYrRPQya11NJnJiCn7xGVYHoapyylzknJ71btn3W5GMlfWqNwfnHoefxq2Z00rkMbbZ+OiiteJwqAkAjeB+tY+MyjGMsvOasNIRCGPBXDUk7Gk4c1jd1GYGIY7VmtnGO1LPPvjAxxUYkKkNyeg+lU3cyhDlViaQEKdwINQ5O89ucCrNw/m8jAY9vWmNCQoAXgUDi7LU5X4QH/i2ulDjP77/ANHPXUyAFA6tnPQiuP8AhG3/ABbvSgen77/0a9djbv8ALtBG3nj1pz+JmVBWpxa7InSQeSqkn7w9s1ChBDDqWJJJ5pZInBVkAIHqaXaYYsHAPr6ipL06C2riMEAY4qvPLubPGFGfzphkVR83WmAAoo7GpTNOX7QOwYpnPpSS/KQDjNOaM7ct09ulOKiSIErzj16VQroriQcHnOefasjxjJv8KayOqmym7/7BrQlySwQjP1rP8UL/AMUdrLcf8eM4x/2zaknqgqaQbJPCTH/hD9FOM4sYen/XMVowMjMQVPzYbIrP8IA/8IfopHH+hQY/74WrkA3PkZDYzSk9WFLWBaBCOQCCOua7r4HZPi3xUT3sdO/9GXdcOFXaysvzH+I9a7j4HY/4SzxQB2sNO/8ARl5W2H+I5Md/COPhw13rgGQw1nUjz0/4/ZqztQLwsZEB8th8zf3TWtbgG51k/wDUZ1Mf+Ts1QXCE7sAn1FY1leTM6L91HHalfPHKQqZJHU9AKwrlp74oehHI4rs9RtXYsVwpIxnbXO3gSzi/e4LHj2FYpOO50pqxk+TKkcpG0YHJFc5qDk7QYiHU5DKecf1rrEJkAzKSSMLxgD/GqF9bRM6yBUMo4ynrXRTdtTGa1tY5qUFxllcjup5596qmCSQEIh2BdxweK6EW8bOQRIr5BIPGag1GNpVYIMRL0jQYB9zWqkzOcU9ylYwosLLBHvmI+eT+FfYHvUiA20XynMsnGQOE9vrTLC9McqoGKKo5A/wq1IDLHtYKLjPyn++Ov5022ZxS6GH5sltcOSWUjpjvT5E+0xv5TfOcM6/Srlyn2meMCIq6j7x7j0qBoriCfzYbbKnj5QTn8Ku66GbT6mSqt5oKMCwP3T2+tO8tkYtNjGOM961Lm3i2POYGVl5KFe59KzyvmGR1OQOgNXzXI5bEMNqbk4hCh/7ueoqWbTJU2qCCwH4EetVkZ42DAMuOh96tyalcKiqrDzFB+fHJB6ik+boJcr0ZVMTxOPLKv6hecVdtXaWQxTDaSfujqf8A61VFG90B47sM4qOWUZxCSv04z70WuCdtUWrtIo5WjPJ4PyngVHbs5jeMEENyQf8AGmQxtPlnbLDgcEk1Ygj8l2X5HYDnuFHqTSdkrFK7dyI/eODG3pyRj6VIN/lEPHhCc7uuTUEjMD5anb2OK0tNs0u0KRzspxyD2pSdlc0ppuVkX9O8wvF+52kenQ8V1VvG0kKM3JVfzrF0/Tp4JEwd6A8c5x9a3rdHeNVBOOea4KjueglZaDbmVLZW+bLsCF47VDDItxEFuEPI6461JLHFEW83fvyAPerd5ZYhjkgJZeCVrJ3NFYpnw7aKY3fBXORxW0sUVpEqLhVUcKKktbOSW2QSqMnoM/dFXn0+Gd497t8g24Hek+aRN0jD07U5vtwgIzG5wjHtXW6RazQXM8kr71fGPaobLQ7ZJhIF6HcM10MSqPTFawi+plOaekSxa5LKG+tZ/jk7vBfiA5/5h9x/6Lar8BOCR9KzvGQ/4ofX8/8AQPuD/wCQ2rog9Uc09j6Zooor0TzTyr9oT/kDeF/+w1/7Z3VeY3lwrW0QbHyDjFeo/H5d2l+Fl9dZ/wDbO6ryT7PmQbhx0BNcGKvz2XY9jL7ezd+/+RWLFhvXgA5Oach3nKnjHB9avT2SrEA2OnY1Wji2YUdAOlctrHpKSaHwbiWyCMjBxUccO2Vg/LDoPWtOztcw7iMmlmjA5X73arSMHLUx2g3yBTu252gdPyre0/SIBESynJqhBbz3F15drDLNIP4Y1LH8hWvBebIikyMsqMVKkYOfpVwS6k1nK1omJqNoInYIAB6is4H5yowQT1rauS1xMEAxzjFZr2ywvIT/AAnoKzmrvQ3pS0s9x5yNmDg5Gac/DNjGD7daYC0jjB467abuZnY9Rng0kkjS5MjMsZ49/pVmBgzrwOeM9qptnB3fUVbjAMa4OO5p3JlsaN48K7fs4IUDnNZ05xjd909D6VMvCjcBycDvmnSRblwR9c1bd9jOKUSt2UkZK8fhU4i8yEc4yDjPSnLAoX5j06A9/apNpLDGQM8ewppXG59EV4NxgAwd4GGBo3MqjBIBPIz1+takVqQgOcjGcdhUE9tvUhTjnOMdKrlsJVE2CtkKQOnOKmaYbigOTtyKjtoySSxUEcVDKStxgfcxgGgiybsch8Jf+Se6V9Jsf9/nrrI28tmHXdyK5H4TDPw/0knoPN59P3r12Cj7xOciifxMmi7Uo+iL8O5kiVzyaivxuUjHGentTYZcszAjAG0Go5Zg7FT09aHZISi+YpXHMIOeAM/Si1ZmjXpyODTJZAQR1zwRjpSWfypjIGD0P8qzR1W900MhYi2Ccdu9MV8RnbgBulMRwFLHIzxz3pI12wkkE4yaq5jykHygOzAZ3cD1rM8WOg8K60gBybCc89P9W1ahCluvB5+tYvi/nwzrJU/L9imH/kNuKcdx1FeLLHhWRo/COgjAC/YYPx/drWha4O7+9mqPhRAfBWiEf8+UP/ota0rWLGc457Up7ipNciJ41DDA6nqa7f4ILt8W+KAOn2DTv/Rl5XHLEWCjoucY9a7b4Mrt8ZeKR/04ad/6MvK2ofEceOf7uxxtpIv23Wl3jcNZ1LK5/wCn2apLkcbhzjrxVSFtuo61gD/kM6lz/wBvs1aMZ3R4FZy96TRnBWgvQxblGP3T+7PavOtfS7kvngdiqdVGOor0+8tso46huCBXPX+liZWDNmPHCnqD6g1lJNG9OVjzu2kmyyP5oA4O08fjWgpBiQyhEUEYWtKfTUsw+zcTnlmPJqlPCuVK7SRwu49KXNrY0laxA8vnMxVfkAPzH+lUruOW4sMqo3dQBWpZ2rpbgfMZDktnkVLFBm3dUwvODzgZrVO5zySRxQEjtsdSWAyCDVyG1lCfOCGyCOeRWs9mhlIIUN1x0prqkCPG5Cxqu7OeTWqlfUyaS0Qx8wRb7khItucj5iT9Khg1WKa4WHLeTjhiu0k+1ZMlxHIxiICA93OMVnufLmR4i42n5S1WomL1OwlhiuNyZ3IFOY2ODnsa5PVrOS2dWVWUH5iP7vNaNhrFwsjjaH3dC3rTotRjnM0cpLvgkFuh9aS91g02rM5zyzs3AksefWlCNuVlBOevfFac2nTK26JNytyO35etEFlNHFcSXFu5QIfmHABrRzRKp6mZMoRXWHcVY8kjkiqpQ5G0E55q+0UuwEHIA5A7ZqBFcK3UZ6Yqk7ENXJYJHWZAATgcgHrV2SKR9ohQRg8qgHUfWs+EbSxQbtv3jWncyK+1Tu5wS0YzjFZT30N4K6KUg+yMFaM+YeWcnJxWjoxDzfuUwQAC1Zl1IjSbg7NxtIYfMDV3S2ZM7iVA6dsVM1eJpRaUjsbVysoyNxx0q6G6BP3e5vmNZuiyhgyhldR/GOo9q1yodCxHAHauNpo6r6ks6JNGEJBJOB61etZI40SJ3UOBjBNZ9qY4/LZV4fhQeufWnyWiG+WTncxAxUbalrszet5PMcqjDaB39aqgT/2ukMQY8gk+1P8AsbSxbUPzFuccYFdBp8G3A7AYz3NNRc9GQ2oliNGAGKuxRA88cCkjTBJPapYydpNdChY5nIfFHhCB0rM8bKR4I8Qen9nXH/opq14m4rL8ckf8IR4h/wCwdcf+imq47kSeh9JUUUV3nnnl/wAewTpnhcDr/bB/9IrqvK5HVAFR+2Md69W+PH/IP8KjGc6yf/SK6ry77PiJ9xGSc5rgxfxr0PXy+3s3fuQ+bwN2Scd6gfOcqeDyDimTAmTIB29D7Gp1jLJyNxI5rjuelZJFu1nygBPar+mWs99M/khEjhG6WaXiOMerE/y79gajstKjtYEvtWd7e2YZjiUfvZ/90Hov+0ePTPSn6lqcl2q20ca29ki5jt4z8oPqT1Zv9o1stNzFrmfundzeObW38Hzw6e6C/wB/2dHjiEW8bQTKFH3epA98HjoPOrSESBmzg1T2HcM5+taNmAVI34PtTc3N6kKlGkny9SvdQb4+AFwNpIqpK4MJG3BAwfrW1dSoq4HA7ViTkeZnOAe3rUM0pttajtOQrdwnZ5kiyBxHjO/HJGPSneJRm+lkUBmMhcGJsqmeQvHHTj2ohlDscD7vGT3pbK5P2QQqF8tSwxjv1pqzXKU+ZS5rFa3ieYbW/hGcmrnlMDGoxtbnrnApy3KXJMpUCXOGUjH6VPFHnBHLHvTjGw5SfUdDGAwPXFWNvmyNIRhBxkdzS28eTx8xzj0FXI4CSDxkdF7Ct4Quc06limLf5hubBJzipLa2UMwUP/eJPetVYxtzsBI7nsPaoxxMgx97PQ9BWqppGDrN6EQhBQHtTJ7YtjHXt7VobFJwvApCMkjHH86rkI9o0YhjaPceCR3I/nQlr54Uh1BPVa0ngj3FipLYxx6VWjgLEsvykH86zcDdVLo8k8MSeKvDOgW2kS+EvOa335kOpRJu3OW6c+uOtbLa94ski+XwXgMM5/tWHn9K9BmQuV8wZK9GNV5oyMZ6dqmT1u0EFaKSk9PT/I89g8QeKoy8f/CIbuSQDqcXHt05o/t3xUrc+DjzyAdTi/wrsLqzaSVXQ7GHX3qKQOhXzB7ZHes7+X5/5nR7NvVTf4f5HHnWvFLM4/4RA+uP7Si4/Slh1nxSrnb4PJLdv7Ti/wAK65NvEkjEHoF7GrMERdQ7KVOOmc4ouu35jlGSXxv8P8jjRr/ihyU/4Q7J9DqkX+FSN4g8VBCp8G4Hr/akX+Fdjsw5JXYpFRzockJ973ocl2/P/Mjlb+2/w/yOM/tvxSOng75unGpxfyxVHVbrxVf6Te2Z8KFDcwvEX/tKI7dykZx3xn1r0GCLjceSe9Lcxcjy+QD60r9Uvz/zG4t6c7/D/IzfC0U1loGl2tyhSWC0ijkTIOGCAEccdq1I1ZnyAAOmfaltoRIDnkDrjufSr0ce4AEcAcY6UrOTE2oKyEgBJU9+1df8HP8Akc/FP/Xhp3/oy8rmoojghuG7V1HwgGPGvikZOf7P07P/AH8vK6aKs7nBi5XgcTZ24a81t/72talyP+v2arWwL0/KoLKNftetP/F/bWpf+ls1XVXnGO1Zte8wg/cVyu2GVwwxkcEViagjhGA4J4B9DW8cBsY5H61nX0YKNxke1RJaGkXY4O8DRqy3MhKA5JJ4z7e9V4xBKC0eCwOfm5/SrXiiPbbYIOcZCjvXPaHLumMGGXgsSe5rJKyubrU2Wk4ZNwDZ7dzWf9piDyK0oUgYPaor+4ki2rAV2qpJ9QfWs26LRgOAwATk4zyf51cdjJx6lmR2aRtvI4Gen41k3lz5S7Yc/LjBYZye+fSr9hM0jhpEwq4BBPT3qeWyjnYmD5yvXHUe9aRZE4nKOOZGlUh3GRu/lUEdwsUeCpZyfwxXU6hbrEsa7PNiYdAvOfesO+hgYrw6sBhhjBNbRlfRo5pK2qZQuZlyDCxwRnJ/lSW6yXDbRjd2J4qN1TkDIOeARVqGEeQpEilz1QHn6Vo9FoZrV6li2MyP5e4uQPuNz+Rq1BeM6xRSq391hydw/wAazYlZpfMRWXacsRkgCmO5kl8xCQWzgLwRWbgpbmnNbY07uwFvmS2bfGex64qh9lbYQo3J255HrVyK7ltFUSne2BkNztqaDVGWY+VFGozk5XJNR7yVi9GZxtHW3LFHUnhcL1+vtSCd/syqFxtbBPqa6C2uBO5zkMOq54/CotQa1ESqY8DOSqjIz60ubuaQjZ6GVDpqXih0fY20lgafaLAjskhKyIOOe1Mi+1SvugiIA+VSew/rTTATMAzrOw4OB/Wk77NlaN3ijU0R2F7KImzGUO70zXUwu6WZYEc1y1hcww3Udso27uMgdPaurSPfaIMhR3NYSvubiW8gluFO4YBx9T7VegiLagVDndt+THb3qWysI0iBhBL+pFa2lacBL50mS3Tms7N6DckibSLby4WYlmdm5YnrW7AAsdVdhY7UGPSrMCMMBucDmtYRtoYN3LO75QKmThT61AiE5qfYQvFbEMcp7k1leNHP/CFeIB2/s+4/9FtWoEOKyvGoA8Fa/wD9g+4/9FtTWjIlsfTVFFFdp555r8bhm28JjAP/ABOTwf8Aryu683mhbcysMqMkEdvavSfjYA1v4SB/6DJ/9IruuAuIyHOM4rjxKuz08DK0X6mTa2U1zdCGGJ5JZGwqKMk+2K3I47PRPvCK81IfwZDQwH3/AL7e33R79Ko/a7q0jmit38tJwFkZV+Yr/d3dQD3A61SXrtHpk/SuNWjtuei0577E91PLeTSTXUryTSHJZzk1XOAyk/NxSgbpflPA60soBHoBgCi9ykraDCByc06JihIIHrTZhsA54zyabIwaP0z0p3G1cfK/mZLN0Gc9hVFcFwc8E8U/J8sgj5v0pII+QCMjGaQ1GyGSgwxOwGGJyTUFhLHbSRxhgTIepPX3P+NXJF86do3HAU7vcVSudNSeDzrLh0GQD0I7ioknui07qzNhCshV1IODtzitC2jIOF6k4+lY2mbsICPmA5963IOAACPUnPSt6Wupz1dNEX4IwhXGOn5CrKqrHHQ1UR92PLYZ7mp4t68MckcD3Ndq0OGa7locfL6UGEMQGXryOP1FMVxnBYZHWkt4/LnuJUdyk7BzG3IVgMFl/wB7jI6cZ7mrRjqh4i5OD0pzDC5NSZyBjioyCGAP6Uyb3GFeMYGDUTKFOOmelWlPJB69qjmXK5wPXmpKi9St5Ix3LU3yRgnoatDaRkdaTbnk/nUuNzRTZREAOcpx9KZLaK42sFI9uK0Of4cEe9Ltz95Tx61PIivatGLNp4ZSEC5Pf0qZbdgR3UDoMfnWqUUjsPel2DPAxR7NDddvcyJLYMMbRk+pyfzpPsYk5A5HUeta5XKnKj3pFQfw9egpezQlWZlm3fy8rGSo9elNNuSBngDnC1qugXqMqeoqNYY0IKqB9KTpjVVso29sVc553e2MD0q55QIAAAx6ipQuDwOaD8p9zVKKRLm2NUDnAwa3vhOMeOPFP/YO07/0ZeVzy+d9pAKKYcH94rd/Qr/Wui+FAx448UZ/6B2nf+jbytIbmFf4TirAbbjXGyTnWdS4J4/4/Zqvg5AI69c1QsVLXOtgu4U6zqXAx/z+zVfJA4HUVzy+JmkPhRFKMndxmqs6K64I+lWpF3ZwcVCwwAT3pFpmRd6dDPCytGM543DOK56fRRbNI8ESfMMZQYx9a7IqCT1FVpI8FuOvtUSgWpWPOf7K33DyXSbh2APQVDc2eY/mA2n7qj+Gu2vrQPgrjcO471zWsC4t4ncwFUAyD6VHqO5zE8QiJD9+AV6kVdt28t/lXbvPPv7VhLcvPOVKsS/Rj7en9K1ESVoIvK3B15VjxketW1Yl6lvzfs08kagHIJwBk1ma3aM0AuzJnkAIR1Psa3LeN1RfOC7sbgTzn8aytQ08yWzrvZETLEsc8euK0jLQwcbM5SaMZkmnjaMPwueTn1Aplqke7KswaPnpg5rZjuo0jBXZIE4DEZPt1pJoJHtJZXjxEB99I+UB6ZNXzPYnkRnxAx7gsjbjnDBsYJ7U6xiaB2bA3rwM89e9U8y7CkQIVT1PGamXzI4GycA/KPrVbEpobcZZfKRDnOc9SabbRSLMpbhyercGpDG0bbGYMwHUHO4UscnDGRcjp83b3o0RaT3LkMe+ZN/G7kHPpUtw0drujkctuXII4wapGZo4WQsTkgqAeRVi4SUP2bK9KyZquxDaSpPKqSOzgnJ5/THSo5g7XLyA7UVsbemfQVHLas54jYOejKa1dLs8rm43Mq/MAx70m0ti4K+jL2k2P2p0uDEFxzuA6e1dda2ZnnRWG2MdKj0K1MsKZQKp+6B6V1NlZ4fLAVi1dluZNZWsccSjaDj2q75akDAwfYU5EAXjp2qVUwcmtUkkYN3YyFfmz6VOB8p96amOgqUc8UITYkY44qcD5RmmxqOlTIhPanYlsaBWP44GPBWv/wDYPuP/AEW1dB5Vc/48GPBev/8AXhcf+i2qktSG9D6XooorsOM85+M/+r8I/wDYZP8A6Q3dcdPGSuVxkV2XxlGV8If9ho/+kN3XLBRnHUGsKqu7HZh3aJkX0Xmx4C8islFOSrjDdya6aaPOeMEVQntg/wA3euOcD0KVXSxksNj8enT1pzcIS2APSrU1uQ+R1Xt602WIeWc59u/NZ2N1JFWZN6YA/A9ajjiD5WUgVcERC7mOWPpUMqfMCOooK5uhVkgw4BHOak2hSMVKE3r84yPeleE7cKcE8imkNS6MriD995oHJPrxmpoowoYjO5j0x3qfyvkBcE+w61ZSHGD0q1Azc7FNF8lVUggk8+3t7VoxwqwJddxYUqqkhIA6d6kjlwcODvzwMcGt4QsZSnpoPjjaIKUOB0wamTdnLA5/pUmC20yc7RgY9PQVONvlnAznt7Vqkc0pkWzPt9RzU8YGOBwKU/MvHHpSKH4O4fQVRk3cM5ByAKUKcACmsM/WjftAz09aBWJM49D71FJyOxNDSYPGfak3cg54NFxpD1UIgz6ZNKBwSuCelRyM23A6+vpTVcdUO5iMfWlcLPck3BGw+Ae1OZ8DK81XbO4A/NiplxtGeSKLg11EUbuePWnMueORioUlIkZdhwParCkEc8fXtTFK6IxnGMUuw7s5xj0qXPFIDknH0/GiwrjJV+c45HUVFg7unNWCPlznGaYVPWkNPQYFPQCnLGT16e9L0IK8GnZbHPX0oG2NEe0YJyK1/hVn/hOfFGRg/wBm6d/6Nvaymbjn61rfCv8A5HnxPz/zDdO/9G3tVHcyqu8DiNPUm71s7vl/tnUxjH/T7N3q7gjkgnHBqhYrN9s1oq0YT+2tS6gk/wDH7NV8E4IIrll8TN4fCvQQk9hURHXpg09iTj5RnpTMYz6HrSuX6EbjAwRx2NDKGXkYIFPZiMHGaCwKnjHtTQMpyQru6DpVS4tlcMrAFT1B71oTc4Kn8KjkAC9qLIa0OZk8N2CuZEgEb9QV7VVi0CC3/wBU7EdcNzj2rrWQlBiqs0Ybp1qXFD5mcvd6e5UhX3Z6A9K5bUbhV8y1bdDMOnmE7W/GvRZbc7getZesaUl2paNR9oUHbnoTSi7MmUeZaHmFnbObmScurP0VcYBPbj0pUsLkmSSSVlZ12MgP3gTyDXT6dokhlc3WUVWI8scD8/rWymmW8SEqm3PXvW129bmWiVjgNQs3igXO3Yo4A6D6Gs2VChjAk3qeTx0r0q5sI3jx2PBHrWNe6Aki4jxG2O3SjYaONhLhWWLnPI45FIqtHMUOS2eh/WujTw9cQxv9nKkk9ScYFR3GkNDbAMY0lY4z6CpckaJHPzRtAvm8Z7nrU0BNxEzyffyApLdPwrZsPCF9ejIZNvUF8gflXX6H4NhtET7Y6vIOSFHU0SkraEpO92cjo+l3EhG9pHDH5Y8c12On+Htih7pQq9oh3PvXT2ljDb/6qFUPr3qcpvk+bgCs3ruXcitrVYkG1e1XIlPGKSP5lOKliXvigTY5iMhfSnZz3pAoxz1NSRqMUyRkYPWp4lJNPiQGrUaKv1ppEuQ2JfWrAG2mlgBgAU0nPerM27j2cCuY+IU6jwhrig9bGcf+Q2raupQqmuZ8aIB4O1yWc8mxnCj/ALZtQ3ZjUbn1TRRRXYcR5z8ZziPwj/2Gj/6RXdcsCCea6b42jNv4SB/6DJ/9IruuVQtgZ6EYrnqytI7cOrwJJTljz+dV3IOdygen1qZsED9KRtpXLAY6c1k9ToiZ7Ly2T1pFRgMkZq4Ihkt97tg88U8AbQCvA71HJcvnMsg9ABz1zQsAJz1FXZIgJfQYzmmhVyRzjscUuUvnGeXHsIK/Q+1VvKBcFScCrhA6c8+lIFHYDJ6U+W4oysQhNpJxUvlF4yuePWkZW4BOO5qQyDkKcD+QrRaA32Kzh4gNoGem31qxFEz8liCe47VIg3LuIyT+ntQNw6nC+1aIlyJk3Kv3wSPWpIpd7MroVI7n+lQsoZQyttfswqSL5uStUjF7EzNjhuh9aRCOMcE+op6oGGaRvkfnpTMxHPfFMDEdRn+tSk5z6e1QNkE8DaO9JlICM9sc/pTjgrx0HNVjPvH7pd3+0Thfz7/hR+8HXZknoueB+NTzF8pY+8AQf/r0IDnA4Hr6U1WIx70+PBxjI9s0xNCgFywyFI709F2sRgMOpJ65pgyGyc4NPDYIIPtTEx7qMetCBcdBn1puT0PX1pYVwhBwWH607mdtBxYBvYUgYdOM0H7yYx9KdtCkHHNFwsMcfOM9O9OyONvNDHoODntSA87SSD6UAGznmn4wODimBdretPByOaQMYyjvWr8KwV8c+JwTn/iW6d/6NvazCAF54FanwsOfHXijH/QN07/0be1UdzOp8BxNh/x8aycZH9s6n/6WzVZY5HFV7A4n1nAPOs6n/wCls1WJFJAwOa5pL3mdNN+6hQxPBHHqaaycnI6UqlgfmA/Clzu4PUUrDemxG2Ae+aY+B+NTBTznGaQ4PBGaVguVXVRx+NI0WVH61LKFwVHIpijAxzSKGhQBjvUE0XX3q2BwQ1MYD6g1VhXKixBh71BJbnnOM44JrQC4qOXkdKLILswbmAjG7BYDrVQKScMoJ9QK3pl4yR0PNVpbISS7w20H09anma2G431MtbNpeBzj8Kl/sosNzMoPpWtGgX5etSHAXFPmZLSMddJjByzEj0FPXSLMTiTyQ0g6FznH0rUPOOOKfEo3E4qdx7FVYMNiPgevpU6RgHJ5OOtSlQCeeaUEBelBIgVVx6mmsvNP4Jz2FGelACIoGcd6epAH40wgBsinRruXLUDHd6mjGMUJGcDiptoA96aRLHxnaaUzVWlcqeDUDybRkmqvYh6mh5oJqKacDheTWcbruTtHuap3WpxxKREcue5o5xqmzRmnSD5pm3P2HpXLeNbvz/DOs7j/AMuc2B/wA024vGdiWPWsfxLIz+HdWGf+XOYnP+4ahO7RtyWifalFFFeieUc9418K2/iu0sYbi+vrF7K5+1wzWfl7w/lyR4PmI6kbZG7elc1/wqxMf8jd4k/75sf/AJGoopOKe6KU5LZif8KrT/obvEn/AHzZf/I1N/4VRFjH/CXeJcfSy/8AkaiilyR7D9pPux3/AAqtMY/4S7xJj/dsv/kal/4VYn/Q3eJP++bL/wCRqKKOWPYPaT7iN8KozjPi3xJx/s2X/wAjUn/CqYuf+Kt8Sc/7Nl/8jUUUcsewe0n3Yn/Cp4f+ht8SflZf/I1B+FMRx/xVviTj/Zsv/kaiijkj2D2s+7Gn4SwHOfFniTnnpZf/ACNQfhLBkn/hLPEmTyflsv8A5Gooo5Y9h+1n/Mx3/CqIsY/4S3xLj6WX/wAjU7/hVUYGP+Eu8SY/3bL/AORqKKfKuwvaT7sT/hVUfH/FXeJOPRbL/wCRqVfhWijjxd4l/wC+bL/5Gooosg9pLuOHwvA6eL/Ev/fNj/8AI1OPwwz18X+JP++LH/5Goop2Fzy7jB8LV/6G/wASf982X/yNTX+FMbjD+LvEpGc4xZf/ACNRRSsg55dxT8K4z/zNviT/AL5sv/kak/4VVHnP/CW+JP8Avmy/+RqKKOVdh+0n3FX4VRrnb4u8SDP+zZf/ACNQPhWgYsPF3iTJ/wBmy/8AkaiijlQe0l3Hf8KuX/ob/Ev/AHzY/wDyNQvwtVc7fF/iXnr8tj/8jUUUWQueXcP+FXD/AKG/xJ/3zY//ACNS/wDCsOMf8Jh4kx/u2P8A8jUUUWQc8u4g+FwHTxf4l/75sv8A5Gp3/CsP+pw8S/8AfNj/API1FFFkHPLuIPheM5/4TDxJ/wB82P8A8jUf8KvGc/8ACX+Jf++bH/5Gooosg55dw/4Vh/1OHiTn/Zsf/kalPww4/wCRw8Sf982P/wAjUUUWQc8u4n/CsB/0N/iT/vmx/wDkatvwd4Mg8MX2oXiapqWo3F7FDC73nkjYkRkKhRFGg6yvnOe1FFFkJyb3ZhT/AAptXvLye38S+ILVLm5muzDF9kKI8sjSMF3QM2NznGSab/wqmL/obvEv5WX/AMjUUUuVdhqcu4h+E8OMf8Jb4l/Ky/8Akak/4VND/wBDb4k/Ky/+RqKKOSPYOeXcD8J4T/zNviX8rL/5Go/4VLB/0NniT8rL/wCRqKKOWPYOeXcQ/CS3PP8AwlniT8rL/wCRqD8JLc/8zZ4k/Ky/+RqKKOSPYPaS7gfhJbkY/wCEs8SflZf/ACNTf+FRW3/Q1+JPysv/AJHooo5Y9g55dw/4VFbf9DX4k/Ky/wDkak/4VBa/9DX4k/Ky/wDkeiijkj2H7SXcafg7Znr4q8S/+Sf/AMj0n/CnLPGP+Eq8S4/7c/8A5Hooo5I9g9pPuwHwcsh08VeJP/JP/wCR6Q/BqyPXxT4l/wDJP/5Hoopckewe0n3Yo+DlkOnirxJ/5J//ACPTh8HrQdPFXiT/AMk//keiinyR7B7SXcP+FPWmf+Rq8Sf+Sf8A8j0f8KftP+hr8Sf+Sf8A8j0UUckewueXcP8AhT1p/wBDV4k/8k//AJHoHwetB/zNXiT/AMk//keiijkj2Dnl3D/hT1p/0NXiT/yT/wDkenD4Q2o6eK/En5WX/wAj0UUckewc8u48fCaAf8zZ4k/Ky/8Akamn4SW7dfFniX8rL/5Gooo5Y9g5pdxrfCC1YYbxX4lI/wC3P/5Hpn/Cm7L/AKGrxL/5J/8AyPRRRyR7Bzy7kMnwS02T7/ijxKf+BWn/AMj1EfgXpB6+JfEv/fVp/wDI9FFL2cew/az7safgRo56+JPEv/fVp/8AI9Nm+AuizW09vJ4i8SNDMhjkXdacqQQRn7P6E0UU+SPYHVm92z2CiiiqIP/Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (A) Milia-like cysts (white arrows) and comedo-like openings (black arrows).",
"    <br>",
"     (B) Network-like structures and fingerprint-like structures (solid square).",
"     <br>",
"      (C) Hairpin vessels (solid square), milia-like cysts (white arrow), and comedo-like openings (black arrow).",
"      <br>",
"       (D) Fissures and ridges.",
"       <div class=\"footnotes\">",
"       </div>",
"       <div class=\"reference\">",
"        Reproduced with permission from: Drs. Ashfaq Marghoob and Natalia Jaimes.",
"       </div>",
"      </br>",
"     </br>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_27_11703=[""].join("\n");
var outline_f11_27_11703=null;
var title_f11_27_11704="Anaplastic large cell lymphoma skin 1";
var content_f11_27_11704=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F83089&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F83089&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Primary cutaneous anaplastic large cell lymphoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 401px; height: 504px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Primary cutaneous anaplastic large cell lymphoma on the neck of a 24-year-old man.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: The Dermatology Online Atlas, www.dermis.net. Copyright &copy; 2012. All rights reserved.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_27_11704=[""].join("\n");
var outline_f11_27_11704=null;
var title_f11_27_11705="Systemic treatment for metastatic breast cancer: Combination chemotherapy";
var content_f11_27_11705=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Systemic treatment for metastatic breast cancer: Combination chemotherapy",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/27/11705/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/27/11705/contributors\">",
"     Daniel F Hayes, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/27/11705/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/27/11705/contributors\">",
"     Julie R Gralow, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?11/27/11705/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?11/27/11705/contributors\">",
"     Don S Dizon, MD, FACP",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?11/27/11705/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   May 30, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H626741245\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although metastatic breast cancer is unlikely to be cured, meaningful improvements in survival have been seen, coincident with the introduction of newer systemic therapies [",
"    <a class=\"abstract\" href=\"UTD.htm?11/27/11705/abstract/1-3\">",
"     1-3",
"    </a>",
"    ]. Median overall survival approaches two years, with a range from a few months to many years [",
"    <a class=\"abstract\" href=\"UTD.htm?11/27/11705/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The selection of a therapeutic strategy depends upon both tumor biology and clinical factors, with the goal being a tailored approach. Although a subset of patients with oligometastatic disease may benefit from an intensified locoregional approach, most patients with metastatic breast cancer receive systemic medical therapy, consisting of chemotherapy, endocrine therapy,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    biologic therapies, and supportive care measures [",
"    <a class=\"abstract\" href=\"UTD.htm?11/27/11705/abstract/5,6\">",
"     5,6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The efficacy and dosing of combination chemotherapy regimens are presented here. General principles of management of metastatic breast cancer, selection of chemotherapy regimen, and use of single agent chemotherapy, biologic therapies, endocrine therapy, surgical options, and supportive care are discussed separately.",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?7/11/7354?source=see_link\">",
"       \"Systemic treatment for metastatic breast cancer: General principles\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?31/20/32072?source=see_link\">",
"       \"Systemic treatment for metastatic breast cancer: Selection of chemotherapy regimen\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?20/55/21370?source=see_link\">",
"       \"Treatment approach to metastatic hormone receptor-positive breast cancer: Endocrine therapy\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/53/29528?source=see_link\">",
"       \"Systemic treatment for metastatic breast cancer: Single agent chemotherapy\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/43/22202?source=see_link\">",
"       \"Systemic treatment for metastatic breast cancer: Molecular targeted therapy\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/63/35831?source=see_link\">",
"       \"Metastatic breast cancer: Local treatment\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?39/60/40903?source=see_link\">",
"       \"Treatment of metastatic breast cancer in older women\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2392223\">",
"    <span class=\"h1\">",
"     INDICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Treatment principles for the use of chemotherapy in metastatic breast cancer are outlined here. &nbsp;",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Treatment gains in disease response and survival must be balanced with effects on quality of life and tolerability.",
"     </li>",
"     <li>",
"      Chemotherapy is indicated for patients with hormone-insensitive metastatic breast cancer (ie, patients with hormone receptor-negative breast cancer and those with hormone receptor-positive breast cancer who have become resistant to endocrine therapy) or for those with hormone receptor-positive breast cancer and an aggressive phenotype (ie, visceral crisis",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      a short disease-free interval).",
"     </li>",
"     <li>",
"      Human epidermal growth factor receptor 2 (HER2)-directed therapy has demonstrated improved survival for patients with tumors that overexpress HER2 and thus should be part of first-line therapy for these patients.",
"     </li>",
"     <li>",
"      Chemotherapy can be given singly or in combination. Without an appreciable survival advantage with combination chemotherapy, sequential therapy with single agents is often preferred. Toxicity is less with single agent therapy and quality of life appears better. However, combination therapy may be a more appropriate first-line choice for symptomatic patients or those with rapidly progressive visceral metastases because of the greater likelihood of an objective response.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The aims and indications for systemic therapy, including chemotherapy, endocrine therapy, and biologic (molecularly targeted) therapy and general principles in selecting systemic treatment for metastatic breast cancer, are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/11/7354?source=see_link\">",
"     \"Systemic treatment for metastatic breast cancer: General principles\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26024122\">",
"    <span class=\"h1\">",
"     ACTIVE CHEMOTHERAPY REGIMENS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Of the many active combination chemotherapy regimens in metastatic breast cancer, none is established as the optimal first-line regimen. Prior exposure to anthracyclines",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    taxanes is a major limiting factor when selecting a regimen.",
"   </p>",
"   <p>",
"    The selection of chemotherapy, including choice of regimen, timing, and sequencing, are reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/20/32072?source=see_link\">",
"     \"Systemic treatment for metastatic breast cancer: Selection of chemotherapy regimen\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Some preferred regimens are as follows [",
"    <a class=\"abstract\" href=\"UTD.htm?11/27/11705/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <strong>",
"     Chemotherapy combinations",
"    </strong>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      <span class=\"nowrap\">",
"       CAF/FAC",
"      </span>",
"      <span class=\"nowrap\">",
"       (",
"       <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"        cyclophosphamide",
"       </a>",
"       /",
"       <a class=\"drug drug_general\" href=\"UTD.htm?35/37/36440?source=see_link\">",
"        doxorubicin",
"       </a>",
"       /",
"       <a class=\"drug drug_general\" href=\"UTD.htm?32/32/33280?source=see_link\">",
"        fluorouracil",
"       </a>",
"       )",
"      </span>",
"     </li>",
"     <li>",
"      FEC",
"      <span class=\"nowrap\">",
"       (",
"       <a class=\"drug drug_general\" href=\"UTD.htm?32/32/33280?source=see_link\">",
"        fluorouracil",
"       </a>",
"       /",
"       <a class=\"drug drug_general\" href=\"UTD.htm?4/27/4536?source=see_link\">",
"        epirubicin",
"       </a>",
"       /",
"       <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"        cyclophosphamide",
"       </a>",
"       )",
"      </span>",
"     </li>",
"     <li>",
"      AC",
"      <span class=\"nowrap\">",
"       (",
"       <a class=\"drug drug_general\" href=\"UTD.htm?35/37/36440?source=see_link\">",
"        doxorubicin",
"       </a>",
"       /",
"       <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"        cyclophosphamide",
"       </a>",
"       )",
"      </span>",
"     </li>",
"     <li>",
"      EC",
"      <span class=\"nowrap\">",
"       (",
"       <a class=\"drug drug_general\" href=\"UTD.htm?4/27/4536?source=see_link\">",
"        epirubicin",
"       </a>",
"       /",
"       <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"        cyclophosphamide",
"       </a>",
"       )",
"      </span>",
"     </li>",
"     <li>",
"      AT",
"      <span class=\"nowrap\">",
"       (",
"       <a class=\"drug drug_general\" href=\"UTD.htm?35/37/36440?source=see_link\">",
"        doxorubicin",
"       </a>",
"       /",
"       <a class=\"drug drug_general\" href=\"UTD.htm?40/59/41913?source=see_link\">",
"        docetaxel",
"       </a>",
"       ;",
"      </span>",
"      <span class=\"nowrap\">",
"       doxorubicin/",
"       <a class=\"drug drug_general\" href=\"UTD.htm?16/58/17320?source=see_link\">",
"        paclitaxel",
"       </a>",
"       )",
"      </span>",
"     </li>",
"     <li>",
"      CMF",
"      <span class=\"nowrap\">",
"       (",
"       <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"        cyclophosphamide",
"       </a>",
"       /",
"       <a class=\"drug drug_general\" href=\"UTD.htm?23/38/24170?source=see_link\">",
"        methotrexate",
"       </a>",
"       /",
"       <a class=\"drug drug_general\" href=\"UTD.htm?32/32/33280?source=see_link\">",
"        fluorouracil",
"       </a>",
"       )",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"nowrap\">",
"       <a class=\"drug drug_general\" href=\"UTD.htm?40/59/41913?source=see_link\">",
"        Docetaxel",
"       </a>",
"       /",
"       <a class=\"drug drug_general\" href=\"UTD.htm?40/0/40967?source=see_link\">",
"        capecitabine",
"       </a>",
"      </span>",
"     </li>",
"     <li>",
"      GT",
"      <span class=\"nowrap\">",
"       (",
"       <a class=\"drug drug_general\" href=\"UTD.htm?31/1/31769?source=see_link\">",
"        gemcitabine",
"       </a>",
"       /",
"       <a class=\"drug drug_general\" href=\"UTD.htm?16/58/17320?source=see_link\">",
"        paclitaxel",
"       </a>",
"       )",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"nowrap\">",
"       <a class=\"drug drug_general\" href=\"UTD.htm?10/11/10423?source=see_link\">",
"        Ixabepilone",
"       </a>",
"       /",
"       <a class=\"drug drug_general\" href=\"UTD.htm?40/0/40967?source=see_link\">",
"        capecitabine",
"       </a>",
"      </span>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <strong>",
"     Biologic agents",
"    </strong>",
"    (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/43/22202?source=see_link\">",
"     \"Systemic treatment for metastatic breast cancer: Molecular targeted therapy\"",
"    </a>",
"    )",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?2/20/2377?source=see_link\">",
"       Bevacizumab",
"      </a>",
"      with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?16/58/17320?source=see_link\">",
"       paclitaxel",
"      </a>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <strong>",
"     HER2-positive disease",
"    </strong>",
"    (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/43/22202?source=see_link\">",
"     \"Systemic treatment for metastatic breast cancer: Molecular targeted therapy\"",
"    </a>",
"    )",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?6/39/6776?source=see_link\">",
"       Trastuzumab",
"      </a>",
"      with:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?16/58/17320?source=see_link\">",
"       Paclitaxel",
"      </a>",
"      with or without",
"      <a class=\"drug drug_general\" href=\"UTD.htm?37/61/38873?source=see_link\">",
"       carboplatin",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?40/59/41913?source=see_link\">",
"       Docetaxel",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?0/59/953?source=see_link\">",
"       Vinorelbine",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?40/0/40967?source=see_link\">",
"       Capecitabine",
"      </a>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?9/23/9592?source=see_link\">",
"       Lapatinib",
"      </a>",
"      with:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?40/0/40967?source=see_link\">",
"       Capecitabine",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?16/58/17320?source=see_link\">",
"       Paclitaxel",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?6/39/6776?source=see_link\">",
"       Trastuzumab",
"      </a>",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26024911\">",
"    <span class=\"h1\">",
"     ANTHRACYCLINE-BASED REGIMENS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anthracycline-based regimens are some of the most widely used as first-line chemotherapy, as they have produced response rates of up to 60 percent in previously untreated patients with metastatic breast cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?11/27/11705/abstract/8-11\">",
"     8-11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    These regimens include",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/37/36440?source=see_link\">",
"     doxorubicin",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/27/4536?source=see_link\">",
"     epirubicin",
"    </a>",
"    with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    (AC and EC); doxorubicin, cyclophosphamide and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/32/33280?source=see_link\">",
"     fluorouracil",
"    </a>",
"    (FAC or CAF); and epirubicin with cyclophosphamide and fluorouracil (FEC). These regimens are more active but also more toxic than single agent regimens or nonanthracycline-containing combinations [",
"    <a class=\"abstract\" href=\"UTD.htm?11/27/11705/abstract/12,13\">",
"     12,13",
"    </a>",
"    ]. Furthermore, anthracycline-based regimens have not demonstrated a benefit in overall survival compared to single-agent anthracyclines.",
"   </p>",
"   <p>",
"    Patients relapsing more than 12 months after anthracycline-based treatment may be reinduced with anthracycline-based chemotherapy up to cumulative doses of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/37/36440?source=see_link\">",
"     doxorubicin",
"    </a>",
"    (450 to 550",
"    <span class=\"nowrap\">",
"     mg/m",
"     <sup>",
"      2",
"     </sup>",
"     )",
"    </span>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/27/4536?source=see_link\">",
"     epirubicin",
"    </a>",
"    (800 to 1000",
"    <span class=\"nowrap\">",
"     mg/m",
"     <sup>",
"      2",
"     </sup>",
"     ).",
"    </span>",
"    Liposomal formulations of doxorubicin have shown comparable efficacy when compared to single agent doxorubicin.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/13/10458?source=see_link\">",
"     Liposomal doxorubicin",
"    </a>",
"    in combination with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/59/41913?source=see_link\">",
"     docetaxel",
"    </a>",
"    has shown efficacy and cardiac safety when evaluated in small studies, but has not been directly compared to standard doxorubicin-based regimens [",
"    <a class=\"abstract\" href=\"UTD.htm?11/27/11705/abstract/14,15\">",
"     14,15",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/46/41706?source=see_link\">",
"     \"Cardiotoxicity of anthracycline-like chemotherapy agents\"",
"    </a>",
"    and",
"    <span class=\"nowrap\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/53/29528?source=see_link&amp;anchor=H84534185#H84534185\">",
"      \"Systemic treatment for metastatic breast cancer: Single agent chemotherapy\", section on 'Anthracyclines'",
"     </a>",
"     .)",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26026452\">",
"    <span class=\"h1\">",
"     ANTHRACYCLINE/TAXANE COMBINATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anthracycline/taxane",
"    combinations, including",
"    <span class=\"nowrap\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?35/37/36440?source=see_link\">",
"      doxorubicin",
"     </a>",
"     /",
"     <a class=\"drug drug_general\" href=\"UTD.htm?16/58/17320?source=see_link\">",
"      paclitaxel",
"     </a>",
"    </span>",
"    and",
"    <span class=\"nowrap\">",
"     doxorubicin/",
"     <a class=\"drug drug_general\" href=\"UTD.htm?40/59/41913?source=see_link\">",
"      docetaxel",
"     </a>",
"    </span>",
"    (both AT), have been compared with non-taxane anthracycline combinations (FAC, AC, or EC) as first-line treatment for women with metastatic breast cancer in multiple trials, with conflicting results [",
"    <a class=\"abstract\" href=\"UTD.htm?11/27/11705/abstract/16-20\">",
"     16-20",
"    </a>",
"    ]. Two pooled analyses found no significant difference in overall survival between",
"    <span class=\"nowrap\">",
"     anthracycline/taxane",
"    </span>",
"    combinations and non-taxane anthracycline combinations [",
"    <a class=\"abstract\" href=\"UTD.htm?11/27/11705/abstract/21,22\">",
"     21,22",
"    </a>",
"    ]. Specifically, one of the analyses pooled individual patient data from eight trials (3000 patients) and found that",
"    <span class=\"nowrap\">",
"     anthracycline/taxane",
"    </span>",
"    combinations as compared to non-anthracycline combinations had a significantly higher objective response rate (57 versus 46 percent) and modestly but significantly better progression-free survival (hazard ratio [HR] 0.92, 95% CI 0.85-0.99) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/27/11705/abstract/22\">",
"     22",
"    </a>",
"    ]. However, there was no significant survival advantage to one over the other (HR 0.97, 95% CI 0.90-1.04).",
"   </p>",
"   <p>",
"    <span class=\"nowrap\">",
"     Anthracycline/taxane",
"    </span>",
"    combinations are associated with significant hematologic toxicity. In one pooled analysis, the rates of severe neutropenia and febrile neutropenia were significantly higher with taxane-containing as compared to nontaxane-containing regimens (relative risk [RR] 1.19 for neutropenia and RR 2.82 for febrile neutropenia) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/27/11705/abstract/21\">",
"     21",
"    </a>",
"    ]. The cardiac toxicity associated with the combination of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?16/58/17320?source=see_link\">",
"     paclitaxel",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/37/36440?source=see_link\">",
"     doxorubicin",
"    </a>",
"    has been lessened by administering paclitaxel after doxorubicin, but this does not eliminate it [",
"    <a class=\"abstract\" href=\"UTD.htm?11/27/11705/abstract/23-25\">",
"     23-25",
"    </a>",
"    ]. The combination of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/59/41913?source=see_link\">",
"     docetaxel",
"    </a>",
"    with either doxorubicin or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/27/4536?source=see_link\">",
"     epirubicin",
"    </a>",
"    is associated with lower cardiotoxicity, but impressive hematologic toxicity [",
"    <a class=\"abstract\" href=\"UTD.htm?11/27/11705/abstract/26,27\">",
"     26,27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    It is not clear whether the added toxicity of an",
"    <span class=\"nowrap\">",
"     anthracycline/taxane",
"    </span>",
"    combination (as compared to non-taxane anthracycline combinations) is justified by a substantially greater therapeutic benefit. It is also not clear that",
"    <span class=\"nowrap\">",
"     anthracycline/taxane",
"    </span>",
"    regimens provide clear benefit over sequential use of each agent alone [",
"    <a class=\"abstract\" href=\"UTD.htm?11/27/11705/abstract/28,29\">",
"     28,29",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26026459\">",
"    <span class=\"h1\">",
"     NONANTHRACYCLINE TAXANE COMBINATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Non-anthracycline taxane combinations are highly effective regimens and are particularly useful in patients with rapidly progressive visceral metastases who were previously treated with an anthracycline. However, it is not clear whether combination therapy is superior to sequential therapy, especially given their toxicity.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      As described below, two taxane combinations,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?40/59/41913?source=see_link\">",
"       docetaxel",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?40/0/40967?source=see_link\">",
"       capecitabine",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?16/58/17320?source=see_link\">",
"       paclitaxel",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?31/1/31769?source=see_link\">",
"       gemcitabine",
"      </a>",
"      , have demonstrated improved survival compared to single-agent taxane [",
"      <a class=\"abstract\" href=\"UTD.htm?11/27/11705/abstract/30,31\">",
"       30,31",
"      </a>",
"      ]. However, there was incomplete cross-over in these trials, and both combinations were associated with significantly increased toxicity.",
"     </li>",
"     <li>",
"      Another trial found that",
"      <a class=\"drug drug_general\" href=\"UTD.htm?40/59/41913?source=see_link\">",
"       docetaxel",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?31/1/31769?source=see_link\">",
"       gemcitabine",
"      </a>",
"      is as efficacious as docetaxel and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?40/0/40967?source=see_link\">",
"       capecitabine",
"      </a>",
"      , with substantially less toxicity [",
"      <a class=\"abstract\" href=\"UTD.htm?11/27/11705/abstract/32\">",
"       32",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      However, when",
"      <a class=\"drug drug_general\" href=\"UTD.htm?40/59/41913?source=see_link\">",
"       docetaxel",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?31/1/31769?source=see_link\">",
"       gemcitabine",
"      </a>",
"      was compared to weekly",
"      <a class=\"drug drug_general\" href=\"UTD.htm?16/58/17320?source=see_link\">",
"       paclitaxel",
"      </a>",
"      , weekly paclitaxel resulted in a significantly superior overall survival [",
"      <a class=\"abstract\" href=\"UTD.htm?11/27/11705/abstract/33\">",
"       33",
"      </a>",
"      ]. &nbsp;",
"      <span class=\"nowrap\">",
"      </span>",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26030947\">",
"    <span class=\"h2\">",
"     Capecitabine/taxane regimens",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/0/40967?source=see_link\">",
"     Capecitabine",
"    </a>",
"    /taxane",
"    regimens are highly active, even in women previously treated with a taxane [",
"    <a class=\"abstract\" href=\"UTD.htm?11/27/11705/abstract/30,34-39\">",
"     30,34-39",
"    </a>",
"    ]. They have demonstrated favorable survival outcomes when compared to single agent taxane and to",
"    <span class=\"nowrap\">",
"     anthracycline/taxane",
"    </span>",
"    combinations.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/0/40967?source=see_link\">",
"     Capecitabine",
"    </a>",
"    (1250",
"    <span class=\"nowrap\">",
"     mg/m",
"     <sup>",
"      2",
"     </sup>",
"     ,",
"    </span>",
"    twice daily for 14 of every 21 days) and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/59/41913?source=see_link\">",
"     docetaxel",
"    </a>",
"    (75",
"    <span class=\"nowrap\">",
"     mg/m",
"     <sup>",
"      2",
"     </sup>",
"    </span>",
"    every 21 days) compared to docetaxel alone (100",
"    <span class=\"nowrap\">",
"     mg/m",
"     <sup>",
"      2",
"     </sup>",
"    </span>",
"    every 21 days) in 511 women with anthracycline-refractory metastatic breast cancer resulted in significant improvements in objective response rate (42 versus 30 percent), time to progression (6.1 versus 4.2 months), and median overall survival (14.5 versus 11.5 months) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/27/11705/abstract/30\">",
"     30",
"    </a>",
"    ]. However, in this trial, fewer patients treated with docetaxel alone received subsequent chemotherapy and in particular, capecitabine. Nevertheless, some, but not all trials that stipulated capecitabine on progression showed a survival benefit for the combination [",
"    <a class=\"abstract\" href=\"UTD.htm?11/27/11705/abstract/36,39\">",
"     36,39",
"    </a>",
"    ]. Diarrhea, stomatitis, and hand-foot syndrome were more common with combined therapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26030954\">",
"    <span class=\"h2\">",
"     Gemcitabine/taxane regimens",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/1/31769?source=see_link\">",
"     Gemcitabine",
"    </a>",
"    , in combination with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?16/58/17320?source=see_link\">",
"     paclitaxel",
"    </a>",
"    , is approved in the United States, for first-line treatment of metastatic breast cancer after failure of anthracycline-based adjuvant therapy.",
"   </p>",
"   <p>",
"    When 266 patients who relapsed after adjuvant anthracyclines were randomly assigned to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/1/31769?source=see_link\">",
"     gemcitabine",
"    </a>",
"    (1250",
"    <span class=\"nowrap\">",
"     mg/m",
"     <sup>",
"      2",
"     </sup>",
"    </span>",
"    on days 1 and 8) and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?16/58/17320?source=see_link\">",
"     paclitaxel",
"    </a>",
"    (175",
"    <span class=\"nowrap\">",
"     mg/m",
"     <sup>",
"      2",
"     </sup>",
"    </span>",
"    on day 1) or paclitaxel alone at the same dose, the combination showed a significantly higher response rate (41 versus 26 percent), median time to tumor progression (6 versus 4 months), and median overall survival (the primary endpoint, 18.5 versus 15.8 months) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/27/11705/abstract/31\">",
"     31",
"    </a>",
"    ]. However, only 16 percent of patients treated with paclitaxel alone crossed over to gemcitabine on progression. Although the incidence of grade 4 hematologic toxicity was greater with combined therapy, it was still uncommon in both groups (neutropenia, 17 versus 7 percent, febrile neutropenia 0.4 versus 0 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/27/11705/abstract/40\">",
"     40",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although combinations of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/1/31769?source=see_link\">",
"     gemcitabine",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/59/41913?source=see_link\">",
"     docetaxel",
"    </a>",
"    were promising in phase II trials, there was no difference in objective response rate, time to progression, or overall survival when combined therapy (eight cycles of gemcitabine 1000",
"    <span class=\"nowrap\">",
"     mg/m",
"     <sup>",
"      2",
"     </sup>",
"    </span>",
"    on days 1 and 8 plus docetaxel 75",
"    <span class=\"nowrap\">",
"     mg/m",
"     <sup>",
"      2",
"     </sup>",
"    </span>",
"    on day 8) was compared to sequential therapy (four cycles of docetaxel 100",
"    <span class=\"nowrap\">",
"     mg/m",
"     <sup>",
"      2",
"     </sup>",
"    </span>",
"    on day 1 followed by four cycles of gemcitabine 1250",
"    <span class=\"nowrap\">",
"     mg/m",
"     <sup>",
"      2",
"     </sup>",
"    </span>",
"    on days 1 and 8, both in a 21-day schedule) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/27/11705/abstract/41\">",
"     41",
"    </a>",
"    ]. When the same doses of gemcitabine and docetaxel were compared to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/0/40967?source=see_link\">",
"     capecitabine",
"    </a>",
"    and docetaxel, there was no significant difference in objective response rate, progression-free survival, or overall survival. However, non-hematologic toxicity (diarrhea, mucositis, and hand-foot-syndrome) favored gemcitabine and docetaxel [",
"    <a class=\"abstract\" href=\"UTD.htm?11/27/11705/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26031069\">",
"    <span class=\"h1\">",
"     OTHER TWO- AND THREE-DRUG REGIMENS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Increased use of anthracyclines and taxanes as adjuvant and neoadjuvant treatment limits the treatment options for patients upon relapse. Some multidrug, non-anthracycline, non-taxane-containing regimens have high response rates, but have failed to demonstrate superior survival when compared to less toxic regimens and single agents. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H175493247\">",
"    <span class=\"h2\">",
"     Ixabepilone and capecitabine",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/11/10423?source=see_link\">",
"     Ixabepilone",
"    </a>",
"    is an epothilone, a class of non-taxane tubulin polymerizing agents. Preclinical data showed that ixabepilone retains activity in tumors that use multidrug resistance pumps and in tumors that are",
"    <a class=\"drug drug_general\" href=\"UTD.htm?16/58/17320?source=see_link\">",
"     paclitaxel",
"    </a>",
"    -resistant [",
"    <a class=\"abstract\" href=\"UTD.htm?11/27/11705/abstract/42\">",
"     42",
"    </a>",
"    ]. While ixabepilone has demonstrated significant activity in heavily pretreated patients, toxicity, especially peripheral neuropathy, is a concern. Ixabepilone as monotherapy and in combination with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/0/40967?source=see_link\">",
"     capecitabine",
"    </a>",
"    may be best reserved for select patients with aggressive disease and limited treatment options.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/11/10423?source=see_link\">",
"     Ixabepilone",
"    </a>",
"    (40",
"    <span class=\"nowrap\">",
"     mg/m",
"     <sup>",
"      2",
"     </sup>",
"    </span>",
"    every three weeks) and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/0/40967?source=see_link\">",
"     capecitabine",
"    </a>",
"    (1000",
"    <span class=\"nowrap\">",
"     mg/m",
"     <sup>",
"      2",
"     </sup>",
"    </span>",
"    twice daily for 14 of every 21 days) compared with capecitabine alone (1250",
"    <span class=\"nowrap\">",
"     mg/m",
"     <sup>",
"      2",
"     </sup>",
"    </span>",
"    twice daily for 14 of every 21 days) demonstrated significantly higher progression-free survival (median, 5.8 versus 4.2 months) but not overall survival in 752 heavily pretreated (anthracycline- and taxane-resistant) patients [",
"    <a class=\"abstract\" href=\"UTD.htm?11/27/11705/abstract/43\">",
"     43",
"    </a>",
"    ]. Grade 3 and 4 treatment-related sensory neuropathy (21 versus 0 percent), fatigue (9 versus 3 percent), neutropenia (68 versus 11 percent), and death as a result of toxicity (3 versus 1 percent) were more frequent with combination therapy.",
"   </p>",
"   <p>",
"    Consequently,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/11/10423?source=see_link\">",
"     ixabepilone",
"    </a>",
"    is approved by the United States Food and Drug Administration (FDA) as monotherapy in patients whose tumors are resistant to anthracyclines, taxanes, and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/0/40967?source=see_link\">",
"     capecitabine",
"    </a>",
"    and in combination with capecitabine for the treatment of patients with metastatic breast cancer (or locally advanced breast cancer) who are resistant to an anthracycline and a taxane, or whose cancer is taxane-resistant and for whom further anthracycline therapy is contraindicated. It was refused marketing authorization by the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) in 2008 due to its marginal benefit with significant peripheral neuropathy [",
"    <a class=\"abstract\" href=\"UTD.htm?11/27/11705/abstract/44\">",
"     44",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A preplanned subset analysis of patients with triple-negative metastatic breast cancer from the",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/11/10423?source=see_link\">",
"     ixabepilone",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/0/40967?source=see_link\">",
"     capecitabine",
"    </a>",
"    trial described above suggests that ixabepilone may have notable activity in these patients [",
"    <a class=\"abstract\" href=\"UTD.htm?11/27/11705/abstract/45\">",
"     45",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/40/34441?source=see_link\">",
"     \"Epidemiology, risk factors and the clinical approach to ER/PR negative, HER2-negative (Triple-negative) breast cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H175493266\">",
"    <span class=\"h2\">",
"     Cyclophosphamide, methotrexate, and fluorouracil (CMF)",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"     Cyclophosphamide",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/38/24170?source=see_link\">",
"     methotrexate",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/32/33280?source=see_link\">",
"     fluorouracil",
"    </a>",
"    (CMF) remains an option for treatment of metastatic breast cancer. Although other regimens have demonstrated superior response rates, overall survival was similar when CMF was compared to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?36/31/37368?source=see_link\">",
"     mitoxantrone",
"    </a>",
"    , fluorouracil, and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/54/24423?source=see_link\">",
"     leucovorin",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?11/27/11705/abstract/46\">",
"     46",
"    </a>",
"    ] or CEF (cyclophosphamide,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/27/4536?source=see_link\">",
"     epirubicin",
"    </a>",
"    , and fluorouracil) [",
"    <a class=\"abstract\" href=\"UTD.htm?11/27/11705/abstract/47\">",
"     47",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H175493280\">",
"    <span class=\"h2\">",
"     Other",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/1/31769?source=see_link\">",
"     Gemcitabine",
"    </a>",
"    has been combined with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?20/51/21305?source=see_link\">",
"     cisplatin",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?11/27/11705/abstract/48-50\">",
"     48-50",
"    </a>",
"    ],",
"    <a class=\"drug drug_general\" href=\"UTD.htm?0/59/953?source=see_link\">",
"     vinorelbine",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?11/27/11705/abstract/51,52\">",
"     51,52",
"    </a>",
"    ] and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/27/4536?source=see_link\">",
"     epirubicin",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?16/58/17320?source=see_link\">",
"     paclitaxel",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?11/27/11705/abstract/53\">",
"     53",
"    </a>",
"    ], and these combinations have been associated with response rates of 36 to 70 percent. Cisplatin and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/61/38873?source=see_link\">",
"     carboplatin",
"    </a>",
"    have been combined with many other drugs, including taxanes [",
"    <a class=\"abstract\" href=\"UTD.htm?11/27/11705/abstract/54,55\">",
"     54,55",
"    </a>",
"    ],",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/0/40967?source=see_link\">",
"     capecitabine",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?11/27/11705/abstract/56\">",
"     56",
"    </a>",
"    ],",
"    <a class=\"drug drug_general\" href=\"UTD.htm?29/57/30617?source=see_link\">",
"     etoposide",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?11/27/11705/abstract/57\">",
"     57",
"    </a>",
"    ], and vinorelbine [",
"    <a class=\"abstract\" href=\"UTD.htm?11/27/11705/abstract/58\">",
"     58",
"    </a>",
"    ]. Vinorelbine has also been combined with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/37/36440?source=see_link\">",
"     doxorubicin",
"    </a>",
"    or epirubicin [",
"    <a class=\"abstract\" href=\"UTD.htm?11/27/11705/abstract/59,60\">",
"     59,60",
"    </a>",
"    ]. Despite high response rates, often in heavily pretreated patients, these regimens have failed to demonstrate superior survival when compared to less toxic regimens or even single agents [",
"    <a class=\"abstract\" href=\"UTD.htm?11/27/11705/abstract/53,59-61\">",
"     53,59-61",
"    </a>",
"    ]. An exception may be triple-negative breast cancer and breast cancer 1 gene (BRCA1)-associated carcinomas, where platinum agents may have particular activity [",
"    <a class=\"abstract\" href=\"UTD.htm?11/27/11705/abstract/62-65\">",
"     62-65",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/40/34441?source=see_link&amp;anchor=H98882362#H98882362\">",
"     \"Epidemiology, risk factors and the clinical approach to ER/PR negative, HER2-negative (Triple-negative) breast cancer\", section on 'Treatment approach to triple-negative breast cancer'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26895893\">",
"    <span class=\"h3\">",
"     High-dose therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several individual trials have shown that high dose chemotherapy with autologous stem cell transplantation has failed to improve overall survival in any subset of patients, including those with oligometastatic disease. This conclusion is supported by a year 2011 meta-analysis [",
"    <a class=\"abstract\" href=\"UTD.htm?11/27/11705/abstract/66\">",
"     66",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2392501\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chemotherapy for metastatic breast cancer can be given as single agents or in combination.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      We suggest sequential single agent chemotherapy for most patients with metastatic breast cancer who require chemotherapy (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). Combination chemotherapy may be preferable for select patients with rapidly progressive disease, visceral crisis, or if quick symptom control is desired. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?7/11/7354?source=see_link&amp;anchor=H129020#H129020\">",
"       \"Systemic treatment for metastatic breast cancer: General principles\", section on 'Sequential single agents versus combination chemotherapy'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Of the many active combination chemotherapy regimens in metastatic breast cancer, none is established as the optimal first-line regimen. (See",
"      <a class=\"local\" href=\"#H26024122\">",
"       'Active chemotherapy regimens'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Anthracycline-based regimens are some of the most widely used; however, their use is limited by prior exposure to anthracyclines.",
"      <br/>",
"      <br/>",
"      These regimens include",
"      <a class=\"drug drug_general\" href=\"UTD.htm?35/37/36440?source=see_link\">",
"       doxorubicin",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?4/27/4536?source=see_link\">",
"       epirubicin",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?9/20/9546?source=see_link\">",
"       cyclophosphamide",
"      </a>",
"      (AC and EC); doxorubicin, cyclophosphamide and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/32/33280?source=see_link\">",
"       fluorouracil",
"      </a>",
"      (FAC or CAF); and epirubicin with cyclophosphamide and fluorouracil (FEC).",
"     </li>",
"     <li>",
"      <span class=\"nowrap\">",
"       Anthracycline/taxane",
"      </span>",
"      combinations (including",
"      <span class=\"nowrap\">",
"       <a class=\"drug drug_general\" href=\"UTD.htm?35/37/36440?source=see_link\">",
"        doxorubicin",
"       </a>",
"       /",
"       <a class=\"drug drug_general\" href=\"UTD.htm?16/58/17320?source=see_link\">",
"        paclitaxel",
"       </a>",
"      </span>",
"      and",
"      <span class=\"nowrap\">",
"       doxorubicin/",
"       <a class=\"drug drug_general\" href=\"UTD.htm?40/59/41913?source=see_link\">",
"        docetaxel",
"       </a>",
"      </span>",
"      [both AT]) are associated with significant hematologic toxicity and have not demonstrated a significant survival advantage compared with non-taxane anthracycline combinations (FAC, AC, or EC).",
"     </li>",
"     <li>",
"      Other effective regimens include taxanes combined with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?40/0/40967?source=see_link\">",
"       capecitabine",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?31/1/31769?source=see_link\">",
"       gemcitabine",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?10/11/10423?source=see_link\">",
"       ixabepilone",
"      </a>",
"      and capecitabine (especially for patients with anthracycline-",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      taxane-resistant metastatic breast cancer), and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?2/20/2377?source=see_link\">",
"       bevacizumab",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?16/58/17320?source=see_link\">",
"       paclitaxel",
"      </a>",
"      .",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Selection of chemotherapy regimen is discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?31/20/32072?source=see_link\">",
"       \"Systemic treatment for metastatic breast cancer: Selection of chemotherapy regimen\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      There is no demonstrable survival benefit for high-dose chemotherapy with autologous stem cell transplantation, and we recommend against its use outside of the context of a clinical trial (",
"      <a class=\"grade\" href=\"._grade_1?title=Grade 1A\">",
"       Grade 1A",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H26895893\">",
"       'High-dose therapy'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11705/abstract/1\">",
"      Chia SK, Speers CH, D'yachkova Y, et al. The impact of new chemotherapeutic and hormone agents on survival in a population-based cohort of women with metastatic breast cancer. Cancer 2007; 110:973.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11705/abstract/2\">",
"      Gennari A, Conte P, Rosso R, et al. Survival of metastatic breast carcinoma patients over a 20-year period: a retrospective analysis based on individual patient data from six consecutive studies. Cancer 2005; 104:1742.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11705/abstract/3\">",
"      Dafni U, Grimani I, Xyrafas A, et al. Fifteen-year trends in metastatic breast cancer survival in Greece. Breast Cancer Res Treat 2010; 119:621.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11705/abstract/4\">",
"      Greenberg PA, Hortobagyi GN, Smith TL, et al. Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer. J Clin Oncol 1996; 14:2197.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11705/abstract/5\">",
"      Pagani O, Senkus E, Wood W, et al. International guidelines for management of metastatic breast cancer: can metastatic breast cancer be cured? J Natl Cancer Inst 2010; 102:456.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11705/abstract/6\">",
"      Beslija S, Bonneterre J, Burstein HJ, et al. Third consensus on medical treatment of metastatic breast cancer. Ann Oncol 2009; 20:1771.",
"     </a>",
"    </li>",
"    <li>",
"     National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology are available online at file://www.nccn.org/professionals/physician_gls/f_guidelines.asp (Accessed on July 28, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11705/abstract/8\">",
"      Hortobagyi GN, Bodey GP, Buzdar AU, et al. Evaluation of high-dose versus standard FAC chemotherapy for advanced breast cancer in protected environment units: a prospective randomized study. J Clin Oncol 1987; 5:354.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11705/abstract/9\">",
"      Falkson G, Tormey DC, Carey P, et al. Long-term survival of patients treated with combination chemotherapy for metastatic breast cancer. Eur J Cancer 1991; 27:973.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11705/abstract/10\">",
"      Coombes RC, Bliss JM, Wils J, et al. Adjuvant cyclophosphamide, methotrexate, and fluorouracil versus fluorouracil, epirubicin, and cyclophosphamide chemotherapy in premenopausal women with axillary node-positive operable breast cancer: results of a randomized trial. The International Collaborative Cancer Group. J Clin Oncol 1996; 14:35.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11705/abstract/11\">",
"      Blomqvist C, Elomaa I, Rissanen P, et al. Influence of treatment schedule on toxicity and efficacy of cyclophosphamide, epirubicin, and fluorouracil in metastatic breast cancer: a randomized trial comparing weekly and every-4-week administration. J Clin Oncol 1993; 11:467.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11705/abstract/12\">",
"      Joensuu H, Holli K, Heikkinen M, et al. Combination chemotherapy versus single-agent therapy as first- and second-line treatment in metastatic breast cancer: a prospective randomized trial. J Clin Oncol 1998; 16:3720.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11705/abstract/13\">",
"      A prospective randomized trial comparing epirubicin monochemotherapy to two fluorouracil, cyclophosphamide, and epirubicin regimens differing in epirubicin dose in advanced breast cancer patients. The French Epirubicin Study Group. J Clin Oncol 1991; 9:305.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11705/abstract/14\">",
"      Livi L, Meattini I, Cardillo Cde L, et al. Non-pegylated liposomal doxorubicin in combination with cyclophosphamide or docetaxel as first-line therapy in metastatic breast cancer: a retrospective analysis. Tumori 2009; 95:422.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11705/abstract/15\">",
"      Trudeau ME, Clemons MJ, Provencher L, et al. Phase II multicenter trial of anthracycline rechallenge with pegylated liposomal doxorubicin plus cyclophosphamide for first-line therapy of metastatic breast cancer previously treated with adjuvant anthracyclines. J Clin Oncol 2009; 27:5906.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11705/abstract/16\">",
"      Biganzoli L, Cufer T, Bruning P, et al. Doxorubicin and paclitaxel versus doxorubicin and cyclophosphamide as first-line chemotherapy in metastatic breast cancer: The European Organization for Research and Treatment of Cancer 10961 Multicenter Phase III Trial. J Clin Oncol 2002; 20:3114.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11705/abstract/17\">",
"      Langley RE, Carmichael J, Jones AL, et al. Phase III trial of epirubicin plus paclitaxel compared with epirubicin plus cyclophosphamide as first-line chemotherapy for metastatic breast cancer: United Kingdom National Cancer Research Institute trial AB01. J Clin Oncol 2005; 23:8322.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11705/abstract/18\">",
"      Jassem J, Piekowski T, Puzaska A, et al. Doxorubicin and paclitaxel versus fluorouracil, doxorubicin, and cyclophosphamide as first-line therapy for women with metastatic breast cancer: final results of a randomized phase III multicenter trial. J Clin Oncol 2001; 19:1707.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11705/abstract/19\">",
"      Nabholtz JM, Falkson C, Campos D, et al. Docetaxel and doxorubicin compared with doxorubicin and cyclophosphamide as first-line chemotherapy for metastatic breast cancer: results of a randomized, multicenter, phase III trial. J Clin Oncol 2003; 21:968.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11705/abstract/20\">",
"      Bontenbal M, Creemers GJ, Braun HJ, et al. Phase II to III study comparing doxorubicin and docetaxel with fluorouracil, doxorubicin, and cyclophosphamide as first-line chemotherapy in patients with metastatic breast cancer: results of a Dutch Community Setting Trial for the Clinical Trial Group of the Comprehensive Cancer Centre. J Clin Oncol 2005; 23:7081.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11705/abstract/21\">",
"      Bria E, Giannarelli D, Felici A, et al. Taxanes with anthracyclines as first-line chemotherapy for metastatic breast carcinoma. Cancer 2005; 103:672.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11705/abstract/22\">",
"      Piccart-Gebhart MJ, Burzykowski T, Buyse M, et al. Taxanes alone or in combination with anthracyclines as first-line therapy of patients with metastatic breast cancer. J Clin Oncol 2008; 26:1980.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11705/abstract/23\">",
"      Gianni L, Munzone E, Capri G, et al. Paclitaxel by 3-hour infusion in combination with bolus doxorubicin in women with untreated metastatic breast cancer: high antitumor efficacy and cardiac effects in a dose-finding and sequence-finding study. J Clin Oncol 1995; 13:2688.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11705/abstract/24\">",
"      Giordano SH, Booser DJ, Murray JL, et al. A detailed evaluation of cardiac toxicity: a phase II study of doxorubicin and one- or three-hour-infusion paclitaxel in patients with metastatic breast cancer. Clin Cancer Res 2002; 8:3360.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11705/abstract/25\">",
"      Valero V, Hortobagyi GN. Are anthracycline-taxane regimens the new standard of care in the treatment of metastatic breast cancer? J Clin Oncol 2003; 21:959.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11705/abstract/26\">",
"      Gamucci T, D'Ottavio AM, Magnolfi E, et al. Weekly epirubicin plus docetaxel as first-line treatment in metastatic breast cancer. Br J Cancer 2007; 97:1040.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11705/abstract/27\">",
"      Aihara T, Takatsuka Y, Itoh K, et al. Phase II study of concurrent administration of doxorubicin and docetaxel as first-line chemotherapy for metastatic breast cancer. Oncology 2003; 64:124.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11705/abstract/28\">",
"      Sledge GW, Neuberg D, Bernardo P, et al. Phase III trial of doxorubicin, paclitaxel, and the combination of doxorubicin and paclitaxel as front-line chemotherapy for metastatic breast cancer: an intergroup trial (E1193). J Clin Oncol 2003; 21:588.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11705/abstract/29\">",
"      Alba E, Mart&iacute;n M, Ramos M, et al. Multicenter randomized trial comparing sequential with concomitant administration of doxorubicin and docetaxel as first-line treatment of metastatic breast cancer: a Spanish Breast Cancer Research Group (GEICAM-9903) phase III study. J Clin Oncol 2004; 22:2587.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11705/abstract/30\">",
"      O'Shaughnessy J, Miles D, Vukelja S, et al. Superior survival with capecitabine plus docetaxel combination therapy in anthracycline-pretreated patients with advanced breast cancer: phase III trial results. J Clin Oncol 2002; 20:2812.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11705/abstract/31\">",
"      Albain KS, Nag SM, Calderillo-Ruiz G, et al. Gemcitabine plus Paclitaxel versus Paclitaxel monotherapy in patients with metastatic breast cancer and prior anthracycline treatment. J Clin Oncol 2008; 26:3950.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11705/abstract/32\">",
"      Chan S, Romieu G, Huober J, et al. Phase III study of gemcitabine plus docetaxel compared with capecitabine plus docetaxel for anthracycline-pretreated patients with metastatic breast cancer. J Clin Oncol 2009; 27:1753.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11705/abstract/33\">",
"      Fountzilas G, Dafni U, Dimopoulos MA, et al. A randomized phase III study comparing three anthracycline-free taxane-based regimens, as first line chemotherapy, in metastatic breast cancer: a Hellenic Cooperative Oncology Group study. Breast Cancer Res Treat 2009; 115:87.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11705/abstract/34\">",
"      Gradishar WJ, Meza LA, Amin B, et al. Capecitabine plus paclitaxel as front-line combination therapy for metastatic breast cancer: a multicenter phase II study. J Clin Oncol 2004; 22:2321.",
"     </a>",
"    </li>",
"    <li>",
"     Lueck H, Minckwitz GV, Du Bois A, et al. Epirubicin/paclitaxel (EP) vs. capecitabine/paclitaxel (XP) in first-line metastatic breast cancer: a prospective, randomized multicentre phase III study of the AGO breast cancer study group (abstract #517). J Clin Oncol 2006; 24:7s.",
"    </li>",
"    <li>",
"     Soto C, Torrecillas L, Reyes S, et al. Capecitabine (X) and taxanes in patients with anthracycline-pretreated metastatic breast cancer: sequential vs. combined therapy results from a MOSG randomized phase III trial (abstract). J Clin Oncol 2006; 24:20s.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11705/abstract/37\">",
"      Blum JL, Dees EC, Chacko A, et al. Phase II trial of capecitabine and weekly paclitaxel as first-line therapy for metastatic breast cancer. J Clin Oncol 2006; 24:4384.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11705/abstract/38\">",
"      Blum JL, Dees EC, Vukelja SJ, et al. Phase II trial of capecitabine and weekly paclitaxel in patients with metastatic breast cancer previously treated with every-3-week taxane therapy. Clin Breast Cancer 2007; 7:465.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11705/abstract/39\">",
"      Bernhard J, Zahrieh D, Castiglione-Gertsch M, et al. Adjuvant chemotherapy followed by goserelin compared with either modality alone: the impact on amenorrhea, hot flashes, and quality of life in premenopausal patients--the International Breast Cancer Study Group Trial VIII. J Clin Oncol 2007; 25:263.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11705/abstract/40\">",
"      O'Shaughnessy J, Nag et al. Gemcitabine plus paclitaxel versus paclitaxel as first-line treatment for anthracycline-pretreated metastatic breast cancer: interim results of a global phase III study (abstract). Proc Am Soc Clin Oncol 2003; 22:7a.",
"     </a>",
"    </li>",
"    <li>",
"     Tomova A, Brodowicz V, Tzekova V, et al. Concomitant docetaxel plus gemcitabine versus sequential docetaxel followed by gemcitabine. J Clin Oncol 2008; 26:15S (abstr #1106).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11705/abstract/42\">",
"      Vahdat LT. Clinical studies with epothilones for the treatment of metastatic breast cancer. Semin Oncol 2008; 35:S22.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11705/abstract/43\">",
"      Thomas ES, Gomez HL, Li RK, et al. Ixabepilone plus capecitabine for metastatic breast cancer progressing after anthracycline and taxane treatment. J Clin Oncol 2007; 25:5210.",
"     </a>",
"    </li>",
"    <li>",
"     European Medicines Agency (EMEA) Committee for Medicinal Products for Human Use (CHMP) recommendation for refusal of marketing authorization for ixabepilone, available online at file://www.esmo.org/no_cache/view-news.html?tx_ttnews[tt_news]=480&amp;tx_ttnews[backPid]=585&amp;cHash=9385b0342b .",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11705/abstract/45\">",
"      Perez EA, Patel T, Moreno-Aspitia A. Efficacy of ixabepilone in ER/PR/HER2-negative (triple-negative) breast cancer. Breast Cancer Res Treat 2010; 121:261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11705/abstract/46\">",
"      Hainsworth JD. Mitoxantrone, 5-fluorouracil and high-dose leucovorin (NFL) in the treatment of metastatic breast cancer: randomized comparison to cyclophosphamide, methotrexate and 5-fluorouracil (CMF) and attempts to improve efficacy by adding paclitaxel. Eur J Cancer Care (Engl) 1997; 6:4.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11705/abstract/47\">",
"      Ackland SP, Anton A, Breitbach GP, et al. Dose-intensive epirubicin-based chemotherapy is superior to an intensive intravenous cyclophosphamide, methotrexate, and fluorouracil regimen in metastatic breast cancer: a randomized multinational study. J Clin Oncol 2001; 19:943.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11705/abstract/48\">",
"      Nagourney RA, Link JS, Blitzer JB, et al. Gemcitabine plus cisplatin repeating doublet therapy in previously treated, relapsed breast cancer patients. J Clin Oncol 2000; 18:2245.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11705/abstract/49\">",
"      Seo JH, Oh SC, Choi CW, et al. Phase II study of a gemcitabine and cisplatin combination regimen in taxane resistant metastatic breast cancer. Cancer Chemother Pharmacol 2007; 59:269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11705/abstract/50\">",
"      Burch PA, Mailliard JA, Hillman DW, et al. Phase II study of gemcitabine plus cisplatin in patients with metastatic breast cancer: a North Central Cancer Treatment Group Trial. Am J Clin Oncol 2005; 28:195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11705/abstract/51\">",
"      Mart&iacute;n M, Ruiz A, Mu&ntilde;oz M, et al. Gemcitabine plus vinorelbine versus vinorelbine monotherapy in patients with metastatic breast cancer previously treated with anthracyclines and taxanes: final results of the phase III Spanish Breast Cancer Research Group (GEICAM) trial. Lancet Oncol 2007; 8:219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11705/abstract/52\">",
"      Pallis AG, Boukovinas I, Ardavanis A, et al. A multicenter randomized phase III trial of vinorelbine/gemcitabine doublet versus capecitabine monotherapy in anthracycline- and taxane-pretreated women with metastatic breast cancer. Ann Oncol 2012; 23:1164.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11705/abstract/53\">",
"      Zielinski C, Beslija S, Mrsic-Krmpotic Z, et al. Gemcitabine, epirubicin, and paclitaxel versus fluorouracil, epirubicin, and cyclophosphamide as first-line chemotherapy in metastatic breast cancer: a Central European Cooperative Oncology Group International, multicenter, prospective, randomized phase III trial. J Clin Oncol 2005; 23:1401.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11705/abstract/54\">",
"      Spielmann M, Llombart A, Zelek L, et al. Docetaxel-cisplatin combination (DC) chemotherapy in patients with anthracycline-resistant advanced breast cancer. Ann Oncol 1999; 10:1457.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11705/abstract/55\">",
"      Fountzilas G, Kalofonos HP, Dafni U, et al. Paclitaxel and epirubicin versus paclitaxel and carboplatin as first-line chemotherapy in patients with advanced breast cancer: a phase III study conducted by the Hellenic Cooperative Oncology Group. Ann Oncol 2004; 15:1517.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11705/abstract/56\">",
"      Donadio M, Ardine M, Berruti A, et al. Weekly cisplatin plus capecitabine in metastatic breast cancer patients heavily pretreated with both anthracycline and taxanes. Oncology 2005; 69:408.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11705/abstract/57\">",
"      Icli F, Akbulut H, Uner A, et al. Cisplatin plus oral etoposide (EoP) combination is more effective than paclitaxel in patients with advanced breast cancer pretreated with anthracyclines: a randomised phase III trial of Turkish Oncology Group. Br J Cancer 2005; 92:639.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11705/abstract/58\">",
"      Vassilomanolakis M, Koumakis G, Demiri M, et al. Vinorelbine and cisplatin for metastatic breast cancer: a salvage regimen in patients progressing after docetaxel and anthracycline treatment. Cancer Invest 2003; 21:497.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11705/abstract/59\">",
"      Norris B, Pritchard KI, James K, et al. Phase III comparative study of vinorelbine combined with doxorubicin versus doxorubicin alone in disseminated metastatic/recurrent breast cancer: National Cancer Institute of Canada Clinical Trials Group Study MA8. J Clin Oncol 2000; 18:2385.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11705/abstract/60\">",
"      Ejlertsen B, Mouridsen HT, Langkjer ST, et al. Phase III study of intravenous vinorelbine in combination with epirubicin versus epirubicin alone in patients with advanced breast cancer: a Scandinavian Breast Group Trial (SBG9403). J Clin Oncol 2004; 22:2313.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11705/abstract/61\">",
"      Carrick S, Ghersi D, Wilcken N, Simes J. Platinum containing regimens for metastatic breast cancer. Cochrane Database Syst Rev 2004; :CD003374.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11705/abstract/62\">",
"      Isakoff SJ. Triple-negative breast cancer: role of specific chemotherapy agents. Cancer J 2010; 16:53.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11705/abstract/63\">",
"      Staudacher L, Cottu PH, Di&eacute;ras V, et al. Platinum-based chemotherapy in metastatic triple-negative breast cancer: the Institut Curie experience. Ann Oncol 2011; 22:848.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11705/abstract/64\">",
"      Koshy N, Quispe D, Shi R, et al. Cisplatin-gemcitabine therapy in metastatic breast cancer: Improved outcome in triple negative breast cancer patients compared to non-triple negative patients. Breast 2010; 19:246.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11705/abstract/65\">",
"      Rhiem K, Wappenschmidt B, Bosse K, et al. Platinum sensitivity in a BRCA1 mutation carrier with advanced breast cancer. Clin Oncol (R Coll Radiol) 2009; 21:448.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?11/27/11705/abstract/66\">",
"      Berry DA, Ueno NT, Johnson MM, et al. High-dose chemotherapy with autologous hematopoietic stem-cell transplantation in metastatic breast cancer: overview of six randomized trials. J Clin Oncol 2011; 29:3224.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 771 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-125.69.132.100-0D12DA5E94-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_27_11705=[""].join("\n");
var outline_f11_27_11705=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H2392501\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H626741245\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2392223\">",
"      INDICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26024122\">",
"      ACTIVE CHEMOTHERAPY REGIMENS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26024911\">",
"      ANTHRACYCLINE-BASED REGIMENS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26026452\">",
"      ANTHRACYCLINE/TAXANE COMBINATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26026459\">",
"      NONANTHRACYCLINE TAXANE COMBINATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26030947\">",
"      Capecitabine/taxane regimens",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26030954\">",
"      Gemcitabine/taxane regimens",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26031069\">",
"      OTHER TWO- AND THREE-DRUG REGIMENS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H175493247\">",
"      Ixabepilone and capecitabine",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H175493266\">",
"      Cyclophosphamide, methotrexate, and fluorouracil (CMF)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H175493280\">",
"      Other",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26895893\">",
"      - High-dose therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2392501\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/46/41706?source=related_link\">",
"      Cardiotoxicity of anthracycline-like chemotherapy agents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/40/34441?source=related_link\">",
"      Epidemiology, risk factors and the clinical approach to ER/PR negative, HER2-negative (Triple-negative) breast cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/63/35831?source=related_link\">",
"      Metastatic breast cancer: Local treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/11/7354?source=related_link\">",
"      Systemic treatment for metastatic breast cancer: General principles",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/43/22202?source=related_link\">",
"      Systemic treatment for metastatic breast cancer: Molecular targeted therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/20/32072?source=related_link\">",
"      Systemic treatment for metastatic breast cancer: Selection of chemotherapy regimen",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/53/29528?source=related_link\">",
"      Systemic treatment for metastatic breast cancer: Single agent chemotherapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/55/21370?source=related_link\">",
"      Treatment approach to metastatic hormone receptor-positive breast cancer: Endocrine therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/60/40903?source=related_link\">",
"      Treatment of metastatic breast cancer in older women",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f11_27_11706="FL grade 2";
var content_f11_27_11706=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F85890&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F85890&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Follicular lymphoma, grade 2",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Scattered throughout the centrocyte-like cells are five to 15 large, centroblast-like cells. Hematoxylin, phloxine, and saffron stain.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Ioachim HL, Medeiros LJ. Ioachim's Lymph Node Pathology, 4th ed, Lippincott Williams &amp; Wilkins, Philadelphia 2009. Copyright &copy; 2009 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_27_11706=[""].join("\n");
var outline_f11_27_11706=null;
var title_f11_27_11707="Causes and diagnosis of tall R waves in V1";
var content_f11_27_11707=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F72039&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F72039&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Causes and diagnosis of tall R waves in V1",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Diagnosis",
"       </td>",
"       <td class=\"subtitle1\">",
"        Confirmatory clues",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        True posterior infarct",
"       </td>",
"       <td>",
"        ST &darr;, T &uarr; in V1-V2; Q waves and ST",
"&uarr; V7-V9",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Right ventricular hypertrophy",
"       </td>",
"       <td>",
"        RAD; RAE; secondary ST-Ts; V7-V9 normal",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ventricular septal hypertrophy",
"       </td>",
"       <td>",
"        Associated Q waves; LVH; V7-V9 normal or deep narrow Q",
"waves",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Right bundle branch block",
"       </td>",
"       <td>",
"        Wide QRS; broad S in V1, V6; R peaks late in V1; V7-V9",
"normal or broad S waves",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Wolff-Parkinson-White syndrome",
"       </td>",
"       <td>",
"        Short PR; delta wave; V7-V9 normal or delta wave",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Normal variant",
"       </td>",
"       <td>",
"        No other abnormalities",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     LVH: left ventricular hypertrophy; RAD: right-axis deviation; RAE: right atrial enlargement.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_27_11707=[""].join("\n");
var outline_f11_27_11707=null;
var title_f11_27_11708="Checklists for alcohol use and dependence";
var content_f11_27_11708=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PSYCH%2F82740&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PSYCH%2F82740&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Checklists for alcohol use and dependence",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Checklist for alcohol abuse*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Determine whether, in the past 12 months, your patient's drinking has repeatedly caused or contributed to...",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Risk of bodily harm (eg, drinking and driving, operating machinery, swimming)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Relationship trouble (family or friends)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Role failure (interference with home, work, or school obligations)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Run-ins with the law (arrests or other legal problems)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Checklist for alcohol dependence",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Determine whether, in the past 12 months, your patient has...",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Not been able to stick to drinking limits (repeatedly gone over them)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Not been able to cut down or stop (repeated failed attempts)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Shown tolerance (needed to drink a lot more to get the same effect)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Shown signs of withdrawal (tremors, sweating, nausea, or insomnia when trying to quit or cut down)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Kept drinking despite problems (recurrent physical or psychological problems)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Spent a lot of time drinking (or anticipating or recovering from drinking)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Spent less time on other matters (activities that had been important or pleasurable)",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * One symptom indicates abuse.",
"     <br>",
"      <span class=\"bullet\">",
"       &bull;",
"      </span>",
"      Three symptoms indicate dependence.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: National Institute on Alcohol Abuse and Alcoholism. Helping Patients Who Drink Too Much: A Clinician's Guide, 2nd ed, National Institutes of Health, Bethesda, MD 2007.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_27_11708=[""].join("\n");
var outline_f11_27_11708=null;
var title_f11_27_11709="DSM-IV-TR criteria for ADHD";
var content_f11_27_11709=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PSYCH%2F50326&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PSYCH%2F50326&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    DSM-IV-TR criteria for attention deficit hyperactivity disorder",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Presence of either 1 or 2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        1. Six (or more) of the following symptoms of inattention have persisted for at least six months to a degree that is maladaptive and inconsistent with developmental level:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Often fails to give close attention to details or makes careless mistakes in schoolwork, work, or other activities",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Often has difficulty sustaining attention in tasks or play activities",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Often does not seem to listen when spoken to directly",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Often does not follow through on instructions and fails to finish schoolwork, chores, or duties in the workplace (not due to oppositional behavior or failure to understand instructions)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Often has difficulty organizing tasks and activities",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Often avoids, dislikes, or is reluctant to engage in tasks that require sustained mental effort (such as schoolwork or homework)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Often loses things necessary for tasks or activities (eg, toys, school assignments, pencils, books, or tools)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Is often easily distracted by extraneous stimuli",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Is often forgetful in daily activities",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        2. Six (or more) of the following symptoms of hyperactivity-impulsivity have persisted for at least six months to a degree that is maladaptive and inconsistent with developmental level:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2_start\">",
"        Hyperactivity",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Often fidgets with hands or feet or squirms in seat",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Often leaves seat in classroom or in other situations in which remaining seated is expected",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Often runs about or climbs excessively in situations in which it is inappropriate (in adolescents or adults, may be limited to subjective feelings of restlessness)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Often has difficulty playing or engaging in leisure activities quietly",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Is often \"on the go\" or often acts as if \"driven by a motor\"",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Often talks excessively",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2_start\">",
"        Impulsivity",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Often blurts out answers before questions have been completed",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Often has difficulty awaiting turn",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Often interrupts or intrudes on others (eg, butts into conversations or games)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Additional criteria",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Some hyperactive-impulsive or inattentive symptoms that caused impairment were present before age seven years.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Some impairment from the symptoms is present in two or more settings (eg, at school [or work] and at home).",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        There must be clear evidence of clinically significant impairment in social, academic, or occupational functioning.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        The symptoms do not occur exclusively during the course of a pervasive developmental disorder, schizophrenia, or other psychotic disorder and are not better accounted for by another mental disorder (eg, mood disorder, anxiety disorder, dissociative disorder, or a personality disorder).*",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * In children and adolescents it it also important to exclude other medical or situational conditions that could account for the symptoms (see text for details). However, this is not a Diagnostic and Statistical Manual criterion.",
"    </div>",
"    <div class=\"reference\">",
"     Footnote added for this publication. Reprinted with permission from the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (Copyright &copy; 2000). American Psychiatric Association.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_27_11709=[""].join("\n");
var outline_f11_27_11709=null;
var title_f11_27_11710="Symptom prevalence in palliative care patients";
var content_f11_27_11710=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PALC%2F87163&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PALC%2F87163&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Symptom prevalence in palliative care patients",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"11\" width=\"9%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Symptom",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"2\">",
"        Cancer",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"2\">",
"        AIDS",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"2\">",
"        Heart disease",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"2\">",
"        Chronic obstructive pulmonary disease",
"        <br/>",
"        (COPD)",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"2\">",
"        Renal disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        Number of patients",
"       </td>",
"       <td class=\"subtitle2\">",
"        <p>",
"         Percentage",
"        </p>",
"        <p>",
"         with symptom",
"        </p>",
"       </td>",
"       <td class=\"subtitle2\">",
"        Number of patients",
"       </td>",
"       <td class=\"subtitle2\">",
"        Percentage with symptom",
"       </td>",
"       <td class=\"subtitle2\">",
"        Number of patients",
"       </td>",
"       <td class=\"subtitle2\">",
"        Percentage with symptom",
"       </td>",
"       <td class=\"subtitle2\">",
"        Number of patients",
"       </td>",
"       <td class=\"subtitle2\">",
"        Percentage with symptom",
"       </td>",
"       <td class=\"subtitle2\">",
"        Number of patients",
"       </td>",
"       <td class=\"subtitle2\">",
"        Percentage with symptom",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pain",
"       </td>",
"       <td class=\"centered\">",
"        10,379",
"       </td>",
"       <td class=\"centered\">",
"        35 to 96",
"       </td>",
"       <td class=\"centered\">",
"        942",
"       </td>",
"       <td class=\"centered\">",
"        63 to 80",
"       </td>",
"       <td class=\"centered\">",
"        882",
"       </td>",
"       <td class=\"centered\">",
"        41 to 77",
"       </td>",
"       <td class=\"centered\">",
"        372",
"       </td>",
"       <td class=\"centered\">",
"        34 to 77",
"       </td>",
"       <td class=\"centered\">",
"        370",
"       </td>",
"       <td class=\"centered\">",
"        47 to 50",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Depression",
"       </td>",
"       <td class=\"centered\">",
"        4378",
"       </td>",
"       <td class=\"centered\">",
"        3 to 77",
"       </td>",
"       <td class=\"centered\">",
"        616",
"       </td>",
"       <td class=\"centered\">",
"        10 to 82",
"       </td>",
"       <td class=\"centered\">",
"        80",
"       </td>",
"       <td class=\"centered\">",
"        9 to 36",
"       </td>",
"       <td class=\"centered\">",
"        150",
"       </td>",
"       <td class=\"centered\">",
"        37 to 71",
"       </td>",
"       <td class=\"centered\">",
"        956",
"       </td>",
"       <td class=\"centered\">",
"        5 to 60",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Anxiety",
"       </td>",
"       <td class=\"centered\">",
"        3274",
"       </td>",
"       <td class=\"centered\">",
"        13 to 79",
"       </td>",
"       <td class=\"centered\">",
"        346",
"       </td>",
"       <td class=\"centered\">",
"        8 to 34",
"       </td>",
"       <td class=\"centered\">",
"        80",
"       </td>",
"       <td class=\"centered\">",
"        49",
"       </td>",
"       <td class=\"centered\">",
"        1008",
"       </td>",
"       <td class=\"centered\">",
"        51 to 75",
"       </td>",
"       <td class=\"centered\">",
"        72",
"       </td>",
"       <td class=\"centered\">",
"        39 to 70",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Confusion",
"       </td>",
"       <td class=\"centered\">",
"        9154",
"       </td>",
"       <td class=\"centered\">",
"        6 to 93",
"       </td>",
"       <td class=\"centered\">",
"        ?",
"       </td>",
"       <td class=\"centered\">",
"        30 to 65",
"       </td>",
"       <td class=\"centered\">",
"        343",
"       </td>",
"       <td class=\"centered\">",
"        18 to 32",
"       </td>",
"       <td class=\"centered\">",
"        309",
"       </td>",
"       <td class=\"centered\">",
"        18 to 33",
"       </td>",
"       <td class=\"centered\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\">",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fatigue",
"       </td>",
"       <td class=\"centered\">",
"        2888",
"       </td>",
"       <td class=\"centered\">",
"        32 to 90",
"       </td>",
"       <td class=\"centered\">",
"        1435",
"       </td>",
"       <td class=\"centered\">",
"        54 to 85",
"       </td>",
"       <td class=\"centered\">",
"        409",
"       </td>",
"       <td class=\"centered\">",
"        69 to 82",
"       </td>",
"       <td class=\"centered\">",
"        285",
"       </td>",
"       <td class=\"centered\">",
"        68 to 80",
"       </td>",
"       <td class=\"centered\">",
"        116",
"       </td>",
"       <td class=\"centered\">",
"        73 to 87",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Breathlessness",
"       </td>",
"       <td class=\"centered\">",
"        10,029",
"       </td>",
"       <td class=\"centered\">",
"        10 to 70",
"       </td>",
"       <td class=\"centered\">",
"        504",
"       </td>",
"       <td class=\"centered\">",
"        11 to 62",
"       </td>",
"       <td class=\"centered\">",
"        948",
"       </td>",
"       <td class=\"centered\">",
"        60 to 88",
"       </td>",
"       <td class=\"centered\">",
"        372",
"       </td>",
"       <td class=\"centered\">",
"        90 to 95",
"       </td>",
"       <td class=\"centered\">",
"        334",
"       </td>",
"       <td class=\"centered\">",
"        11 to 62",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Insomnia",
"       </td>",
"       <td class=\"centered\">",
"        5606",
"       </td>",
"       <td class=\"centered\">",
"        9 to 69",
"       </td>",
"       <td class=\"centered\">",
"        504",
"       </td>",
"       <td class=\"centered\">",
"        74",
"       </td>",
"       <td class=\"centered\">",
"        146",
"       </td>",
"       <td class=\"centered\">",
"        36 to 48",
"       </td>",
"       <td class=\"centered\">",
"        150",
"       </td>",
"       <td class=\"centered\">",
"        55 to 65",
"       </td>",
"       <td class=\"centered\">",
"        351",
"       </td>",
"       <td class=\"centered\">",
"        31 to 71",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Nausea",
"       </td>",
"       <td class=\"centered\">",
"        9140",
"       </td>",
"       <td class=\"centered\">",
"        6 to 68",
"       </td>",
"       <td class=\"centered\">",
"        689",
"       </td>",
"       <td class=\"centered\">",
"        43 to 49",
"       </td>",
"       <td class=\"centered\">",
"        146",
"       </td>",
"       <td class=\"centered\">",
"        17 to 48",
"       </td>",
"       <td class=\"centered\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\">",
"        362",
"       </td>",
"       <td class=\"centered\">",
"        30 to 43",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Constipation",
"       </td>",
"       <td class=\"centered\">",
"        7602",
"       </td>",
"       <td class=\"centered\">",
"        23 to 65",
"       </td>",
"       <td class=\"centered\">",
"        689",
"       </td>",
"       <td class=\"centered\">",
"        34 to 35",
"       </td>",
"       <td class=\"centered\">",
"        80",
"       </td>",
"       <td class=\"centered\">",
"        38 to 42",
"       </td>",
"       <td class=\"centered\">",
"        150",
"       </td>",
"       <td class=\"centered\">",
"        27 to 44",
"       </td>",
"       <td class=\"centered\">",
"        483",
"       </td>",
"       <td class=\"centered\">",
"        29 to 70",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Diarrhea",
"       </td>",
"       <td class=\"centered\">",
"        3392",
"       </td>",
"       <td class=\"centered\">",
"        3 to 29",
"       </td>",
"       <td class=\"centered\">",
"        504",
"       </td>",
"       <td class=\"centered\">",
"        30 to 90",
"       </td>",
"       <td class=\"centered\">",
"        80",
"       </td>",
"       <td class=\"centered\">",
"        12",
"       </td>",
"       <td class=\"centered\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\">",
"        &nbsp;",
"       </td>",
"       <td class=\"centered\">",
"        19",
"       </td>",
"       <td class=\"centered\">",
"        21",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Anorexia",
"       </td>",
"       <td class=\"centered\">",
"        9113",
"       </td>",
"       <td class=\"centered\">",
"        30 to 92",
"       </td>",
"       <td class=\"centered\">",
"        504",
"       </td>",
"       <td class=\"centered\">",
"        51",
"       </td>",
"       <td class=\"centered\">",
"        146",
"       </td>",
"       <td class=\"centered\">",
"        21 to 41",
"       </td>",
"       <td class=\"centered\">",
"        150",
"       </td>",
"       <td class=\"centered\">",
"        35 to 67",
"       </td>",
"       <td class=\"centered\">",
"        395",
"       </td>",
"       <td class=\"centered\">",
"        25 to 64",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Original figure modified for this publication. Solano JP, Gomes B, Higginson IJ. A comparison of symptom prevalence in far advanced cancer, AIDS, heart disease, chronic obstructive pulmonary disease and renal disease. J Pain Symptom Manage 2006; 31:58. Table used with the permission of Elsevier Inc. All rights reserved.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_27_11710=[""].join("\n");
var outline_f11_27_11710=null;
var title_f11_27_11711="Trypanosomiasis Romanas sign";
var content_f11_27_11711=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F58601&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F58601&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Roma&ntilde;a&rsquo;s sign",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 381px; height: 193px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCADBAX0DASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD5mWnA8VGDk57e9KCQaixKdicHgA84pCeDx171EDTgcVNhjmGAO1LGm9gM8dzU88W5Ld0GQ6449qtWMETziJpNhxl2IyFHpQFy/p0QS3CK3fOR/M1eHlSPtijzEh5d+dx+lV4o57nUFtYsR24XcCMEMPXNa1olxdSeVap8qDcTxhVHc/Ws5aCWpsWLzjSmbYyo6lEXGM+9S21qbSylPmEXMg+Ykc49BWtoWmSt9lXUZQlqMzySZycHgAVjeL76TzZLWyXLMxjiCjJIPf61zJ3dkaWsrnO6tPNq1wunae7naCZAOmPaug0Wyi03RkhiiVriaTH+0CB0NZkkH/COaOyuhF+z5mdhgj0Wui8D+fqFyl1f4eUqx8w98L3q5O0brYdtbGnYWg0DT0NwynapklHUu5NeXeM9TF1NMSCpY7VGfujviuy8Wa3MsYjRw5PGfYdK8q1SYzyhmPPP55qsPBt80uoSa2RSJyfakpTye2KSu0gKcqnGcZFBGF5P4UAUhpDggI4yasQwlsDFT2Nk9zFIYjl0G4r3x6itzRtIe5dQgzn2rGpUUTSMLmZb2bMQAMmui03w9cXEkaxxMS3b2rtPDfhPfLGzKrDPfsK9S0Lw/Gm6dkHPyqMdq8qvjbO0TshR/mPM9H8DsdvmJk9/au20jwdHENqxhRwTxXfWumLHt7YGeBWpDabF3EcmuGVSpUerNbxjscjpvhuONyRGPl6ZFbsOkooGAMj2rct7f5Mkcnrx0qwIFUA46URoX3IlWMmO2UxuQMHp9KswwKgAAwVGCB3qzNGSuUTBHXmnKjEktjP1rSNNIhzuNXb/AAjHHPFQOQJwcEDPPH61aBPQcH60yXzOPk4B7d60asiUyU4dBnJ/Sq0xORhckenegO8bBEThuQM9P8KVjKSRhVH0JoeoWsYuqWBuI2khYRXA5Ujsay1vHa3eC/VQ5+VsHjPriunkgSZSJXyevpWD4h0GO6h86EhbiPlXz19j7Vzyg1qjaMlszHsSsM0kSt8u7H0P/wBeqviyziubcNMo2N97I6Ed6qm4E8zRnCXCDLJ0zjuKnivEuo5LSVj5nXLY5rNNmttTjZNtxZy2M+GYfNC55BFcZ4msmi+8MHHboa7TXYm0pyyKZIic47rXP3cqXMDIcPG3Q+ld1GTT5lsZT25WeaGbyJWXHXt61dgufNi3K+5V4ZW6im69YMd0kPEiNz61jW1ypl/e/J2b3r1oe8ro4JqzN6eJZYSyMssfdT95ax5rKDaxSYqc/cNSR+fZyebbkyQ+o7VbBtNQ5YhXHUEYOarVEGMBbqwCs28dz2qYQfNv2Lns6tWjcWSRptliBU9DVRIYlBWJ8fXmqTuIieB5RgYz6gdap3QZGCvjIGDitdEkX/WSJ7Z4zSMiyKd0aE54YdaV7DMFl5ynBo2sQPkzj0rUbSpJn226sfWoJrR7dtnmZPcDtVqQigOucUpHHXFL3pM0zMU9aM00kg805Bk+1AzU04E2VwMjIXegI/M06HMNmAy5edufXFV9NuRFfozjMR+Rl9VPFdBo1gt/r9vExKwR9WPQis5O2oy/odp9nt2aRZBJOCAvXC47Ct2HTnitEWYNbrKRmP8AiY9hUtteWcPiZwv74QoxGOi8cZqxos6380+oX4ZyCFgQnkk965pybLijW1KNLLTILaJmdUAedgOnoKwtHjeS5bUdxZlbZCndPet/xHLst0tYwgluQGdR6AcA1n24jhhwqBUXAbHXcTzWUZWRrbU5LxVJNcXfnXbCRycgD1966e3u10jS0NuArFF8wnp83p+FVdWsUi1GO3bY8e7duH8Qrk9X1D5SqSMEDnKk8HHSt7c6SMyhrV99q1CZAxwuQtYBjiRyZnByOMc4NKJW8+Rx7n86qOSWOa6oxsSxCSaSlII69aFGTz0rQQYwasRJkgetRr82QefrWpp1qZJE4zms5ysi4q5q+G9MlnnjaEfNnNet+FPD8YdVxsY/eGOn0rK8E6b5drEzIdzdsfrXp2k2KpC7N8x4ORxk14OLxLb5UejRpqKuy9pmnpEQsSDbjGa6mziVAqIM7efbNZljC+ESP7q9TnvW9ZoY0G/HvjpXHTV2VNk0EIXgLuY1aWMnGegoj5bIzzUu7sfrzXZGNjmlIVVXJODmnYx1wfxphIxweKTdx71pckbOQnlsCQdwBA7g8U9Rxk461GSepIOegxTt+O3HvTEBwByOD1OKhYtk+napmwcZJGOeKYwGMjFS1cpMqEkpgjHpzUTyTKp/jHbsatOmcVBJ1POayktC0yoZm5G1x+FRzO+xgPlHv1q2V4ODznrUEqAryeaycXYtNHH+IdOy63UCDzE5YAdRXIahcNHMty6sATjcOn416bdg425yprk9a08eXJJEOP4l/vetYp8rOmLujAnul1a1JjcB065rhbxZbO6lChhzynY/Q11F/aSWn77TpDGxx8jHIasa8uob07JB5FwflZD6+orrou2q2MprSzMG5tIrrMkTBH/iB6/jXHarZeVKwmj2kn7y9DXaXls0T+YAeOCayb5t33vXkHnFejSn2ZyTicpbXFxYsDEdydMHkGtCBLbUCXGIJuuB0NSXbQg8oCD26VXaK3kJMeYWPXmuu9zmasaonntVRblElh7Z/wAaen2C6Yjb5UrDv0qlBPJEnkykSR9s0NFbzEbG2SdgTU2As3FmtuCPkIPcVQmWFVIjAyOuDiibzrZgJAxT8xULyI5JifbnnpTuFhUuJYSBE7ID1xUE1y5fMjR59xUF204bJfIHGRVQuT6H8KpICEc/1oIPOPzzTD36fSjaSCQOh7VrYzsKFI6Zp6bgGbGe1Rkn1OOtPU9M5OTQwLsVsVmhEhwWIOB1rs9FmCW6rAhz93pyxrkrVWW/UOeFAwfbtXXeHN83iKxs5G2W8b7nOPujrzWNTYfkPiufs9w8EKBrudi0+R9wE9K6fR4xcazHHExW3tk+ZjyGasHTD5F7r2oTbdqStHGTjkknFdH4fZINM3hsSOAXJ9OSc1zVeppBbE99PFJf3MsPzEusQL84x1I9Kh12Qq5S0JZ0kHyY5znJ+tSEo5tyFYNKGkGejkHtSa4gDy3TMn7wiRWUcqwHK1nC3MXK9jP1+WIajC8fyW9yN0bA/d3D5h9civK9Slk8+WJwQVcjmuo1bVvNjgtpW3SqfMjI4+b0/GuV1wBr15wGKS/MfY12Uo23Mm7lJWBY+9NC4LYHTpTVPtkipHY7RjvW4iJuWoGRTn5wR3600Eg4IpgWLaMs4Wuu8P2JmlTA9FWuc0uEyzKqjB7V6/4G0Jcxyy5ZxgAVwYut7ONzpoQ5mdb4c01rdAIsopHBJyD+ddfAJ5pUi8sKijLMOSaXS7BQEYKQRW/aW4WRiRzivn3ebuei2krElkERFEavx61qQfMVDk1XWLaMjAarsMeCCcZrenBnNNpk6huvOOmakGR70IOODTx6CupRMWyMvlTx+BppDFetSlQeopMDk9M07BcikK4XOcg/rTl+709qbIvAxjFEbAR88NTAlI9Tx9aaSGJGc+1MyPSkLZINAA+cYBH4VFjHP8XrUhIz8vAppPIBpNBcrMOfpUMvQ7eDU8jfMeAKquevzEse9ZSSNEylcg9wCfesm9U8lQtbEo8zdmqU0IOQa5ZxZvB2OL1Kx3h2QZBPKf3fpXD+INGN0haM4lXv3FesXNtk7sDI7Vk6jpcdwCSvlydNwFKnUdN3Rq7SVmeNQ3Vzav5F4m9RwD3Ipl7b284Z4eBjkd1rt9R0h8mOSNWweDjn8K5rUNCkQNLbud390ivQp14yd9mc86TS7o4i9jMUhV+fRj0rPkkkj/hDp6elb12BkwzjZID1PSsO9tpIiTGcg16EGccoiQOkjZVyOc7Wq5IQw5jGR0IrIZCqb5Qyc9R3pVuJEX93LlR2attzNo0mvpIlKuCw+lVmktrhv7hPcVX+0uT90Y77agYLI/7sYPU5p2ESzQSxAlW3oe45qrT90iEjJppbPUDNUgIWjYHgAj2oVXU7lBGOc4oIz0P5U9WYI+GOTziruZihwxxNCre4O01OhsS65ScH03AiqWM4zmrFumZF4yDxSYGlZXEUK3EoiaQ7cLvPSus0a9UTXV0kYRxbKCI/wBrh13LKYlGMkqQK7XRIfM0i8lV0DiMMU7kDrisai0KWhb1JFl0mFYAwF3Jl1x0x3rekUHSvKjjGUQbQCct71VuoHa00yaFdqtbDkDgnODTbm5mhtYSi/IhYFgfQ9q537xexq2ktq7WiohBji28+p61ma3epBDKi4MqTMr5PRSO49ar6ddsQyl8IEyhHVSDWBr9w88lxKzbGdPmxzkg8GnCHvBKV1Y5rVoneN5A3MLBWHfB6N9KqxXjNbSwN9yTlh7+op95L58e9CVkxtYZ4IrOU4IrtSuiELjDEH9KlTGBnkelRyZDfhTk6ccZpvYAYfwjGPemgfMB0NOU4cg1KqbnAHUmlew0dL4SszLcxnG47s49K+gvB2nhYVd+C3X3ryjwDp5kkQPGwz0OK990C2ENsiKjHHAJr5/HVOafKj0aEeWNzWtYsIAiEsenFaUMZDEsOfSmwRbVxn5uuRVkQt9R35rGENAlIQcHirEbEcEn8qRITkDvUoiIORk5reMWjJsejEkADI71ICOp69KjKjjtT9pAGCelarQhjjwD6UZB4B5pq9cd8VGW6diB1p3CwMTnkkj1pmcE8A/WlBI703PUqevak2Mcrj+I4+lG7gc00jvTQBn044pXEBIPI4+tHXI/lSMcDHJprgDkHB70hpDJcEnoBVSYEcD9asZUk4IOODUMq9eah6lrQrFsdeSe1Quu7tVkp0wM+tJ5XrWTjc0TSM14wxIxn3qtJANvzCtsxjPTt0qrNAqpjGABgCocC1I5jULVZAQ69e461zN9Z7HIcA57kda7i6XGeCfY1kXVsJQRsIH8qw1TNos801nw3bXwJYGOXoCO9cNreiXmlPyPMgPRhzj617dPp5UnIBX0rLvdMimRlUAMR0boa66OKlDR7EVKMZ+p4PMZAp/iXuGFU3WNzx+7NeieIPCZXfJahkfOSuMiuCvbWSGZllQq+euK9ijVjUV0zgnTcdyoVaNuCpz701nZgSVA9xSnjgimnHeugyaASHBHY9aZjNLiimQR0o4J44PFJ70Z5qjMMc+1XNOQyXCxgZLdKqcmrlk4gZJm/hPQUmNEjgWjSZGZRkZ9K3fCeotFvhO5mkDbvdSOf8awViNzcFV6O/X2q+Hj0+7hC4yeGJ7DpUNXVhnqU0Uk3hXTUiOIxlgegyDyM+9YOpXCixljhC+WHHyZ5yR1rb0aZl8JQxSSB4ldmjK9s8FT+WRXEO5E1wGRs4Oe3PrXJTWrXZmr6Mihu/KugDuMT5yuar3l0txAVA/fR569GB6Zqle3DiQMowwG4H3FVL6Xcwfo2ByvRga6kiGUJAOQvH9Krn1796sOecFSVxx60yaAxhW3LtbkEGtkxDZHEhzjHQCiM9u4pPlUcfMfyp7Yzkcn2o8gECnfyeOtX9OhEtwvXCnJqmBuIOOa6fwpY/aLlUxyTk5rGrPljcuEbux7D8OLBUgjdgS38q9d09MBQRXG+DrIRafESmOBxXoNjGqwh2XBx+NfN3dSo2enL3Y2NC2QBctxgVZVQp5PFYN/rUFo2zeufQGsyfxfawofMkX12Z5FdSnFaHO4t6nZllHTHrSGQYwP/ANVefr4/0kBi10gZTyD2/wAa27HxNp11HmG6iPb7wz+VacxHKdJnd0zn1oyygbjVGPUIZMDzB+BHT1qy1whQAEf0p8ysK1hd3HJ60hc8jGFqNpo8csMHoailmVWJ3YP0qXIq1yximLgDbHgDoB6VXSTzPmUlc1MvIyWPB9aXNcLWJsDHJ496TgjnpUbfe/i/OkYghckmncVhScOckY7AU1jznHHamlsk5/KmzEFSB29DUtlJAx3Mfmx61E+Oo6mkMvGMCoyw/Co5irCk9SSc+lIcYJzj1pGBJBABx2pquuDu60rjsOLY45qCU5yPlGabLcKhIBywOMCqUl8iDLso/HpUSki1EW4jznOV9CKzJlWFNpJPfNJda9b7chwQf4s8VyOv+MrS13gEOwH3QRzWfI5v3UaJ8q1Ohk2FTnGPasa9eCMtlvfBNeX6t8QpnmZbUGNfc5zXOXPjS7lBWQFhnrnBzXTDAVJasyeJitj1a9vYVfIZfTnpXLa5a2d3G80kJB6bxyK4NvEl5KxAdgT2J4qSLXruAFJEyvfDZFdcMHKGqeplLEKXQr6hp/lsWhYMmelZkidsYxxWwNVik+9EQTyT2qO4W3nG6JgGx908GuyLcdzF2exjcgFSAabgfw5q1LFtbtzTNjZJB6+1bJmbRRYjpRkYpr/XvSAdznFaWMrEyDcwHrU6qZW2r0Hf0qOHKxGQ9Puj604TfKypwp6+9Sxo07BgI8KRhTgtVYSLclRPwBwHXr+NGjXMdtd5uF3QsNrj2o1OzawuQR80Eo3xOOjLU2A7fQNRa3s7WNnjniG5CrDIx7+1Qa/p3l3rXFlvMMi/MjfejPpnv7H0rkoLsCIrjaScgKa29M1mWBQqN5se3Y6SDII9KxcGnzItPSzMK93RuA+VKkrg1TkOAAc8cZ9q29RVZV3W8h5ODG/I/A1hTxyRkq64Hr2NbR1ExivxsJ47HNRuMMaTB6jOPWrBxPBkACSMc/7Q/wDrVpsIgK4AweooViPoaQHFBJzz/wDrpgWYGUyKCeM16h8PtPEl0JW4A4WvK7eNnb5c16R4Z1uLSLSGUp5kv8Kk9x6+1cOMTcbRN6DSd2fQemy2el6bHJfyiNVAOKyNa+IMcsbx2SiJOiyMc5PsByT7V5S+pah4juAMTiL7rOCQp9h6Cu58J+B5AheeQtxwRyR/9avJ9lGkveevY67ubutjMPiC7guQltCbm5/idzjGfQdqztWh8TakzvhLe3fjYgBIHt7165ZaAluSp+YDphVGP0q9DpUabjNFvX1UURq21jFA4X3Z8+XCapp6qk4DIn99Bn86prqhhkknZGin3ZJUnmvoXU/DFrKpZEBVhkx461yOo+CLLduWLy8856EVusWl8cTP2F/hZx2meNbmMJGPLliHaViRXTQeOCIwdgjP3T5UxKk/jXPah4Kjt5jJEoZTy2OMVHD4feHBjG5MYZTUSnRlqjSNOaO/t9au9RMXl3L29uCGkCH52/8ArV1djqUdzKI3wsnoTwfpXlWlW0tlcbQWVDyue1dVaOwkjcFt3cjoDXJKVnozbk7noKTgLkYz0x71Yjl3EA4zXM292xjJbk4zkVr2lwGwzZAPXFXCrfQylA0s8cUnJGar+cHyFPGaejYOMZz71rzGdhQ+CMkcU2XAOcjkUNg+30qB+AR26jilzFWHEhuTyR6VG8nBBGe3NMYcnjg1DK2CAce1ZubKUSysnXNZt3cNHnaQNvUetEk3IYdDWdcMSjtk4JrOU7lxiU7/AFFbeIsxO89K4PxBrNzsLvKQ38KdAv1rqr1DKhBGW/vVyOo6KZmYsSxc8k+lVScb+8XKLtocHq2tXEyNud854xwD9BXP3MjspDlieuD0FelTeGInkLuw44x6VC3hy2dh5gGF6KBXpQxNOK0OSVCUmeXR2NxO2FQjP8WK0rLw1PM2ApJx0r0630yBMDYCRwFxxWjBBFCMLEOe+OtEsc/soccL3PKn8IzK21lIHamnwpICFUkeoJ5r1wQR53bN2fUdKBZJIA0mM9u2Ky+vz6mn1aJ4zceGbiMHAbb24rMu9Mu7c5aJwMccEV739kiVGAUHPUnrWdfadbznAiQjHO81cMwd9URLCroeEF5EOGzx2NSxsHBJ4Ndz4n8MOuXQxFcZ4XGPxrhprOWJypU16FOrGoro5JwcHZmex/nS5JPOBTe3t7UuD2HSuowHh8whPfNNGM8dab7Ac04Db97r6UgHgEDtVpJXktPKZ1Cocrv7ewqmzE4IzikVztK9uv40rDJA2H461atrh7WUnnaw5B7io7BGkb7o45JNXdR+zNHEiH95nO/PH41LavYF3GyBWPmq5CNxu9KpBhuIlLY6cHrToyy5UkgNxQ6AYVhhx1z0NJaFEEiqAdhI74psb+WwZByD371KR8xB6e1NkiweDnPQ+tWmKwyVVLZjbIPOPSo6eRkjOQR2xSAHjAqkBZspPJfcMkenSt7w1Yz6heqEGQWHWsCOFiw4IycV7D8NdHVFjnJRivVWWuLFVVTg5HRQhzyseg+FPDdta28ZlRfMA4+bI/Ku702Bo/kjJx6Af1qho1ruCsihB1IrrrKBUAG3j614UIyqSuztnJRVkRRQswxIo54wBVtLdggG0D3q0IlXGMACnnGMhhj+ddsadkcrncoSW3GHbt2FZV3ZRlm3MctyA3OK6CRlXALAcck8mqkkkOGJlBx3GOKU6aY4zaOB1i0EIyd2O2FrmZpFRuFZR2BGK9Kv1hmBMaEg91PWuQ1mx81ipDrjhd/OPwFcMocr0O6nO+5gJMATyK0LebeBycDsaxbmFoJMK5Y9CCOlNhuZI5MMGx2z0qHG+xta52dnMCvl7gT/ADrXt5d33eq9q42znLyKev411WnHcoPc+tQr3M5qxtQHGMAE1dUDaSw71Sgxntir6RjGT1IrrgrnLIiY/Nx+lMcZ79KtNF8uQCRmoZEI+Yfp3qnFkplaU4PYiqcpGCTg85zmrkqAA56k1Rki+XIOT+VYzuaRM+diGOPqM9BWc8rKhJyeelX7oEfd7+/SsO7kZAdzZ9qwZutRlzcgnnpWVdXSrkHk/Wq99ehVIIAI6VyOta4kOctz9a2p0nN6FNqK1N64vgerDr1zVE3oJYE//XrgbzxNJuIjGT04qkut6lOwEER59q744OVjneIij1KC7+XJIx05NW454GwC2B3HrXl8V1r23cYRgepxU8OsarEMyWwbHXFJ4SXRgsRE9TEoxhW/WlQl2Pc9688tfFjRsFuoWQj2rf0/xDa3AGyRd2c4zisJ4ecd0aKrF7M6sdPT2qCcHnaSCarRXiyjI6fXOKlecdc1hytM0vcy9Qg8zO/kdvauQ1TRhJcblVRn1au1uJFdSCayZ4Qz5PBNdlCbic1WKZ4pjkUu0HPvTgKDXu3PKsJkAccVEcnk8jrUjD0603p657VSEKirt+dselPxtHyoCp71EWI/3u9TRAnGeATQxio7ggKxGKuRGJwDOOvcf4VAWIcpgMBxU8GFJLQc1DVwTGtbhQHjdWQnoeoqSOEzEIchwMge1XUdCm0xqox3qFZRvBdsMh4K8VndloijsZGdljAKkchhUTWsi7vMU8duhq9BfXRnKxQ7nfj5f4qdfSXBVmuowGXtjBx70cz2H5mU6KFHfjkU+xtPtN0kSDJJ78U1ixO1cLxmut8AaPJfvNPgbE6+v4UqlT2cXJlQjzOxXm0/y7hFOTtAHr+tev8AgmNY4IVTJyK5N9I8ubcyksDw3qK7LwlsjlIPCgdM9a8fFVeeJ6FGnys9T0ZVRFC8e1b0L+gBI7Eda53TZozEHD5HXGOla8d2gHBFTRaSM6kW2aalyoHygfrSmMFDl2XPoKypb8LnBAxVC51b5cbzxW0q0ImapSZ0DeSvJH4k1nXMlqNyOw+meD+ArmtR1ox/cJ24+Y561zd74gCbwhChv1rnniU9Io6KeGkzrL++jjdhC4Hy8gcfyrltUvZgpYEPjup2muT1PxRbwAtNKsYHIyetc1d+OrFmIW4Le/NQqdSpsjo5I0/iZ097fhixAZZM9D1FFvOsoxuy3fvXE3HiCG+GY5lLjlSP61Z0HVj9pCSkfNgHNaPDyUQVSLdkehafuD5/lXUacXJG1+B1rmdMGVV0JIPrXW6TGSBxk1xPccnobmnruUZPPUVrxx9BnIqjZKPlxwR1rTgjIA2oBnnI6V20o6HDUeojIMHHX6VE8RI47VoCIggk/Wo5U6nJFbuFzJSsZUqbff2qhPjZ1Fas0R3nGfr2rOmhIB3d656iNoMxL1euOK5nVjg47Guq1D92hLZOAScVyF/MlxG5Thhzg8EVyqOp1RZwPirUDbKyKcsRjrzXn86zXUhMjHHcntXYeKkELPPcHkkhR3rkIkn1G5EUA2pnBr2cNFKF0cleV3qQObW2QkfO46jriqTaxKn+rAT6Gup1LwtLY6LcSsnznn8K4VomHY/WuylyS13OSbfU2LG6vtSnMcV1CkhOAk0mzd9CeKgk1G/tZnhlkIdDtYA5GaoPbhZQsjDBxkjtV60sYZY92SW5AOa1cYmfMy1DrdxjM8Kyp645/OtK0n06+GR+5l9+Dmuz+FPh03en3n2i3jlgzgFxnn2rE8ceC1026M1kwRG5K54Fc0pQcuTY1i3a5XgnvdOYPDMZYR6nNdJpWvR3KBZvkfjIPf6V5pZancWcvlyNvjHBHUVuWsscjb4zsJ5K9vwrGrQT3OinVZ6E8kbf3SPeoUVcZUZB9awbW5fCgfqa2YLgGMFmGa5OTlNZSueLCg0fzor3DzBpzj1pp5B/rTjRxzTIBEBwXxgUrucgqMY6Ck60KMsBkUDEUtu3ZqcTOBjcaYyFWINJjJpMaNGVt1tGW++Ota/g7QrjxJrUFjbj5nPJxwB3rAySQeor134DMkOuzOFG8x9fSuXEzdOm5I1ornkkepaL4I0TSbCOFrOOWXGWkIBYMO+a84+Nnhu0sLK21S3mQM7+WYwOor1PX9XighPmtsOeCDzXk/xX1iLUdMSFmRtrbwR1OPWvHwtWUqyZ6FWnam2eLtlnyPvHse1e5fDPTvs/h2OZhgzAueK8StommuAF5ycV9Q6JpostC06Ar923BwOMmu7Mp2gonPhV71zBvYQBwKp2c7wXQwPlzXQXkO4EMqg84wc5rl9SXyPnbI968uD5tGegtNTr7bXmjTauDj1NXoNeYjaVwfyxXka+JYra4KXCuEz98AnFb0HijTHjBjlVm9zVSw810NIypzO+k1l9hLEewzzWdda0Qmd49Oa4258RWzIT5yLz2NY994mt4kOGLn0WlHDzl0NP3cdWzqb/AFiSQPltvvmuC8UeKfs+6K2cSXB6tnhax9U1zUNQ3JbI0cR755rJtdEvbucKkTOxPWvSoYSMPeqHJWxba5aS+ZSuZproNNcyPIxPUmolVChJByBXoGk+AJbhcylI/l3fM3+fyrtND+GFpMA11ckIeMBMAfUnrXS8VTjojg+rzlqzw61Rt5YZGPTvWtp+oSW9wnnE7QeCa+jtK+Hnh22YKkLyD+84Byat33wu0rU1YCBEHYlcH8xWMsWpu3Lc0jR5NeY5/wAFj7bp8citkECvQtNidSBj2NZPhLwsfDcRsTIZYQTtz2FdjZ24VOxz6V5fs+absdM6mhNboqsMngd8dK0oSAAEJ/75NVoo9rDBxjrWhF65PPT2rtpxscU5Dlzt5JI9hUUnA5UkH2q0BgYpjgD5q2sZpmVcbicBcVQmjZyc44rVuAA2OMntVCUZOOMdq5akTeDMS+ty8bAHB/nXM31io8xyB0xnGcV21xHvBx2OcVkXVoCrYGAa45JrY6oSPmvxzPLfavIiugghOwLn9TVTwtPFFdhJMGvatW8B6TfXLzeSEuH5JHc1jL4Bt7QlwEzyQQu7JrvhiYez5LGMqTcua5LBs1HT2t5CCjqQe+BXjfibQ7nRNQcFC1vuyjgZFe2waPYwqpE8kBUZPHXHfFRNZaZqEbJLdeYjk7Ay8NSo1vZvTYU6bkfOVy5lmdyByeg7Vu+HrCfU5o7a0Qkt1Y9F+pr1ZPBvhKRt0955cpXdsEROParxsNI0sJFaG4jdhwPJ2gn0zXbLGRtojD6u2aWmXVj4W8Px2wm3yryQvdq808Z65Pq9wS6mOHPCDqfwrpdQhvZnH2WExSL18wZP4VHHpUt/KX1O3jMo4JC4yPWuVVop8zNVRdrI81t9MN3LtGBnsR1rYstElhk2tFkdiOMV6DDoVtnaIsrjIB7Vo2mliINvGc4CgD+tKeMvsaRoJas4J9NmVc8ikUSIMMx/GvRpNMGMFQfasa90tVkGFxWMcTfct0ux8/5ozSUZr6A8cUDJAoPX2FNPc0gOOc/nRYB+M0Y9KAelHT60DLKSBkCuM46HvTAoJ+U0RLvwB96pjbvEwMgO09xUjFgTJwQcV6L8Lrs6dr0bD7kq7CfQ1wEbqQ2OgPWug8P6gNPvoXJJXIPSufEQ54OJrSlyyTPW/HhzEXDMQOR714z4gmafC7mJ75717bfPDrOjJLE6srLwRXkOt6d9lvZF5Jzlc152Aai3F7o9DFNygrbGdolti/tI0UF2kUfqK+rLi33RQpsBKRgH8q+cPCmmsNa09nBJadfyzX1NLbggMDgkAVOYPnaSMsOuXc5RrFnkPyn0HtWbqPh7zmYPgKevvXd29nluec8gVK1mrnG35ugzXFCnLc6HVPHL/wADrdblijK468c1zl58NrpSfIiY59etfR1tpqIvIq5Hp8Jb7mTXZD2qWjMnUh1R8pN8PdYWQbbc496v2vw31hziSJQPcV9TiwiUH92CfXFSC1hAOEBx7Vtes+pHtqa2ifO+l/DO9H+tZVAxn5a3rbwZY2dzFbSXBkuH/hAxj0zXty2ibegprWFs1ys3kxmZFwHIG4D0qHRnL4pD+tW2Rwml+EFgVSEVPqMmultdChhwX+c9s9q2XdFXJPGeQPWqk9/HGPvYz3Jq40acNWZyrVJ7DzDFGnyoq446UyNlZzs6e1ZsmpedNtj6ZwK1baIpHjJzjPHbNOM1J+6S4uK94rSQb5Adpx13e/pU6psUDHUelTEjGCMVHgnoM0OKTuLmbRJEnc54NWoRzntVaGRWJXJyOoNXIxxVRRMmP4A4prenQ0ppGGR1xVvYzRSuMFWIAzjg1lsu9yeeO1a9ynBwPoBWa6lWPGBXLVWp0QZXcZ7jcOoqCaDKkkGrhGQecfSmhTs4PB9awcb7mqZhz22fnTOR2qs1j5w6/NjPArpWhDdAMHvmq8trg5XjHOVqVTa3L5zjtQ0mVomQqWRh0asSTQVKFEgMYxgMjZ/MGvTFUMuMDOOQahezjPO0Lmm6XVMpVbbnljeHpTInlSx4C7TvTbx6Vfm0nUioXZbvgDDbield61ihKkAEHvilNpztAHH60nTl1H7VHn0thqbL8yQKRwSDzRDpVzuzMQT04rvmsxjBGKQ2owCADmodNj9qchHpxXk59elWFs9wUgDg5zXTNbAEfL1pv2fHRRj6VLpsPaI52Wz/AIgPb1qpPYhmziupaAAZwRiqktqCRlTUODQ1M+KwRjnjNAP/ANak7gjpQcdRX1x4o9CpOHz07UxiR0FJx9PenAhxhsg+tACrnHengc0oOExjPvRhv7p/KluGg5X2fd61bhui6Mkp7cVSCseik+vFPVSVOcD3NS0MvWwgbIbepNadrGGXALDB4JrAhLAjBwK1luBtXJ4FRJDPSPAGqCOdtNmb5WGU571a8Y6ejybivzL0IrgrXUUiuLedMrLGwww6H6165d+XqmmQXEOCXAzXkYqPsqiqLqelhZKcXBnOeGrWd7yxjHMccqtwvv619HCPdEoHoO1eR6HAbfyZio2hwBgV7AmTGjdMjOKw5/aSY5x5LECLnHA4qdF+bdkc8YxSYKngAijcQCcH6Y5qomb1LQZUUAkA1Ish78DHYVmrIZHwVKgetSSTFVzuye/pWyqdSHA0BMcnngDBxSfalUD5v1xWKdQCgtkY9e9VzqO5sOpXnILcg1LxCQ/Ys3ZLsYwWIIHXpUDXp/gkGB69aw5tQOCBx7A1jXupEyY6kdgMVlLF9jWGHudFe6tg4AIXv71kXWoyTOBE2RjqT2rHa5aQ4ZeD2zir+kQGaXLKQue/TFYSqzqOx0KnGmrnR+H7dmPmHO0d8da3yQuSOeKpQviMBcBAOlTKCea9GnFQjyo4KjcpXHg/NnkU5A4nyGQxgccHcPxpdq4GOfWngAAYAqzO5NEo4YD61Ki4qCBg33Tx3GKsiqRLF7Uhozmk3YqmSRSKufQ4qjcJhuxB5xWhIMgngGqkinB4471jNXNIsz3wPYUJgrwR+FPuFPOMc1DG4xt6kVzbOzN1sTKAR0HFOCZwSBgetNXH0HvTgwJ9CD+lWtSWNeFA2QoHao3jXZjGPWrGNoJHNNxkc9+9VyiuU3iK42H8MUgB4HBNWiuRheo/KmbflABPHely9h3IFXg8cineWMg4/wAakYHaMHmnDnnBB+tCQNkBTr0+lRhAcg4wOlTyOOw596j3fTPY0nYabK80Y5APUVS8s5OKvvIuGA6iqcpYEDJrKSTNItnwz3BpABjjFL1pTX0Z5Ywgjp+NAAz6U/oKCKLgC8DHapUB42uQfTNRjrUgK9vyNSxjiJMHLtge9EUZfLdh1pdxY4UmrDSCCIxjqaQIqs/GB0pfMYKBkc81DzmlU5zRYdy5ZXJjO18MhPQmvc/hNcR6npzWx58nJArwIV618CtQFvrxgc489cD6iuLH0+ak2dOGlyzR6m0BFpIFyPKcHivR9Nk36dA+c5Qd65u3skJmQrgMSD6VvaSpt7NYm528ZzXjUbps7azTRcPJ4FD/ADIcflQwJUHHPpUZ+UEAdOcmugwK0rEcVVlfaT83Xt6VZmJJ+6Djms2cLgljtx2NYzZtAq3sjFWKgewNZ32sAYJwy8Y70+7yF4bHcelY7O5Y579zXM9TpilYvXN/ldqnNZ7SvKxwS3r2xT4LeWV8L85PA4rf03Qm4e5XA64FNQb2Kc4wRnadbPLKAVYsegFdppunrBCoK5Y/e9qnsLWOIAxRqO2QK0Y1HG0Aj1Nd1HDqOrOGtXcthiR7Rhm/LtUo2heM596GOOMConwM57103SOfckJ9+tKjFm/SqbzDdyQB2qxb5IBXPAqFLmYONkaCttjZmOD61MowACcmoISACTxUytn2H863RixR/M0E8ZHNNZguDz9KY0oORjIpiELYbnv/AJxUL8jqaRnx1NMZ8npxUNlpFW7J2Hb0rNLFWyTgCtG4yQQM5xVY2wlQ8lWH6VyVItvQ6INJajopARn29KlDYPXFZ8okt5FVuh6EDirccgcUQlbRhJFkE5zkEegqRRuA4wR+lVg+wABQcmpi67egx7GuiOpmwcYP161H6kc4pRzk5xgcDNNLHB5BzRsFxrbtuR94dqaXK9ce9Nndk2lFzzzSMMnJ4BrNvsUhCw5yBk/pUEhG0kjdj9acw+bI+nNV3Y/xfjWcmaJDSS3JP0HpUUvJpZT2B+tVy5JwGxj14rK/QtI+If4R+FKOp+tFFfTHlDu/40dzRRUjAdaQdaKKBE9t9/8AGi++9+NFFJbjIB3+lA70UUw6jq9D+E3/ACNOnf8AXSiiubFfwpehtT+NH03D1f6VqW/3PwNFFeFS2O+ZaHWobr/U/jRRW7Mo7lOXov0FUNR6D6f1oornkbwMi6/i+lZLf6r/AIFRRWB0o6DQf9X+Irooer/U0UV00fhOStuadv8A6lPpUneiivRgcjEf7rfSqkn3X+lFFZVdiolKb/VNWvB/qfwNFFZ0dx1Ni2vVfrUsf+sf60UV1rY52RH+D6f1pB9w/Uf1oopPcZA3U/WmnrRRWbNCCbr/AJ9abH/Q0UVktyyHVOi1DadFooqX8ZX2S0Oopp+8tFFaIgkT7z/7tD9F+lFFW9hdSKX7o+tJP2oorPoyl0K8n+rNV260UVk9jRbFdP8AXXH4fypjUUVkX0Z//9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Unilateral eyelid edema is the Roma&ntilde;a's sign of Trypanosoma cruzi infection. This agent causes Chagas' disease and is found in Central and South America.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Joy D Jester, Rolando E Saenz, Lee T Nesbitt, Jr, and WA Krotoski. The Skin and Infection: A Color Atlas and Text, Sanders CV, Nesbitt LT Jr (Eds), Williams &amp; Wilkins, Baltimore, 1995.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f11_27_11711=[""].join("\n");
var outline_f11_27_11711=null;
